"","ID","DESC.x","DATE.x","DATE.y","CODE","DESC.y","HT.in","WT.in","AGE","GENDER","Og_RACE","CRF","BMI","first_visit_date","last_visit_date","num_visits_before_frac","num_visits_after_frac","osteo_med_start_date","osteo_med_start_dose","osteo_med_last_date","osteo_med_name"
"1","36994","Dual-energy X-ray absorptiometry (DXA), bone density study, 1 or more sites; axial skeleton (eg, hips, pelvis, spine)",2017-04-20 15:41:00,2017-01-30 00:00:00,"M81.0","Age-related osteoporosis without current pathological fracture",62,120.3,66,"F","W",2,22.0007544224766,2012-08-02 00:00:00,2021-03-17 00:00:00,78,419,NA,NA,NA,"Ibandronate 150 Mg Tablet"
"2","36994","Dual-energy X-ray absorptiometry (DXA), bone density study, 1 or more sites; axial skeleton (eg, hips, pelvis, spine)",2019-04-23 13:55:00,2017-01-30 00:00:00,"M81.0","Age-related osteoporosis without current pathological fracture",62,120.3,66,"F","W",2,22.0007544224766,2012-08-02 00:00:00,2021-03-17 00:00:00,78,419,NA,NA,NA,"Ibandronate 150 Mg Tablet"
"3","133349","Dual-energy X-ray absorptiometry (DXA), bone density study, 1 or more sites; axial skeleton (eg, hips, pelvis, spine)",2017-05-02 10:05:00,2017-04-05 00:00:00,"M81.0","Age-related osteoporosis without current pathological fracture",59,130.9,67,"F","W",4,26.4357081298477,2016-02-25 11:30:00,2021-03-28 01:42:00,29,1013,NA,NA,NA,"Denosumab 60 Mg/Ml Subcutaneous Syringe"
"4","144717","Dual-energy X-ray absorptiometry (DXA), bone density study, 1 or more sites; axial skeleton (eg, hips, pelvis, spine)",2018-05-31 10:52:00,2017-02-21 11:30:00,"823.21","Closed fracture of shaft of fibula alone",65,160.8,83,"F","W",3,26.7555976331361,1996-07-02 14:45:00,2021-03-28 10:04:00,5,720,NA,NA,NA,NA
"5","196653","Dual-energy X-ray absorptiometry (DXA), bone density study, 1 or more sites; axial skeleton (eg, hips, pelvis, spine)",2019-07-23 08:22:00,2017-05-03 00:00:00,"M81.0","Age-related osteoporosis without current pathological fracture",65,166.4,77,"F","W",3,27.6873846153846,1994-11-10 10:45:00,2020-05-07 12:10:00,18,861,NA,NA,NA,"Alendronate 70 Mg Tablet"
"6","202422","Dual-energy X-ray absorptiometry (DXA), bone density study, 1 or more sites; axial skeleton (eg, hips, pelvis, spine)",2016-02-02 11:27:00,2015-09-03 00:00:00,"805.4","Closed fracture of lumbar vertebra without mention of spinal cord injury",66,166.7,67,"F","W",4,26.903145087236,2011-03-22 00:00:00,2018-03-26 00:00:00,522,541,NA,NA,NA,NA
"7","202422","Dual-energy X-ray absorptiometry (DXA), bone density study, 1 or more sites; axial skeleton (eg, hips, pelvis, spine)",2016-02-02 11:34:00,2015-09-03 00:00:00,"805.4","Closed fracture of lumbar vertebra without mention of spinal cord injury",66,166.7,67,"F","W",4,26.903145087236,2011-03-22 00:00:00,2018-03-26 00:00:00,522,541,NA,NA,NA,NA
"8","229176","Dual-energy X-ray absorptiometry (DXA), bone density study, 1 or more sites; axial skeleton (eg, hips, pelvis, spine)",2018-07-17 14:43:00,2017-04-25 00:00:00,"Z87.81","Personal history of (healed) traumatic fracture",65,135.3,66,"F","W",3,22.5126390532544,2016-03-22 15:00:00,2021-03-29 00:00:00,8,1220,NA,NA,NA,"Alendronate 70 Mg Tablet"
"9","239865","Dual-energy X-ray absorptiometry (DXA), bone density study, 1 or more sites; axial skeleton (eg, hips, pelvis, spine)",2015-08-24 08:47:00,2011-09-07 00:00:00,"823.80","Closed fracture of unspecified part of tibia alone",62,134.2,56,"F","W",3,24.5428199791883,2000-12-21 00:00:00,2021-03-26 00:00:00,3,231,NA,NA,NA,"Denosumab 60 Mg/Ml Subcutaneous Syringe"
"10","239865","Dual-energy X-ray absorptiometry (DXA), bone density study, 1 or more sites; axial skeleton (eg, hips, pelvis, spine)",2015-08-24 09:27:00,2011-09-07 00:00:00,"823.80","Closed fracture of unspecified part of tibia alone",62,134.2,56,"F","W",3,24.5428199791883,2000-12-21 00:00:00,2021-03-26 00:00:00,3,231,NA,NA,NA,"Denosumab 60 Mg/Ml Subcutaneous Syringe"
"11","239865","Dual-energy X-ray absorptiometry (DXA), bone density study, 1 or more sites; axial skeleton (eg, hips, pelvis, spine)",2019-10-21 10:43:00,2011-09-07 00:00:00,"823.80","Closed fracture of unspecified part of tibia alone",62,134.2,56,"F","W",3,24.5428199791883,2000-12-21 00:00:00,2021-03-26 00:00:00,3,231,NA,NA,NA,"Denosumab 60 Mg/Ml Subcutaneous Syringe"
"12","239865","Dual-energy X-ray absorptiometry (DXA), bone density study, 1 or more sites; axial skeleton (eg, hips, pelvis, spine)",2019-10-21 10:53:00,2011-09-07 00:00:00,"823.80","Closed fracture of unspecified part of tibia alone",62,134.2,56,"F","W",3,24.5428199791883,2000-12-21 00:00:00,2021-03-26 00:00:00,3,231,NA,NA,NA,"Denosumab 60 Mg/Ml Subcutaneous Syringe"
"13","270379","Dual-energy X-ray absorptiometry (DXA), bone density study, 1 or more sites; axial skeleton (eg, hips, pelvis, spine)",2020-10-15 13:02:00,2017-01-04 00:00:00,"M80.059A","Age-related osteoporosis with current pathological fracture, unspecified femur, initial encounter for fracture",63,181.4,56,"F","W",4,32.1300579491056,2011-07-14 00:00:00,2020-10-15 13:02:00,15,217,NA,NA,NA,"Alendronate 70 Mg Tablet"
"14","325835","Dual-energy X-ray absorptiometry (DXA), bone density study, 1 or more sites; axial skeleton (eg, hips, pelvis, spine)",2020-10-06 10:42:00,2020-07-17 11:50:00,"M97.11XA","Periprosthetic fracture around internal prosthetic right knee joint, initial encounter",67.25,181.6,66,"F","W",5,28.2284213872113,1990-07-27 06:30:00,2021-03-29 00:00:00,161,357,NA,NA,NA,"Denosumab 60 Mg/Ml Subcutaneous Syringe"
"15","325835","Dual-energy X-ray absorptiometry (DXA), bone density study, 1 or more sites; axial skeleton (eg, hips, pelvis, spine)",2020-10-06 10:50:00,2020-07-17 11:50:00,"M97.11XA","Periprosthetic fracture around internal prosthetic right knee joint, initial encounter",67.25,181.6,66,"F","W",5,28.2284213872113,1990-07-27 06:30:00,2021-03-29 00:00:00,161,357,NA,NA,NA,"Denosumab 60 Mg/Ml Subcutaneous Syringe"
"16","341279","Dual-energy X-ray absorptiometry (DXA), bone density study, 1 or more sites; axial skeleton (eg, hips, pelvis, spine)",2019-06-25 14:15:00,2019-03-12 19:53:00,"805.4","Closed fracture of lumbar vertebra without mention of spinal cord injury",66.5,152.8,89,"F","W",3,24.290440386681,1995-08-14 10:00:00,2021-02-08 18:37:00,165,553,NA,NA,NA,"Zoledronic Acid 5 Mg/100 Ml In Mannitol 5 % And Water Intravenous"
"17","360370","Dual-energy X-ray absorptiometry (DXA), bone density study, 1 or more sites; axial skeleton (eg, hips, pelvis, spine)",2020-02-27 15:22:00,1989-03-23 15:54:00,"905.3","Late effect of fracture of neck of femur",62,155.4,32,"F","W",3,28.4199271592092,1989-03-23 15:54:00,2021-02-23 13:28:00,0,133,NA,NA,NA,NA
"18","388907","Dual-energy X-ray absorptiometry (DXA), bone density study, 1 or more sites; axial skeleton (eg, hips, pelvis, spine)",2018-03-08 15:41:00,2018-02-20 18:32:00,"808.2","Closed fracture of pubis",62.008,124.5,80,"F","W",4,22.7629858639937,2013-06-19 00:00:00,2021-03-23 09:00:00,346,933,NA,NA,NA,"Teriparatide 20 Mcg/Dose (600 Mcg/2.4 Ml) Subcutaneous Pen Injector"
"19","388907","Dual-energy X-ray absorptiometry (DXA), bone density study, 1 or more sites; axial skeleton (eg, hips, pelvis, spine)",2018-03-08 15:49:00,2018-02-20 18:32:00,"808.2","Closed fracture of pubis",62.008,124.5,80,"F","W",4,22.7629858639937,2013-06-19 00:00:00,2021-03-23 09:00:00,346,933,NA,NA,NA,"Teriparatide 20 Mcg/Dose (600 Mcg/2.4 Ml) Subcutaneous Pen Injector"
"20","388907","Dual-energy X-ray absorptiometry (DXA), bone density study, 1 or more sites; axial skeleton (eg, hips, pelvis, spine)",2020-07-14 10:21:00,2018-02-20 18:32:00,"808.2","Closed fracture of pubis",62.008,124.5,80,"F","W",4,22.7629858639937,2013-06-19 00:00:00,2021-03-23 09:00:00,346,933,NA,NA,NA,"Teriparatide 20 Mcg/Dose (600 Mcg/2.4 Ml) Subcutaneous Pen Injector"
"21","388907","Dual-energy X-ray absorptiometry (DXA), bone density study, 1 or more sites; axial skeleton (eg, hips, pelvis, spine)",2020-07-14 10:28:00,2018-02-20 18:32:00,"808.2","Closed fracture of pubis",62.008,124.5,80,"F","W",4,22.7629858639937,2013-06-19 00:00:00,2021-03-23 09:00:00,346,933,NA,NA,NA,"Teriparatide 20 Mcg/Dose (600 Mcg/2.4 Ml) Subcutaneous Pen Injector"
"22","414281","Dual-energy X-ray absorptiometry (DXA), bone density study, 1 or more sites; axial skeleton (eg, hips, pelvis, spine)",2020-01-08 12:49:00,2019-10-23 10:14:00,"821.00","Closed fracture of unspecified part of femur",66,131.2,85,"F","W",4,21.1739210284665,2013-05-13 00:00:00,2020-09-14 00:00:00,62,797,NA,NA,NA,NA
"23","414281","Dual-energy X-ray absorptiometry (DXA), bone density study, 1 or more sites; axial skeleton (eg, hips, pelvis, spine)",2020-01-08 12:59:00,2019-10-23 10:14:00,"821.00","Closed fracture of unspecified part of femur",66,131.2,85,"F","W",4,21.1739210284665,2013-05-13 00:00:00,2020-09-14 00:00:00,62,797,NA,NA,NA,NA
"24","435023","Dual-energy X-ray absorptiometry (DXA), bone density study, 1 or more sites; axial skeleton (eg, hips, pelvis, spine)",2019-04-08 08:57:00,2019-01-24 15:01:00,"733.14","Pathologic fracture of neck of femur",50,123.3,88,"F","W",3,34.67196,2016-01-20 11:20:00,2021-01-22 11:11:00,148,292,NA,NA,NA,NA
"25","461114","Dual-energy X-ray absorptiometry (DXA), bone density study, 1 or more sites; axial skeleton (eg, hips, pelvis, spine)",2011-10-03 00:00:00,2011-12-13 11:00:00,"733.14","Pathologic fracture of neck of femur",65,171.5,54,"F","B",4,28.5359763313609,2010-08-06 00:00:00,2012-10-19 16:00:00,191,387,NA,NA,NA,NA
"26","461114","Dual-energy X-ray absorptiometry (DXA), bone density study, 1 or more sites; axial skeleton (eg, hips, pelvis, spine)",2011-10-03 00:00:00,2011-12-13 11:00:00,"733.14","Pathologic fracture of neck of femur",65,171.5,54,"F","B",4,28.5359763313609,2010-08-06 00:00:00,2012-10-19 16:00:00,191,387,NA,NA,NA,NA
"27","533264","Dual-energy X-ray absorptiometry (DXA), bone density study, 1 or more sites; axial skeleton (eg, hips, pelvis, spine)",2015-01-27 11:00:00,2014-11-28 16:08:00,"820.8","Closed fracture of unspecified part of neck of femur",75,190.5,73,"M","W",3,23.8082666666667,2000-09-18 00:00:00,2021-03-23 00:00:00,12,948,NA,NA,NA,"Alendronate 70 Mg Tablet"
"28","533264","Dual-energy X-ray absorptiometry (DXA), bone density study, 1 or more sites; axial skeleton (eg, hips, pelvis, spine)",2015-01-27 11:09:00,2014-11-28 16:08:00,"820.8","Closed fracture of unspecified part of neck of femur",75,190.5,73,"M","W",3,23.8082666666667,2000-09-18 00:00:00,2021-03-23 00:00:00,12,948,NA,NA,NA,"Alendronate 70 Mg Tablet"
"29","533264","Dual-energy X-ray absorptiometry (DXA), bone density study, 1 or more sites; axial skeleton (eg, hips, pelvis, spine)",2017-05-03 13:53:00,2014-11-28 16:08:00,"820.8","Closed fracture of unspecified part of neck of femur",75,190.5,73,"M","W",3,23.8082666666667,2000-09-18 00:00:00,2021-03-23 00:00:00,12,948,NA,NA,NA,"Alendronate 70 Mg Tablet"
"30","533264","Dual-energy X-ray absorptiometry (DXA), bone density study, 1 or more sites; axial skeleton (eg, hips, pelvis, spine)",2017-05-03 14:00:00,2014-11-28 16:08:00,"820.8","Closed fracture of unspecified part of neck of femur",75,190.5,73,"M","W",3,23.8082666666667,2000-09-18 00:00:00,2021-03-23 00:00:00,12,948,NA,NA,NA,"Alendronate 70 Mg Tablet"
"31","533264","Dual-energy X-ray absorptiometry (DXA), bone density study, 1 or more sites; axial skeleton (eg, hips, pelvis, spine)",2019-05-08 08:45:00,2014-11-28 16:08:00,"820.8","Closed fracture of unspecified part of neck of femur",75,190.5,73,"M","W",3,23.8082666666667,2000-09-18 00:00:00,2021-03-23 00:00:00,12,948,NA,NA,NA,"Alendronate 70 Mg Tablet"
"32","533264","Dual-energy X-ray absorptiometry (DXA), bone density study, 1 or more sites; axial skeleton (eg, hips, pelvis, spine)",2019-05-08 08:50:00,2014-11-28 16:08:00,"820.8","Closed fracture of unspecified part of neck of femur",75,190.5,73,"M","W",3,23.8082666666667,2000-09-18 00:00:00,2021-03-23 00:00:00,12,948,NA,NA,NA,"Alendronate 70 Mg Tablet"
"33","554139","Dual-energy X-ray absorptiometry (DXA), bone density study, 1 or more sites; axial skeleton (eg, hips, pelvis, spine)",2020-08-03 09:08:00,2017-01-14 00:00:00,"M81.0","Age-related osteoporosis without current pathological fracture",64,207.3,62,"F","W",3,35.5790771484375,1988-08-30 10:05:00,2021-03-29 00:00:00,29,173,NA,NA,NA,NA
"34","578832","Dual-energy X-ray absorptiometry (DXA), bone density study, 1 or more sites; axial skeleton (eg, hips, pelvis, spine)",2015-12-23 13:00:00,2015-11-24 00:00:00,"M81.0","Age-related osteoporosis without current pathological fracture",61,112,83,"F","W",5,21.159903251814,2011-08-12 00:00:00,2021-03-25 00:00:00,415,781,NA,NA,NA,NA
"35","578832","Dual-energy X-ray absorptiometry (DXA), bone density study, 1 or more sites; axial skeleton (eg, hips, pelvis, spine)",2015-12-23 13:13:00,2015-11-24 00:00:00,"M81.0","Age-related osteoporosis without current pathological fracture",61,112,83,"F","W",5,21.159903251814,2011-08-12 00:00:00,2021-03-25 00:00:00,415,781,NA,NA,NA,NA
"36","588391","Dual-energy X-ray absorptiometry (DXA), bone density study, 1 or more sites; axial skeleton (eg, hips, pelvis, spine)",2014-08-22 09:41:00,2014-07-24 19:28:00,"820.8","Closed fracture of unspecified part of neck of femur",65,140.3,67,"F","W",3,23.3445917159763,2013-07-17 00:00:00,2020-11-27 05:25:00,288,792,NA,NA,NA,"Teriparatide 20 Mcg/Dose (600 Mcg/2.4 Ml) Subcutaneous Pen Injector"
"37","588391","Dual-energy X-ray absorptiometry (DXA), bone density study, 1 or more sites; axial skeleton (eg, hips, pelvis, spine)",2014-08-22 10:03:00,2014-07-24 19:28:00,"820.8","Closed fracture of unspecified part of neck of femur",65,140.3,67,"F","W",3,23.3445917159763,2013-07-17 00:00:00,2020-11-27 05:25:00,288,792,NA,NA,NA,"Teriparatide 20 Mcg/Dose (600 Mcg/2.4 Ml) Subcutaneous Pen Injector"
"38","588391","Dual-energy X-ray absorptiometry (DXA), bone density study, 1 or more sites; axial skeleton (eg, hips, pelvis, spine)",2017-09-07 12:43:00,2014-07-24 19:28:00,"820.8","Closed fracture of unspecified part of neck of femur",65,140.3,67,"F","W",3,23.3445917159763,2013-07-17 00:00:00,2020-11-27 05:25:00,288,792,NA,NA,NA,"Teriparatide 20 Mcg/Dose (600 Mcg/2.4 Ml) Subcutaneous Pen Injector"
"39","588391","Dual-energy X-ray absorptiometry (DXA), bone density study, 1 or more sites; axial skeleton (eg, hips, pelvis, spine)",2017-09-07 13:00:00,2014-07-24 19:28:00,"820.8","Closed fracture of unspecified part of neck of femur",65,140.3,67,"F","W",3,23.3445917159763,2013-07-17 00:00:00,2020-11-27 05:25:00,288,792,NA,NA,NA,"Teriparatide 20 Mcg/Dose (600 Mcg/2.4 Ml) Subcutaneous Pen Injector"
"40","590408","Dual-energy X-ray absorptiometry (DXA), bone density study, 1 or more sites; axial skeleton (eg, hips, pelvis, spine)",2019-02-04 09:44:00,2016-11-07 09:12:00,"733.14","Pathologic fracture of neck of femur",68,280,85,"M","W",3,42.5692041522491,2010-07-30 00:00:00,2021-03-16 11:58:00,759,452,NA,NA,NA,"Alendronate 70 Mg Tablet"
"41","622244","Dual-energy X-ray absorptiometry (DXA), bone density study, 1 or more sites; axial skeleton (eg, hips, pelvis, spine)",2015-11-18 12:33:00,2015-07-20 22:44:00,"820.21","Closed fracture of intertrochanteric section of neck of femur",71,223.6,56,"M","W",4,31.1824637968657,1995-12-04 18:34:00,2015-11-18 12:33:00,30,909,NA,NA,NA,NA
"42","622244","Dual-energy X-ray absorptiometry (DXA), bone density study, 1 or more sites; axial skeleton (eg, hips, pelvis, spine)",2015-11-18 12:59:00,2015-07-20 22:44:00,"820.21","Closed fracture of intertrochanteric section of neck of femur",71,223.6,56,"M","W",4,31.1824637968657,1995-12-04 18:34:00,2015-11-18 12:33:00,30,909,NA,NA,NA,NA
"43","625564","Dual-energy X-ray absorptiometry (DXA), bone density study, 1 or more sites; axial skeleton (eg, hips, pelvis, spine)",2013-11-15 12:00:00,2013-09-18 00:00:00,"820.8","Closed fracture of unspecified part of neck of femur",65.945,193.8,53,"F","W",4,31.3289148650029,2002-04-16 00:00:00,2021-03-24 00:00:00,352,1305,NA,NA,NA,"Teriparatide 20 Mcg/Dose (600 Mcg/2.4 Ml) Subcutaneous Pen Injector"
"44","625564","Dual-energy X-ray absorptiometry (DXA), bone density study, 1 or more sites; axial skeleton (eg, hips, pelvis, spine)",2013-11-15 14:24:00,2013-09-18 00:00:00,"820.8","Closed fracture of unspecified part of neck of femur",65.945,193.8,53,"F","W",4,31.3289148650029,2002-04-16 00:00:00,2021-03-24 00:00:00,352,1305,NA,NA,NA,"Teriparatide 20 Mcg/Dose (600 Mcg/2.4 Ml) Subcutaneous Pen Injector"
"45","625564","Dual-energy X-ray absorptiometry (DXA), bone density study, 1 or more sites; axial skeleton (eg, hips, pelvis, spine)",2016-03-02 13:48:00,2013-09-18 00:00:00,"820.8","Closed fracture of unspecified part of neck of femur",65.945,193.8,53,"F","W",4,31.3289148650029,2002-04-16 00:00:00,2021-03-24 00:00:00,352,1305,NA,NA,NA,"Teriparatide 20 Mcg/Dose (600 Mcg/2.4 Ml) Subcutaneous Pen Injector"
"46","625564","Dual-energy X-ray absorptiometry (DXA), bone density study, 1 or more sites; axial skeleton (eg, hips, pelvis, spine)",2016-03-02 14:07:00,2013-09-18 00:00:00,"820.8","Closed fracture of unspecified part of neck of femur",65.945,193.8,53,"F","W",4,31.3289148650029,2002-04-16 00:00:00,2021-03-24 00:00:00,352,1305,NA,NA,NA,"Teriparatide 20 Mcg/Dose (600 Mcg/2.4 Ml) Subcutaneous Pen Injector"
"47","724790","Dual-energy X-ray absorptiometry (DXA), bone density study, 1 or more sites; axial skeleton (eg, hips, pelvis, spine)",2018-07-13 13:45:00,2012-04-26 14:30:00,"733.13","Pathologic fracture of vertebrae",60.984,185,70,"F","W",4,34.9699684025826,2002-09-23 00:00:00,2021-03-17 19:00:00,188,1635,NA,NA,NA,"Denosumab 60 Mg/Ml Subcutaneous Syringe"
"48","724790","Dual-energy X-ray absorptiometry (DXA), bone density study, 1 or more sites; axial skeleton (eg, hips, pelvis, spine)",2018-07-13 14:01:00,2012-04-26 14:30:00,"733.13","Pathologic fracture of vertebrae",60.984,185,70,"F","W",4,34.9699684025826,2002-09-23 00:00:00,2021-03-17 19:00:00,188,1635,NA,NA,NA,"Denosumab 60 Mg/Ml Subcutaneous Syringe"
"49","799985","Dual-energy X-ray absorptiometry (DXA), bone density study, 1 or more sites; axial skeleton (eg, hips, pelvis, spine)",2018-07-17 11:07:00,2018-02-28 00:00:00,"S32.010D","Wedge compression fracture of first lumbar vertebra, subsequent encounter for fracture with routine healing",71,202.8,76,"M","W",4,28.2817694901805,2003-10-02 00:00:00,2019-06-10 16:55:00,688,2272,NA,NA,NA,NA
"50","875085","Dual-energy X-ray absorptiometry (DXA), bone density study, 1 or more sites; axial skeleton (eg, hips, pelvis, spine)",2019-09-06 10:33:00,1989-06-17 00:15:00,"820.32","Open fracture of subtrochanteric section of neck of femur",64,245,31,"F","W",3,42.049560546875,1989-06-17 00:15:00,2021-03-15 12:27:00,0,433,NA,NA,NA,NA
"51","891488","Dual-energy X-ray absorptiometry (DXA), bone density study, 1 or more sites; axial skeleton (eg, hips, pelvis, spine)",2019-08-13 10:58:00,2019-07-01 11:50:00,"733.14","Pathologic fracture of neck of femur",64,97.4,78,"F","W",3,16.716845703125,1992-09-21 10:26:00,2020-09-01 12:53:00,272,460,NA,NA,NA,"Conjugated Estrogens 0.625 Mg/Gram Vaginal Cream"
"52","912302","Dual-energy X-ray absorptiometry (DXA), bone density study, 1 or more sites; axial skeleton (eg, hips, pelvis, spine)",2015-02-25 15:27:00,2013-03-12 19:52:00,"820.8","Closed fracture of unspecified part of neck of femur",59,132.7,70,"F","W",4,26.7992243608159,2005-03-24 00:00:00,2021-03-15 17:12:00,6,4899,NA,NA,NA,"Denosumab 60 Mg/Ml Subcutaneous Syringe"
"53","912302","Dual-energy X-ray absorptiometry (DXA), bone density study, 1 or more sites; axial skeleton (eg, hips, pelvis, spine)",2015-02-25 15:50:00,2013-03-12 19:52:00,"820.8","Closed fracture of unspecified part of neck of femur",59,132.7,70,"F","W",4,26.7992243608159,2005-03-24 00:00:00,2021-03-15 17:12:00,6,4899,NA,NA,NA,"Denosumab 60 Mg/Ml Subcutaneous Syringe"
"54","912302","Dual-energy X-ray absorptiometry (DXA), bone density study, 1 or more sites; axial skeleton (eg, hips, pelvis, spine)",2017-04-27 13:57:00,2013-03-12 19:52:00,"820.8","Closed fracture of unspecified part of neck of femur",59,132.7,70,"F","W",4,26.7992243608159,2005-03-24 00:00:00,2021-03-15 17:12:00,6,4899,NA,NA,NA,"Denosumab 60 Mg/Ml Subcutaneous Syringe"
"55","912302","Dual-energy X-ray absorptiometry (DXA), bone density study, 1 or more sites; axial skeleton (eg, hips, pelvis, spine)",2017-04-27 14:32:00,2013-03-12 19:52:00,"820.8","Closed fracture of unspecified part of neck of femur",59,132.7,70,"F","W",4,26.7992243608159,2005-03-24 00:00:00,2021-03-15 17:12:00,6,4899,NA,NA,NA,"Denosumab 60 Mg/Ml Subcutaneous Syringe"
"56","912302","Dual-energy X-ray absorptiometry (DXA), bone density study, 1 or more sites; axial skeleton (eg, hips, pelvis, spine)",2018-05-31 14:00:00,2013-03-12 19:52:00,"820.8","Closed fracture of unspecified part of neck of femur",59,132.7,70,"F","W",4,26.7992243608159,2005-03-24 00:00:00,2021-03-15 17:12:00,6,4899,NA,NA,NA,"Denosumab 60 Mg/Ml Subcutaneous Syringe"
"57","912302","Dual-energy X-ray absorptiometry (DXA), bone density study, 1 or more sites; axial skeleton (eg, hips, pelvis, spine)",2018-05-31 14:04:00,2013-03-12 19:52:00,"820.8","Closed fracture of unspecified part of neck of femur",59,132.7,70,"F","W",4,26.7992243608159,2005-03-24 00:00:00,2021-03-15 17:12:00,6,4899,NA,NA,NA,"Denosumab 60 Mg/Ml Subcutaneous Syringe"
"58","912302","Dual-energy X-ray absorptiometry (DXA), bone density study, 1 or more sites; axial skeleton (eg, hips, pelvis, spine)",2019-06-06 13:00:00,2013-03-12 19:52:00,"820.8","Closed fracture of unspecified part of neck of femur",59,132.7,70,"F","W",4,26.7992243608159,2005-03-24 00:00:00,2021-03-15 17:12:00,6,4899,NA,NA,NA,"Denosumab 60 Mg/Ml Subcutaneous Syringe"
"59","912302","Dual-energy X-ray absorptiometry (DXA), bone density study, 1 or more sites; axial skeleton (eg, hips, pelvis, spine)",2019-06-06 13:06:00,2013-03-12 19:52:00,"820.8","Closed fracture of unspecified part of neck of femur",59,132.7,70,"F","W",4,26.7992243608159,2005-03-24 00:00:00,2021-03-15 17:12:00,6,4899,NA,NA,NA,"Denosumab 60 Mg/Ml Subcutaneous Syringe"
"60","914437","Dual-energy X-ray absorptiometry (DXA), bone density study, 1 or more sites; axial skeleton (eg, hips, pelvis, spine)",2017-07-31 10:53:00,2017-07-27 00:00:00,"M84.359D","Stress fracture, hip, unspecified, subsequent encounter for fracture with routine healing",64,129.3,61,"F","W",4,22.1918701171875,1991-12-23 12:06:00,2021-03-22 09:21:00,42,474,NA,NA,NA,"Teriparatide 20 Mcg/Dose (600 Mcg/2.4 Ml) Subcutaneous Pen Injector"
"61","914437","Dual-energy X-ray absorptiometry (DXA), bone density study, 1 or more sites; axial skeleton (eg, hips, pelvis, spine)",2017-07-31 11:25:00,2017-07-27 00:00:00,"M84.359D","Stress fracture, hip, unspecified, subsequent encounter for fracture with routine healing",64,129.3,61,"F","W",4,22.1918701171875,1991-12-23 12:06:00,2021-03-22 09:21:00,42,474,NA,NA,NA,"Teriparatide 20 Mcg/Dose (600 Mcg/2.4 Ml) Subcutaneous Pen Injector"
"62","914437","Dual-energy X-ray absorptiometry (DXA), bone density study, 1 or more sites; axial skeleton (eg, hips, pelvis, spine)",2019-06-17 09:30:00,2017-07-27 00:00:00,"M84.359D","Stress fracture, hip, unspecified, subsequent encounter for fracture with routine healing",64,129.3,61,"F","W",4,22.1918701171875,1991-12-23 12:06:00,2021-03-22 09:21:00,42,474,NA,NA,NA,"Teriparatide 20 Mcg/Dose (600 Mcg/2.4 Ml) Subcutaneous Pen Injector"
"63","914437","Dual-energy X-ray absorptiometry (DXA), bone density study, 1 or more sites; axial skeleton (eg, hips, pelvis, spine)",2019-06-17 09:58:00,2017-07-27 00:00:00,"M84.359D","Stress fracture, hip, unspecified, subsequent encounter for fracture with routine healing",64,129.3,61,"F","W",4,22.1918701171875,1991-12-23 12:06:00,2021-03-22 09:21:00,42,474,NA,NA,NA,"Teriparatide 20 Mcg/Dose (600 Mcg/2.4 Ml) Subcutaneous Pen Injector"
"64","914437","Dual-energy X-ray absorptiometry (DXA), bone density study, 1 or more sites; axial skeleton (eg, hips, pelvis, spine)",2020-06-24 07:21:00,2017-07-27 00:00:00,"M84.359D","Stress fracture, hip, unspecified, subsequent encounter for fracture with routine healing",64,129.3,61,"F","W",4,22.1918701171875,1991-12-23 12:06:00,2021-03-22 09:21:00,42,474,NA,NA,NA,"Teriparatide 20 Mcg/Dose (600 Mcg/2.4 Ml) Subcutaneous Pen Injector"
"65","914437","Dual-energy X-ray absorptiometry (DXA), bone density study, 1 or more sites; axial skeleton (eg, hips, pelvis, spine)",2020-06-24 07:31:00,2017-07-27 00:00:00,"M84.359D","Stress fracture, hip, unspecified, subsequent encounter for fracture with routine healing",64,129.3,61,"F","W",4,22.1918701171875,1991-12-23 12:06:00,2021-03-22 09:21:00,42,474,NA,NA,NA,"Teriparatide 20 Mcg/Dose (600 Mcg/2.4 Ml) Subcutaneous Pen Injector"
"66","930111","Dual-energy X-ray absorptiometry (DXA), bone density study, 1 or more sites; axial skeleton (eg, hips, pelvis, spine)",2021-03-24 11:29:00,2011-05-27 00:00:00,"805.4","Closed fracture of lumbar vertebra without mention of spinal cord injury",72,273.7,48,"M","W",4,37.1163387345679,2002-12-23 00:00:00,2021-03-31 16:36:00,18,952,NA,NA,NA,"Alendronate 70 Mg Tablet"
"67","930111","Dual-energy X-ray absorptiometry (DXA), bone density study, 1 or more sites; axial skeleton (eg, hips, pelvis, spine)",2021-03-24 11:38:00,2011-05-27 00:00:00,"805.4","Closed fracture of lumbar vertebra without mention of spinal cord injury",72,273.7,48,"M","W",4,37.1163387345679,2002-12-23 00:00:00,2021-03-31 16:36:00,18,952,NA,NA,NA,"Alendronate 70 Mg Tablet"
"68","942136","Dual-energy X-ray absorptiometry (DXA), bone density study, 1 or more sites; axial skeleton (eg, hips, pelvis, spine)",2019-06-26 10:37:00,2017-02-07 09:42:00,"M81.0","Age-related osteoporosis without current pathological fracture",63,144.4,80,"F","W",4,25.5765180146133,2012-11-30 00:00:00,2021-03-17 00:00:00,16,187,NA,NA,NA,NA
"69","942862","Dual-energy X-ray absorptiometry (DXA), bone density study, 1 or more sites; axial skeleton (eg, hips, pelvis, spine)",2017-03-01 14:46:00,2016-09-19 00:00:00,"S72.142A","Displaced intertrochanteric fracture of left femur, initial encounter for closed fracture",70,154.2,71,"M","R",3,22.1229795918367,2003-07-17 00:00:00,2021-02-02 00:00:00,841,718,NA,NA,NA,"Teriparatide 20 Mcg/Dose (600 Mcg/2.4 Ml) Subcutaneous Pen Injector"
"70","942862","Dual-energy X-ray absorptiometry (DXA), bone density study, 1 or more sites; axial skeleton (eg, hips, pelvis, spine)",2017-03-01 14:56:00,2016-09-19 00:00:00,"S72.142A","Displaced intertrochanteric fracture of left femur, initial encounter for closed fracture",70,154.2,71,"M","R",3,22.1229795918367,2003-07-17 00:00:00,2021-02-02 00:00:00,841,718,NA,NA,NA,"Teriparatide 20 Mcg/Dose (600 Mcg/2.4 Ml) Subcutaneous Pen Injector"
"71","955901","Dual-energy X-ray absorptiometry (DXA), bone density study, 1 or more sites; axial skeleton (eg, hips, pelvis, spine)",2014-09-24 09:04:00,2019-04-06 18:05:00,"820.21","Closed fracture of intertrochanteric section of neck of femur",60,192.44,86,"F","W",3,37.5792555555556,2012-10-10 00:00:00,2021-03-24 16:26:00,1155,493,NA,NA,NA,"Estrogen receptor positive status [ER+]"
"72","955901","Dual-energy X-ray absorptiometry (DXA), bone density study, 1 or more sites; axial skeleton (eg, hips, pelvis, spine)",2014-09-24 09:17:00,2019-04-06 18:05:00,"820.21","Closed fracture of intertrochanteric section of neck of femur",60,192.44,86,"F","W",3,37.5792555555556,2012-10-10 00:00:00,2021-03-24 16:26:00,1155,493,NA,NA,NA,"Estrogen receptor positive status [ER+]"
"73","955901","Dual-energy X-ray absorptiometry (DXA), bone density study, 1 or more sites; axial skeleton (eg, hips, pelvis, spine)",2015-09-28 09:47:00,2019-04-06 18:05:00,"820.21","Closed fracture of intertrochanteric section of neck of femur",60,192.44,86,"F","W",3,37.5792555555556,2012-10-10 00:00:00,2021-03-24 16:26:00,1155,493,NA,NA,NA,"Estrogen receptor positive status [ER+]"
"74","955901","Dual-energy X-ray absorptiometry (DXA), bone density study, 1 or more sites; axial skeleton (eg, hips, pelvis, spine)",2015-09-28 10:03:00,2019-04-06 18:05:00,"820.21","Closed fracture of intertrochanteric section of neck of femur",60,192.44,86,"F","W",3,37.5792555555556,2012-10-10 00:00:00,2021-03-24 16:26:00,1155,493,NA,NA,NA,"Estrogen receptor positive status [ER+]"
"75","955901","Dual-energy X-ray absorptiometry (DXA), bone density study, 1 or more sites; axial skeleton (eg, hips, pelvis, spine)",2016-09-30 12:43:00,2019-04-06 18:05:00,"820.21","Closed fracture of intertrochanteric section of neck of femur",60,192.44,86,"F","W",3,37.5792555555556,2012-10-10 00:00:00,2021-03-24 16:26:00,1155,493,NA,NA,NA,"Estrogen receptor positive status [ER+]"
"76","955901","Dual-energy X-ray absorptiometry (DXA), bone density study, 1 or more sites; axial skeleton (eg, hips, pelvis, spine)",2016-09-30 12:55:00,2019-04-06 18:05:00,"820.21","Closed fracture of intertrochanteric section of neck of femur",60,192.44,86,"F","W",3,37.5792555555556,2012-10-10 00:00:00,2021-03-24 16:26:00,1155,493,NA,NA,NA,"Estrogen receptor positive status [ER+]"
"77","991072","Dual-energy X-ray absorptiometry (DXA), bone density study, 1 or more sites; axial skeleton (eg, hips, pelvis, spine)",2008-10-28 00:00:00,2017-12-28 00:00:00,"733.14","Pathologic fracture of neck of femur",62,119.9,68,"F","W",3,21.9276014568158,1999-02-21 00:00:00,2021-03-31 00:00:00,813,398,NA,NA,NA,NA
"78","1003708","Dual-energy X-ray absorptiometry (DXA), bone density study, 1 or more sites; axial skeleton (eg, hips, pelvis, spine)",2007-07-12 00:00:00,2019-01-20 20:30:00,"733.14","Pathologic fracture of neck of femur",63,182.4,89,"F","W",3,32.3071806500378,1998-02-06 00:00:00,2019-03-25 13:00:00,219,354,NA,NA,NA,NA
"79","1020834","Dual-energy X-ray absorptiometry (DXA), bone density study, 1 or more sites; axial skeleton (eg, hips, pelvis, spine)",2020-01-06 11:30:00,2019-02-13 00:00:00,"M81.0","Age-related osteoporosis without current pathological fracture",65,139.4,82,"F","W",3,23.1948402366864,2006-06-14 00:00:00,2021-03-31 00:00:00,223,1209,NA,NA,NA,"Zoledronic Acid 5 Mg/100 Ml In Mannitol 5 % And Water Intravenous"
"80","1028313","Dual-energy X-ray absorptiometry (DXA), bone density study, 1 or more sites; axial skeleton (eg, hips, pelvis, spine)",2007-11-06 00:00:00,2015-11-21 13:21:00,"820.8","Closed fracture of unspecified part of neck of femur",65,163.5,87,"F","W",4,27.2048520710059,1993-05-07 09:17:00,2021-03-29 23:09:00,162,677,NA,NA,NA,"Denosumab 60 Mg/Ml Subcutaneous Syringe"
"81","1028313","Dual-energy X-ray absorptiometry (DXA), bone density study, 1 or more sites; axial skeleton (eg, hips, pelvis, spine)",2009-11-18 00:00:00,2015-11-21 13:21:00,"820.8","Closed fracture of unspecified part of neck of femur",65,163.5,87,"F","W",4,27.2048520710059,1993-05-07 09:17:00,2021-03-29 23:09:00,162,677,NA,NA,NA,"Denosumab 60 Mg/Ml Subcutaneous Syringe"
"82","1028313","Dual-energy X-ray absorptiometry (DXA), bone density study, 1 or more sites; axial skeleton (eg, hips, pelvis, spine)",2011-12-14 00:00:00,2015-11-21 13:21:00,"820.8","Closed fracture of unspecified part of neck of femur",65,163.5,87,"F","W",4,27.2048520710059,1993-05-07 09:17:00,2021-03-29 23:09:00,162,677,NA,NA,NA,"Denosumab 60 Mg/Ml Subcutaneous Syringe"
"83","1028313","Dual-energy X-ray absorptiometry (DXA), bone density study, 1 or more sites; axial skeleton (eg, hips, pelvis, spine)",2016-12-29 14:43:00,2015-11-21 13:21:00,"820.8","Closed fracture of unspecified part of neck of femur",65,163.5,87,"F","W",4,27.2048520710059,1993-05-07 09:17:00,2021-03-29 23:09:00,162,677,NA,NA,NA,"Denosumab 60 Mg/Ml Subcutaneous Syringe"
"84","1028313","Dual-energy X-ray absorptiometry (DXA), bone density study, 1 or more sites; axial skeleton (eg, hips, pelvis, spine)",2016-12-29 14:55:00,2015-11-21 13:21:00,"820.8","Closed fracture of unspecified part of neck of femur",65,163.5,87,"F","W",4,27.2048520710059,1993-05-07 09:17:00,2021-03-29 23:09:00,162,677,NA,NA,NA,"Denosumab 60 Mg/Ml Subcutaneous Syringe"
"85","1028313","Dual-energy X-ray absorptiometry (DXA), bone density study, 1 or more sites; axial skeleton (eg, hips, pelvis, spine)",2018-01-19 10:00:00,2015-11-21 13:21:00,"820.8","Closed fracture of unspecified part of neck of femur",65,163.5,87,"F","W",4,27.2048520710059,1993-05-07 09:17:00,2021-03-29 23:09:00,162,677,NA,NA,NA,"Denosumab 60 Mg/Ml Subcutaneous Syringe"
"86","1028313","Dual-energy X-ray absorptiometry (DXA), bone density study, 1 or more sites; axial skeleton (eg, hips, pelvis, spine)",2018-01-19 10:30:00,2015-11-21 13:21:00,"820.8","Closed fracture of unspecified part of neck of femur",65,163.5,87,"F","W",4,27.2048520710059,1993-05-07 09:17:00,2021-03-29 23:09:00,162,677,NA,NA,NA,"Denosumab 60 Mg/Ml Subcutaneous Syringe"
"87","1030377","Dual-energy X-ray absorptiometry (DXA), bone density study, 1 or more sites; axial skeleton (eg, hips, pelvis, spine)",2013-09-16 09:59:00,2014-04-04 00:00:00,"M81.0","Age-related osteoporosis without current pathological fracture",64,154.4,66,"F","W",4,26.4998046875,2000-08-15 14:15:00,2019-04-30 16:29:00,76,1080,NA,NA,NA,NA
"88","1053281","Dual-energy X-ray absorptiometry (DXA), bone density study, 1 or more sites; axial skeleton (eg, hips, pelvis, spine)",2014-06-19 13:31:00,2014-06-16 00:00:00,"M81.0","Age-related osteoporosis without current pathological fracture",66,132.4,87,"F","W",4,21.3675849403122,2006-11-10 11:03:00,2020-12-03 06:45:00,16,734,NA,NA,NA,"Alendronate 70 Mg Tablet"
"89","1053281","Dual-energy X-ray absorptiometry (DXA), bone density study, 1 or more sites; axial skeleton (eg, hips, pelvis, spine)",2014-06-19 13:38:00,2014-06-16 00:00:00,"M81.0","Age-related osteoporosis without current pathological fracture",66,132.4,87,"F","W",4,21.3675849403122,2006-11-10 11:03:00,2020-12-03 06:45:00,16,734,NA,NA,NA,"Alendronate 70 Mg Tablet"
"90","1053281","Dual-energy X-ray absorptiometry (DXA), bone density study, 1 or more sites; axial skeleton (eg, hips, pelvis, spine)",2016-06-22 10:24:00,2014-06-16 00:00:00,"M81.0","Age-related osteoporosis without current pathological fracture",66,132.4,87,"F","W",4,21.3675849403122,2006-11-10 11:03:00,2020-12-03 06:45:00,16,734,NA,NA,NA,"Alendronate 70 Mg Tablet"
"91","1053281","Dual-energy X-ray absorptiometry (DXA), bone density study, 1 or more sites; axial skeleton (eg, hips, pelvis, spine)",2016-06-22 10:40:00,2014-06-16 00:00:00,"M81.0","Age-related osteoporosis without current pathological fracture",66,132.4,87,"F","W",4,21.3675849403122,2006-11-10 11:03:00,2020-12-03 06:45:00,16,734,NA,NA,NA,"Alendronate 70 Mg Tablet"
"92","1053820","Dual-energy X-ray absorptiometry (DXA), bone density study, 1 or more sites; axial skeleton (eg, hips, pelvis, spine)",2019-01-29 15:22:00,2017-01-13 00:00:00,"M81.0","Age-related osteoporosis without current pathological fracture",62.75,124.4,75,"F","W",3,22.2099839685084,2006-10-25 00:00:00,2021-03-03 00:00:00,21,409,NA,NA,NA,"Alendronate 70 Mg Tablet"
"93","1065826","Dual-energy X-ray absorptiometry (DXA), bone density study, 1 or more sites; axial skeleton (eg, hips, pelvis, spine)",2011-03-10 00:00:00,2018-03-10 17:44:00,"M84.452A","Pathological fracture, left femur, initial encounter for fracture",66,176,81,"F","W",3,28.4040404040404,1993-11-10 11:25:00,2021-03-18 00:00:00,1187,965,NA,NA,NA,"Denosumab 60 Mg/Ml Subcutaneous Syringe"
"94","1065826","Dual-energy X-ray absorptiometry (DXA), bone density study, 1 or more sites; axial skeleton (eg, hips, pelvis, spine)",2011-03-10 00:00:00,2018-03-10 17:44:00,"M84.452A","Pathological fracture, left femur, initial encounter for fracture",66,176,81,"F","W",3,28.4040404040404,1993-11-10 11:25:00,2021-03-18 00:00:00,1187,965,NA,NA,NA,"Denosumab 60 Mg/Ml Subcutaneous Syringe"
"95","1070054","Dual-energy X-ray absorptiometry (DXA), bone density study, 1 or more sites; axial skeleton (eg, hips, pelvis, spine)",2016-12-07 14:34:00,2015-04-14 00:00:00,"807.01","Closed fracture of one rib",70,167,69,"M","W",4,23.959387755102,2000-09-28 17:35:00,2021-03-31 13:15:00,302,939,NA,NA,NA,"Alendronate 70 Mg Tablet"
"96","1070054","Dual-energy X-ray absorptiometry (DXA), bone density study, 1 or more sites; axial skeleton (eg, hips, pelvis, spine)",2016-12-07 14:37:00,2015-04-14 00:00:00,"807.01","Closed fracture of one rib",70,167,69,"M","W",4,23.959387755102,2000-09-28 17:35:00,2021-03-31 13:15:00,302,939,NA,NA,NA,"Alendronate 70 Mg Tablet"
"97","1070054","Dual-energy X-ray absorptiometry (DXA), bone density study, 1 or more sites; axial skeleton (eg, hips, pelvis, spine)",2018-08-30 12:35:00,2015-04-14 00:00:00,"807.01","Closed fracture of one rib",70,167,69,"M","W",4,23.959387755102,2000-09-28 17:35:00,2021-03-31 13:15:00,302,939,NA,NA,NA,"Alendronate 70 Mg Tablet"
"98","1070054","Dual-energy X-ray absorptiometry (DXA), bone density study, 1 or more sites; axial skeleton (eg, hips, pelvis, spine)",2018-08-30 12:52:00,2015-04-14 00:00:00,"807.01","Closed fracture of one rib",70,167,69,"M","W",4,23.959387755102,2000-09-28 17:35:00,2021-03-31 13:15:00,302,939,NA,NA,NA,"Alendronate 70 Mg Tablet"
"99","1073140","Dual-energy X-ray absorptiometry (DXA), bone density study, 1 or more sites; axial skeleton (eg, hips, pelvis, spine)",2017-10-26 14:37:00,2017-09-12 00:00:00,"S72.002A","Fracture of unspecified part of neck of left femur, initial encounter for closed fracture",69,190.5,82,"M","W",4,28.1288594833018,1996-10-20 00:00:00,2019-01-28 00:00:00,1663,556,NA,NA,NA,NA
"100","1073140","Dual-energy X-ray absorptiometry (DXA), bone density study, 1 or more sites; axial skeleton (eg, hips, pelvis, spine)",2017-10-26 14:58:00,2017-09-12 00:00:00,"S72.002A","Fracture of unspecified part of neck of left femur, initial encounter for closed fracture",69,190.5,82,"M","W",4,28.1288594833018,1996-10-20 00:00:00,2019-01-28 00:00:00,1663,556,NA,NA,NA,NA
"101","1106152","Dual-energy X-ray absorptiometry (DXA), bone density study, 1 or more sites; axial skeleton (eg, hips, pelvis, spine)",2009-02-10 00:00:00,2012-09-19 09:20:00,"M81.0","Age-related osteoporosis without current pathological fracture",64,170,75,"F","W",4,29.17724609375,1998-05-04 00:00:00,2021-03-23 00:00:00,177,1013,NA,NA,NA,"Alendronate 70 Mg Tablet"
"102","1106152","Dual-energy X-ray absorptiometry (DXA), bone density study, 1 or more sites; axial skeleton (eg, hips, pelvis, spine)",2011-02-10 00:00:00,2012-09-19 09:20:00,"M81.0","Age-related osteoporosis without current pathological fracture",64,170,75,"F","W",4,29.17724609375,1998-05-04 00:00:00,2021-03-23 00:00:00,177,1013,NA,NA,NA,"Alendronate 70 Mg Tablet"
"103","1106152","Dual-energy X-ray absorptiometry (DXA), bone density study, 1 or more sites; axial skeleton (eg, hips, pelvis, spine)",2011-02-10 00:00:00,2012-09-19 09:20:00,"M81.0","Age-related osteoporosis without current pathological fracture",64,170,75,"F","W",4,29.17724609375,1998-05-04 00:00:00,2021-03-23 00:00:00,177,1013,NA,NA,NA,"Alendronate 70 Mg Tablet"
"104","1106152","Dual-energy X-ray absorptiometry (DXA), bone density study, 1 or more sites; axial skeleton (eg, hips, pelvis, spine)",2007-02-15 00:00:00,2012-09-19 09:20:00,"M81.0","Age-related osteoporosis without current pathological fracture",64,170,75,"F","W",4,29.17724609375,1998-05-04 00:00:00,2021-03-23 00:00:00,177,1013,NA,NA,NA,"Alendronate 70 Mg Tablet"
"105","1106152","Dual-energy X-ray absorptiometry (DXA), bone density study, 1 or more sites; appendicular skeleton (peripheral) (eg, radius, wrist, heel)",2007-02-15 00:00:00,2012-09-19 09:20:00,"M81.0","Age-related osteoporosis without current pathological fracture",64,170,75,"F","W",4,29.17724609375,1998-05-04 00:00:00,2021-03-23 00:00:00,177,1013,NA,NA,NA,"Alendronate 70 Mg Tablet"
"106","1107318","Dual-energy X-ray absorptiometry (DXA), bone density study, 1 or more sites; axial skeleton (eg, hips, pelvis, spine)",2008-08-12 00:00:00,2013-07-28 00:00:00,"820.8","Closed fracture of unspecified part of neck of femur",62,139,65,"F","W",4,25.4206555671176,1993-11-23 13:00:00,2021-03-31 11:58:00,64,818,NA,NA,NA,NA
"107","1107318","Dual-energy X-ray absorptiometry (DXA), bone density study, 1 or more sites; axial skeleton (eg, hips, pelvis, spine)",2010-12-20 00:00:00,2013-07-28 00:00:00,"820.8","Closed fracture of unspecified part of neck of femur",62,139,65,"F","W",4,25.4206555671176,1993-11-23 13:00:00,2021-03-31 11:58:00,64,818,NA,NA,NA,NA
"108","1107318","Dual-energy X-ray absorptiometry (DXA), bone density study, 1 or more sites; axial skeleton (eg, hips, pelvis, spine)",2010-12-20 00:00:00,2013-07-28 00:00:00,"820.8","Closed fracture of unspecified part of neck of femur",62,139,65,"F","W",4,25.4206555671176,1993-11-23 13:00:00,2021-03-31 11:58:00,64,818,NA,NA,NA,NA
"109","1107318","Dual-energy X-ray absorptiometry (DXA), bone density study, 1 or more sites; axial skeleton (eg, hips, pelvis, spine)",2013-12-23 09:34:00,2013-07-28 00:00:00,"820.8","Closed fracture of unspecified part of neck of femur",62,139,65,"F","W",4,25.4206555671176,1993-11-23 13:00:00,2021-03-31 11:58:00,64,818,NA,NA,NA,NA
"110","1107318","Dual-energy X-ray absorptiometry (DXA), bone density study, 1 or more sites; axial skeleton (eg, hips, pelvis, spine)",2013-12-23 09:37:00,2013-07-28 00:00:00,"820.8","Closed fracture of unspecified part of neck of femur",62,139,65,"F","W",4,25.4206555671176,1993-11-23 13:00:00,2021-03-31 11:58:00,64,818,NA,NA,NA,NA
"111","1113704","Dual-energy X-ray absorptiometry (DXA), bone density study, 1 or more sites; axial skeleton (eg, hips, pelvis, spine)",2017-01-25 13:26:00,2007-01-13 00:00:00,"825.25","Closed fracture of metatarsal bone(s)",60,136.3,72,"F","W",4,26.6163611111111,1992-04-22 22:59:00,2021-03-02 14:02:00,142,2135,NA,NA,NA,"Denosumab 60 Mg/Ml Subcutaneous Syringe"
"112","1113704","Dual-energy X-ray absorptiometry (DXA), bone density study, 1 or more sites; axial skeleton (eg, hips, pelvis, spine)",2017-01-25 13:40:00,2007-01-13 00:00:00,"825.25","Closed fracture of metatarsal bone(s)",60,136.3,72,"F","W",4,26.6163611111111,1992-04-22 22:59:00,2021-03-02 14:02:00,142,2135,NA,NA,NA,"Denosumab 60 Mg/Ml Subcutaneous Syringe"
"113","1113704","Dual-energy X-ray absorptiometry (DXA), bone density study, 1 or more sites; axial skeleton (eg, hips, pelvis, spine)",2019-06-04 12:40:00,2007-01-13 00:00:00,"825.25","Closed fracture of metatarsal bone(s)",60,136.3,72,"F","W",4,26.6163611111111,1992-04-22 22:59:00,2021-03-02 14:02:00,142,2135,NA,NA,NA,"Denosumab 60 Mg/Ml Subcutaneous Syringe"
"114","1113704","Dual-energy X-ray absorptiometry (DXA), bone density study, 1 or more sites; axial skeleton (eg, hips, pelvis, spine)",2019-06-04 12:49:00,2007-01-13 00:00:00,"825.25","Closed fracture of metatarsal bone(s)",60,136.3,72,"F","W",4,26.6163611111111,1992-04-22 22:59:00,2021-03-02 14:02:00,142,2135,NA,NA,NA,"Denosumab 60 Mg/Ml Subcutaneous Syringe"
"115","1113704","Dual-energy X-ray absorptiometry (DXA), bone density study, 1 or more sites; axial skeleton (eg, hips, pelvis, spine)",2020-06-09 13:52:00,2007-01-13 00:00:00,"825.25","Closed fracture of metatarsal bone(s)",60,136.3,72,"F","W",4,26.6163611111111,1992-04-22 22:59:00,2021-03-02 14:02:00,142,2135,NA,NA,NA,"Denosumab 60 Mg/Ml Subcutaneous Syringe"
"116","1113704","Dual-energy X-ray absorptiometry (DXA), bone density study, 1 or more sites; axial skeleton (eg, hips, pelvis, spine)",2020-06-09 14:04:00,2007-01-13 00:00:00,"825.25","Closed fracture of metatarsal bone(s)",60,136.3,72,"F","W",4,26.6163611111111,1992-04-22 22:59:00,2021-03-02 14:02:00,142,2135,NA,NA,NA,"Denosumab 60 Mg/Ml Subcutaneous Syringe"
"117","1115744","Dual-energy X-ray absorptiometry (DXA), bone density study, 1 or more sites; axial skeleton (eg, hips, pelvis, spine)",2018-11-27 11:00:00,2020-01-16 00:00:00,"M81.0","Age-related osteoporosis without current pathological fracture",64,255.7,80,"F","W",4,43.8860107421875,2000-12-05 00:00:00,2021-03-29 00:00:00,159,551,NA,NA,NA,"Alendronate 70 Mg Tablet"
"118","1116154","Dual-energy X-ray absorptiometry (DXA), bone density study, 1 or more sites; axial skeleton (eg, hips, pelvis, spine)",2015-06-02 09:21:00,2014-04-04 00:00:00,"S72.002A","Fracture of unspecified part of neck of left femur, initial encounter for closed fracture",65,140.3,80,"F","W",4,23.3445917159763,2007-06-26 14:40:00,2017-09-12 00:00:00,84,761,NA,NA,NA,"Alendronate 35 Mg Tablet"
"119","1116154","Dual-energy X-ray absorptiometry (DXA), bone density study, 1 or more sites; axial skeleton (eg, hips, pelvis, spine)",2015-06-02 09:34:00,2014-04-04 00:00:00,"S72.002A","Fracture of unspecified part of neck of left femur, initial encounter for closed fracture",65,140.3,80,"F","W",4,23.3445917159763,2007-06-26 14:40:00,2017-09-12 00:00:00,84,761,NA,NA,NA,"Alendronate 35 Mg Tablet"
"120","1117611","Dual-energy X-ray absorptiometry (DXA), bone density study, 1 or more sites; axial skeleton (eg, hips, pelvis, spine)",2007-03-16 00:00:00,2015-08-31 00:00:00,"M48.50XD","Collapsed vertebra, not elsewhere classified, site unspecified, subsequent encounter for fracture with routine healing",63,169.7,91,"F","W",4,30.0577223481985,2002-10-31 00:00:00,2020-02-12 13:39:00,668,745,NA,NA,NA,"Conjugated Estrogens 0.625 Mg Tablet"
"121","1119271","Dual-energy X-ray absorptiometry (DXA), bone density study, 1 or more sites; axial skeleton (eg, hips, pelvis, spine)",2019-07-03 09:49:00,1997-11-01 00:00:00,"820.8","Closed fracture of unspecified part of neck of femur",60,142,71,"F","W",2,27.7294444444444,1991-11-19 11:15:00,2021-03-24 13:47:00,13,368,NA,NA,NA,"Estrogen receptor positive status [ER+]"
"122","1119271","Dual-energy X-ray absorptiometry (DXA), bone density study, 1 or more sites; axial skeleton (eg, hips, pelvis, spine)",2019-07-03 09:55:00,1997-11-01 00:00:00,"820.8","Closed fracture of unspecified part of neck of femur",60,142,71,"F","W",2,27.7294444444444,1991-11-19 11:15:00,2021-03-24 13:47:00,13,368,NA,NA,NA,"Estrogen receptor positive status [ER+]"
"123","1136756","Dual-energy X-ray absorptiometry (DXA), bone density study, 1 or more sites; axial skeleton (eg, hips, pelvis, spine)",2015-04-22 11:58:00,2013-11-21 12:55:00,"820.8","Closed fracture of unspecified part of neck of femur",62,185,79,"F","W",5,33.8332466181061,2003-07-30 00:00:00,2021-03-25 10:38:00,263,2742,NA,NA,NA,"Raloxifene 60 Mg Tablet"
"124","1136756","Dual-energy X-ray absorptiometry (DXA), bone density study, 1 or more sites; axial skeleton (eg, hips, pelvis, spine)",2015-04-22 12:21:00,2013-11-21 12:55:00,"820.8","Closed fracture of unspecified part of neck of femur",62,185,79,"F","W",5,33.8332466181061,2003-07-30 00:00:00,2021-03-25 10:38:00,263,2742,NA,NA,NA,"Raloxifene 60 Mg Tablet"
"125","1136756","Dual-energy X-ray absorptiometry (DXA), bone density study, 1 or more sites; axial skeleton (eg, hips, pelvis, spine)",2017-05-23 10:19:00,2013-11-21 12:55:00,"820.8","Closed fracture of unspecified part of neck of femur",62,185,79,"F","W",5,33.8332466181061,2003-07-30 00:00:00,2021-03-25 10:38:00,263,2742,NA,NA,NA,"Raloxifene 60 Mg Tablet"
"126","1136756","Dual-energy X-ray absorptiometry (DXA), bone density study, 1 or more sites; axial skeleton (eg, hips, pelvis, spine)",2017-05-23 10:29:00,2013-11-21 12:55:00,"820.8","Closed fracture of unspecified part of neck of femur",62,185,79,"F","W",5,33.8332466181061,2003-07-30 00:00:00,2021-03-25 10:38:00,263,2742,NA,NA,NA,"Raloxifene 60 Mg Tablet"
"127","1136756","Dual-energy X-ray absorptiometry (DXA), bone density study, 1 or more sites; axial skeleton (eg, hips, pelvis, spine)",2018-09-20 11:22:00,2013-11-21 12:55:00,"820.8","Closed fracture of unspecified part of neck of femur",62,185,79,"F","W",5,33.8332466181061,2003-07-30 00:00:00,2021-03-25 10:38:00,263,2742,NA,NA,NA,"Raloxifene 60 Mg Tablet"
"128","1136756","Dual-energy X-ray absorptiometry (DXA), bone density study, 1 or more sites; axial skeleton (eg, hips, pelvis, spine)",2018-09-20 11:56:00,2013-11-21 12:55:00,"820.8","Closed fracture of unspecified part of neck of femur",62,185,79,"F","W",5,33.8332466181061,2003-07-30 00:00:00,2021-03-25 10:38:00,263,2742,NA,NA,NA,"Raloxifene 60 Mg Tablet"
"129","1136756","Dual-energy X-ray absorptiometry (DXA), bone density study, 1 or more sites; axial skeleton (eg, hips, pelvis, spine)",2019-10-11 13:50:00,2013-11-21 12:55:00,"820.8","Closed fracture of unspecified part of neck of femur",62,185,79,"F","W",5,33.8332466181061,2003-07-30 00:00:00,2021-03-25 10:38:00,263,2742,NA,NA,NA,"Raloxifene 60 Mg Tablet"
"130","1136756","Dual-energy X-ray absorptiometry (DXA), bone density study, 1 or more sites; axial skeleton (eg, hips, pelvis, spine)",2019-10-11 13:55:00,2013-11-21 12:55:00,"820.8","Closed fracture of unspecified part of neck of femur",62,185,79,"F","W",5,33.8332466181061,2003-07-30 00:00:00,2021-03-25 10:38:00,263,2742,NA,NA,NA,"Raloxifene 60 Mg Tablet"
"131","1145930","Dual-energy X-ray absorptiometry (DXA), bone density study, 1 or more sites; axial skeleton (eg, hips, pelvis, spine)",2018-11-05 12:30:00,2014-10-01 13:05:00,"820.8","Closed fracture of unspecified part of neck of femur",63,192.5,61,"F","W",4,34.0961199294533,2014-10-01 00:00:00,2019-05-16 00:00:00,1,384,NA,NA,NA,NA
"132","1145930","Dual-energy X-ray absorptiometry (DXA), bone density study, 1 or more sites; axial skeleton (eg, hips, pelvis, spine)",2018-11-05 12:39:00,2014-10-01 13:05:00,"820.8","Closed fracture of unspecified part of neck of femur",63,192.5,61,"F","W",4,34.0961199294533,2014-10-01 00:00:00,2019-05-16 00:00:00,1,384,NA,NA,NA,NA
"133","1152093","Dual-energy X-ray absorptiometry (DXA), bone density study, 1 or more sites; axial skeleton (eg, hips, pelvis, spine)",2010-05-05 00:00:00,2013-01-10 12:34:00,"814.00","Closed fracture of carpal bone, unspecified",61.85,127.6,78,"F","W",3,23.4491222864925,2000-07-18 00:00:00,2019-11-07 19:07:00,104,1118,NA,NA,NA,"Ibandronate 150 Mg Tablet"
"134","1152093","Dual-energy X-ray absorptiometry (DXA), bone density study, 1 or more sites; axial skeleton (eg, hips, pelvis, spine)",2008-04-29 00:00:00,2013-01-10 12:34:00,"814.00","Closed fracture of carpal bone, unspecified",61.85,127.6,78,"F","W",3,23.4491222864925,2000-07-18 00:00:00,2019-11-07 19:07:00,104,1118,NA,NA,NA,"Ibandronate 150 Mg Tablet"
"135","1156977","Dual-energy X-ray absorptiometry (DXA), bone density study, 1 or more sites; axial skeleton (eg, hips, pelvis, spine)",2019-12-27 12:56:00,2019-11-14 00:00:00,"M80.051D","Age-related osteoporosis with current pathological fracture, right femur, subsequent encounter for fracture with routine healing",61,131.7,74,"F","B",4,24.881779091642,1995-03-08 07:00:00,2021-03-05 08:48:00,235,620,NA,NA,NA,"Denosumab 60 Mg/Ml Subcutaneous Syringe"
"136","1156977","Dual-energy X-ray absorptiometry (DXA), bone density study, 1 or more sites; axial skeleton (eg, hips, pelvis, spine)",2019-12-27 13:26:00,2019-11-14 00:00:00,"M80.051D","Age-related osteoporosis with current pathological fracture, right femur, subsequent encounter for fracture with routine healing",61,131.7,74,"F","B",4,24.881779091642,1995-03-08 07:00:00,2021-03-05 08:48:00,235,620,NA,NA,NA,"Denosumab 60 Mg/Ml Subcutaneous Syringe"
"137","1156977","Dual-energy X-ray absorptiometry (DXA), bone density study, 1 or more sites; axial skeleton (eg, hips, pelvis, spine)",2021-03-01 09:55:00,2019-11-14 00:00:00,"M80.051D","Age-related osteoporosis with current pathological fracture, right femur, subsequent encounter for fracture with routine healing",61,131.7,74,"F","B",4,24.881779091642,1995-03-08 07:00:00,2021-03-05 08:48:00,235,620,NA,NA,NA,"Denosumab 60 Mg/Ml Subcutaneous Syringe"
"138","1156977","Dual-energy X-ray absorptiometry (DXA), bone density study, 1 or more sites; axial skeleton (eg, hips, pelvis, spine)",2021-03-01 10:05:00,2019-11-14 00:00:00,"M80.051D","Age-related osteoporosis with current pathological fracture, right femur, subsequent encounter for fracture with routine healing",61,131.7,74,"F","B",4,24.881779091642,1995-03-08 07:00:00,2021-03-05 08:48:00,235,620,NA,NA,NA,"Denosumab 60 Mg/Ml Subcutaneous Syringe"
"139","1160007","Dual-energy X-ray absorptiometry (DXA), bone density study, 1 or more sites; axial skeleton (eg, hips, pelvis, spine)",2019-03-25 11:30:00,2005-11-25 00:00:00,"823.02","Closed fracture of upper end of fibula with tibia",61,154.4,55,"F","W",3,29.1704380542865,2005-05-12 00:00:00,2021-03-12 16:42:00,3,546,NA,NA,NA,"Denosumab 60 Mg/Ml Subcutaneous Syringe"
"140","1160007","Dual-energy X-ray absorptiometry (DXA), bone density study, 1 or more sites; axial skeleton (eg, hips, pelvis, spine)",2019-03-25 11:38:00,2005-11-25 00:00:00,"823.02","Closed fracture of upper end of fibula with tibia",61,154.4,55,"F","W",3,29.1704380542865,2005-05-12 00:00:00,2021-03-12 16:42:00,3,546,NA,NA,NA,"Denosumab 60 Mg/Ml Subcutaneous Syringe"
"141","1160007","Dual-energy X-ray absorptiometry (DXA), bone density study, 1 or more sites; axial skeleton (eg, hips, pelvis, spine)",2021-03-11 11:50:00,2005-11-25 00:00:00,"823.02","Closed fracture of upper end of fibula with tibia",61,154.4,55,"F","W",3,29.1704380542865,2005-05-12 00:00:00,2021-03-12 16:42:00,3,546,NA,NA,NA,"Denosumab 60 Mg/Ml Subcutaneous Syringe"
"142","1160007","Dual-energy X-ray absorptiometry (DXA), bone density study, 1 or more sites; axial skeleton (eg, hips, pelvis, spine)",2021-03-11 12:07:00,2005-11-25 00:00:00,"823.02","Closed fracture of upper end of fibula with tibia",61,154.4,55,"F","W",3,29.1704380542865,2005-05-12 00:00:00,2021-03-12 16:42:00,3,546,NA,NA,NA,"Denosumab 60 Mg/Ml Subcutaneous Syringe"
"143","1171877","Dual-energy X-ray absorptiometry (DXA), bone density study, 1 or more sites; axial skeleton (eg, hips, pelvis, spine)",2019-02-14 14:23:00,2007-09-06 00:00:00,"807.00","Closed fracture of rib(s), unspecified",72,165.4,62,"M","W",4,22.4298225308642,2007-09-06 00:00:00,2021-03-05 10:43:00,0,363,NA,NA,NA,"Alendronate 70 Mg Tablet"
"144","1174562","Dual-energy X-ray absorptiometry (DXA), bone density study, 1 or more sites; axial skeleton (eg, hips, pelvis, spine)",2016-02-12 13:06:00,2013-03-02 15:26:00,"733.10","Pathologic fracture, unspecified site",65.354,229.02,63,"M","W",4,37.6950555620009,1998-02-02 00:00:00,2019-02-06 21:52:00,19,6888,NA,NA,NA,"Zoledronic Acid Ivpb"
"145","1174562","Dual-energy X-ray absorptiometry (DXA), bone density study, 1 or more sites; axial skeleton (eg, hips, pelvis, spine)",2016-02-12 13:18:00,2013-03-02 15:26:00,"733.10","Pathologic fracture, unspecified site",65.354,229.02,63,"M","W",4,37.6950555620009,1998-02-02 00:00:00,2019-02-06 21:52:00,19,6888,NA,NA,NA,"Zoledronic Acid Ivpb"
"146","1178117","Dual-energy X-ray absorptiometry (DXA), bone density study, 1 or more sites; axial skeleton (eg, hips, pelvis, spine)",2019-08-16 14:06:00,2019-06-16 17:49:00,"821.22","Closed fracture of epiphysis, lower (separation) of femur",68,212.2,78,"M","W",3,32.261375432526,2004-08-09 00:00:00,2021-03-24 00:00:00,159,345,NA,NA,NA,NA
"147","1188645","Dual-energy X-ray absorptiometry (DXA), bone density study, 1 or more sites; axial skeleton (eg, hips, pelvis, spine)",2014-10-21 10:00:00,2014-07-27 00:00:00,"821.00","Closed fracture of unspecified part of femur",63.75,173.04,67,"M","X",3,29.9323940023068,2005-10-17 00:00:00,2020-06-02 00:00:00,29,499,NA,NA,NA,NA
"148","1188645","Dual-energy X-ray absorptiometry (DXA), bone density study, 1 or more sites; axial skeleton (eg, hips, pelvis, spine)",2014-10-21 10:15:00,2014-07-27 00:00:00,"821.00","Closed fracture of unspecified part of femur",63.75,173.04,67,"M","X",3,29.9323940023068,2005-10-17 00:00:00,2020-06-02 00:00:00,29,499,NA,NA,NA,NA
"149","1190039","Dual-energy X-ray absorptiometry (DXA), bone density study, 1 or more sites; axial skeleton (eg, hips, pelvis, spine)",2009-04-16 00:00:00,2017-05-23 00:00:00,"M81.0","Age-related osteoporosis without current pathological fracture",62,115.3,74,"F","W",3,21.086342351717,1996-03-01 13:00:00,2020-08-15 14:56:00,435,382,NA,NA,NA,"Alendronate 70 Mg Tablet"
"150","1190039","Dual-energy X-ray absorptiometry (DXA), bone density study, 1 or more sites; axial skeleton (eg, hips, pelvis, spine)",2007-03-29 00:00:00,2017-05-23 00:00:00,"M81.0","Age-related osteoporosis without current pathological fracture",62,115.3,74,"F","W",3,21.086342351717,1996-03-01 13:00:00,2020-08-15 14:56:00,435,382,NA,NA,NA,"Alendronate 70 Mg Tablet"
"151","1190039","Dual-energy X-ray absorptiometry (DXA), bone density study, 1 or more sites; axial skeleton (eg, hips, pelvis, spine)",2011-04-18 00:00:00,2017-05-23 00:00:00,"M81.0","Age-related osteoporosis without current pathological fracture",62,115.3,74,"F","W",3,21.086342351717,1996-03-01 13:00:00,2020-08-15 14:56:00,435,382,NA,NA,NA,"Alendronate 70 Mg Tablet"
"152","1191744","Dual-energy X-ray absorptiometry (DXA), bone density study, 1 or more sites; axial skeleton (eg, hips, pelvis, spine)",2008-12-04 00:00:00,2012-05-20 00:00:00,"820.21","Closed fracture of intertrochanteric section of neck of femur",61,153.5,74,"F","W",4,29.0004031174415,2002-07-19 12:47:00,2021-03-31 09:00:00,357,1204,NA,NA,NA,"Teriparatide 20 Mcg/Dose (600 Mcg/2.4 Ml) Subcutaneous Pen Injector"
"153","1195957","Dual-energy X-ray absorptiometry (DXA), bone density study, 1 or more sites; axial skeleton (eg, hips, pelvis, spine)",2019-06-06 15:03:00,2017-09-21 00:00:00,"M81.0","Age-related osteoporosis without current pathological fracture",68,225.7,73,"F","W",3,34.3138192041523,2008-04-15 00:00:00,2021-03-16 00:00:00,76,1468,NA,NA,NA,"Alendronate 70 Mg Tablet"
"154","1198765","Dual-energy X-ray absorptiometry (DXA), bone density study, 1 or more sites; axial skeleton (eg, hips, pelvis, spine)",2016-10-27 13:58:00,2014-10-07 22:05:00,"812.43","Closed fracture of medial condyle of humerus",67,105,72,"F","W",3,16.4435286255291,2012-02-09 18:15:00,2021-03-31 00:00:00,192,1035,NA,NA,NA,"Teriparatide 20 Mcg/Dose (600 Mcg/2.4 Ml) Subcutaneous Pen Injector"
"155","1198765","Dual-energy X-ray absorptiometry (DXA), bone density study, 1 or more sites; axial skeleton (eg, hips, pelvis, spine)",2016-10-27 14:16:00,2014-10-07 22:05:00,"812.43","Closed fracture of medial condyle of humerus",67,105,72,"F","W",3,16.4435286255291,2012-02-09 18:15:00,2021-03-31 00:00:00,192,1035,NA,NA,NA,"Teriparatide 20 Mcg/Dose (600 Mcg/2.4 Ml) Subcutaneous Pen Injector"
"156","1198765","Dual-energy X-ray absorptiometry (DXA), bone density study, 1 or more sites; axial skeleton (eg, hips, pelvis, spine)",2019-01-07 13:05:00,2014-10-07 22:05:00,"812.43","Closed fracture of medial condyle of humerus",67,105,72,"F","W",3,16.4435286255291,2012-02-09 18:15:00,2021-03-31 00:00:00,192,1035,NA,NA,NA,"Teriparatide 20 Mcg/Dose (600 Mcg/2.4 Ml) Subcutaneous Pen Injector"
"157","1198765","Dual-energy X-ray absorptiometry (DXA), bone density study, 1 or more sites; axial skeleton (eg, hips, pelvis, spine)",2019-01-07 13:13:00,2014-10-07 22:05:00,"812.43","Closed fracture of medial condyle of humerus",67,105,72,"F","W",3,16.4435286255291,2012-02-09 18:15:00,2021-03-31 00:00:00,192,1035,NA,NA,NA,"Teriparatide 20 Mcg/Dose (600 Mcg/2.4 Ml) Subcutaneous Pen Injector"
"158","1208623","Dual-energy X-ray absorptiometry (DXA), bone density study, 1 or more sites; axial skeleton (eg, hips, pelvis, spine)",2007-09-21 00:00:00,2003-04-09 00:00:00,"820.09","Other closed transcervical fracture of neck of femur",62.98,215.13,79,"F","W",3,38.1286114510991,2001-09-26 00:00:00,2008-05-01 16:31:00,356,1111,NA,NA,NA,NA
"159","1211483","Dual-energy X-ray absorptiometry (DXA), bone density study, 1 or more sites; axial skeleton (eg, hips, pelvis, spine)",2017-09-21 13:13:00,2017-07-03 00:00:00,"820.8","Closed fracture of unspecified part of neck of femur",66,133.5,74,"M","W",4,21.5451101928375,1995-06-29 16:38:00,2019-06-18 01:45:00,73,1153,NA,NA,NA,"Denosumab 60 Mg/Ml Subcutaneous Syringe"
"160","1211483","Dual-energy X-ray absorptiometry (DXA), bone density study, 1 or more sites; axial skeleton (eg, hips, pelvis, spine)",2017-09-21 13:22:00,2017-07-03 00:00:00,"820.8","Closed fracture of unspecified part of neck of femur",66,133.5,74,"M","W",4,21.5451101928375,1995-06-29 16:38:00,2019-06-18 01:45:00,73,1153,NA,NA,NA,"Denosumab 60 Mg/Ml Subcutaneous Syringe"
"161","1220108","Dual-energy X-ray absorptiometry (DXA), bone density study, 1 or more sites; axial skeleton (eg, hips, pelvis, spine)",2007-03-08 00:00:00,1999-01-19 00:00:00,"820.09","Other closed transcervical fracture of neck of femur",58,92,79,"F","W",2,19.2259215219976,1997-07-16 00:00:00,2008-11-13 00:00:00,21,325,NA,NA,NA,NA
"162","1220108","Dual-energy X-ray absorptiometry (DXA), bone density study, 1 or more sites; appendicular skeleton (peripheral) (eg, radius, wrist, heel)",2007-03-08 00:00:00,1999-01-19 00:00:00,"820.09","Other closed transcervical fracture of neck of femur",58,92,79,"F","W",2,19.2259215219976,1997-07-16 00:00:00,2008-11-13 00:00:00,21,325,NA,NA,NA,NA
"163","1232707","Dual-energy X-ray absorptiometry (DXA), bone density study, 1 or more sites; axial skeleton (eg, hips, pelvis, spine)",2019-09-16 12:56:00,2017-02-05 19:15:00,"820.21","Closed fracture of intertrochanteric section of neck of femur",56,138.3,84,"F","W",3,31.0028380102041,2003-02-21 00:00:00,2021-03-12 00:00:00,76,442,NA,NA,NA,"Calcitonin (Salmon) 200 Unit/Actuation Nasal Spray"
"164","1239740","Dual-energy X-ray absorptiometry (DXA), bone density study, 1 or more sites; axial skeleton (eg, hips, pelvis, spine)",2008-05-22 00:00:00,2006-04-19 00:00:00,"813.42","Other closed fractures of distal end of radius (alone)",61.5,122.1,52,"F","B",3,22.6945072377553,1987-11-23 13:20:00,2017-12-07 16:03:00,1180,2428,NA,NA,NA,NA
"165","1239740","Dual-energy X-ray absorptiometry (DXA), bone density study, 1 or more sites; appendicular skeleton (peripheral) (eg, radius, wrist, heel)",2008-05-22 00:00:00,2006-04-19 00:00:00,"813.42","Other closed fractures of distal end of radius (alone)",61.5,122.1,52,"F","B",3,22.6945072377553,1987-11-23 13:20:00,2017-12-07 16:03:00,1180,2428,NA,NA,NA,NA
"166","1258287","Dual-energy X-ray absorptiometry (DXA), bone density study, 1 or more sites; axial skeleton (eg, hips, pelvis, spine)",2008-05-30 00:00:00,2005-06-11 00:00:00,"813.01","Closed fracture of olecranon process of ulna",65,220,40,"M","B",3,36.6059171597633,1992-08-19 09:30:00,2021-03-10 08:57:00,244,2627,NA,NA,NA,"Alendronate 70 Mg Tablet"
"167","1258287","Dual-energy X-ray absorptiometry (DXA), bone density study, 1 or more sites; axial skeleton (eg, hips, pelvis, spine)",2011-12-06 00:00:00,2005-06-11 00:00:00,"813.01","Closed fracture of olecranon process of ulna",65,220,40,"M","B",3,36.6059171597633,1992-08-19 09:30:00,2021-03-10 08:57:00,244,2627,NA,NA,NA,"Alendronate 70 Mg Tablet"
"168","1261403","Dual-energy X-ray absorptiometry (DXA), bone density study, 1 or more sites; axial skeleton (eg, hips, pelvis, spine)",2014-06-12 13:37:00,2015-02-18 00:00:00,"M81.0","Age-related osteoporosis without current pathological fracture",63,198.99,53,"F","W",5,35.2456462585034,1992-02-29 16:06:00,2021-03-29 00:00:00,868,676,NA,NA,NA,"Alendronate 70 Mg Tablet"
"169","1261403","Dual-energy X-ray absorptiometry (DXA), bone density study, 1 or more sites; axial skeleton (eg, hips, pelvis, spine)",2014-06-12 13:46:00,2015-02-18 00:00:00,"M81.0","Age-related osteoporosis without current pathological fracture",63,198.99,53,"F","W",5,35.2456462585034,1992-02-29 16:06:00,2021-03-29 00:00:00,868,676,NA,NA,NA,"Alendronate 70 Mg Tablet"
"170","1261621","Dual-energy X-ray absorptiometry (DXA), bone density study, 1 or more sites; axial skeleton (eg, hips, pelvis, spine)",2009-08-20 00:00:00,1997-05-14 00:00:00,"820.22","Closed fracture of subtrochanteric section of neck of femur",64,198.7,68,"F","B",4,34.1030517578125,1992-04-08 07:00:00,2018-07-27 00:00:00,5,1629,NA,NA,NA,NA
"171","1261621","Dual-energy X-ray absorptiometry (DXA), bone density study, 1 or more sites; axial skeleton (eg, hips, pelvis, spine)",2007-08-16 00:00:00,1997-05-14 00:00:00,"820.22","Closed fracture of subtrochanteric section of neck of femur",64,198.7,68,"F","B",4,34.1030517578125,1992-04-08 07:00:00,2018-07-27 00:00:00,5,1629,NA,NA,NA,NA
"172","1261621","Dual-energy X-ray absorptiometry (DXA), bone density study, 1 or more sites; appendicular skeleton (peripheral) (eg, radius, wrist, heel)",2007-08-16 00:00:00,1997-05-14 00:00:00,"820.22","Closed fracture of subtrochanteric section of neck of femur",64,198.7,68,"F","B",4,34.1030517578125,1992-04-08 07:00:00,2018-07-27 00:00:00,5,1629,NA,NA,NA,NA
"173","1262688","Dual-energy X-ray absorptiometry (DXA), bone density study, 1 or more sites; axial skeleton (eg, hips, pelvis, spine)",2017-09-14 15:26:00,2012-01-26 13:30:00,"825.25","Closed fracture of metatarsal bone(s)",64.5,137.3,62,"F","W",5,23.2009855176973,2000-01-11 00:00:00,2021-03-01 14:22:00,275,797,NA,NA,NA,"Calcitonin (Salmon) 200 Unit/Actuation Nasal Spray"
"174","1266695","Dual-energy X-ray absorptiometry (DXA), bone density study, 1 or more sites; axial skeleton (eg, hips, pelvis, spine)",2007-05-08 00:00:00,1998-06-06 00:00:00,"825.25","Closed fracture of metatarsal bone(s)",65,104.3,50,"F","W",3,17.3545325443787,1985-08-09 15:25:00,2021-03-26 00:35:00,6,1902,NA,NA,NA,"Zoledronic Acid Ivpb"
"175","1266695","Dual-energy X-ray absorptiometry (DXA), bone density study, 1 or more sites; appendicular skeleton (peripheral) (eg, radius, wrist, heel)",2007-05-08 00:00:00,1998-06-06 00:00:00,"825.25","Closed fracture of metatarsal bone(s)",65,104.3,50,"F","W",3,17.3545325443787,1985-08-09 15:25:00,2021-03-26 00:35:00,6,1902,NA,NA,NA,"Zoledronic Acid Ivpb"
"176","1267172","Dual-energy X-ray absorptiometry (DXA), bone density study, 1 or more sites; axial skeleton (eg, hips, pelvis, spine)",2015-08-14 10:53:00,2015-02-20 18:34:00,"820.8","Closed fracture of unspecified part of neck of femur",74,204.25,78,"M","W",4,26.2212837837838,1992-11-05 07:30:00,2020-06-23 09:00:00,386,1801,NA,NA,NA,"Teriparatide 20 Mcg/Dose (600 Mcg/2.4 Ml) Subcutaneous Pen Injector"
"177","1267172","Dual-energy X-ray absorptiometry (DXA), bone density study, 1 or more sites; axial skeleton (eg, hips, pelvis, spine)",2015-08-14 10:59:00,2015-02-20 18:34:00,"820.8","Closed fracture of unspecified part of neck of femur",74,204.25,78,"M","W",4,26.2212837837838,1992-11-05 07:30:00,2020-06-23 09:00:00,386,1801,NA,NA,NA,"Teriparatide 20 Mcg/Dose (600 Mcg/2.4 Ml) Subcutaneous Pen Injector"
"178","1283133","Dual-energy X-ray absorptiometry (DXA), bone density study, 1 or more sites; axial skeleton (eg, hips, pelvis, spine)",2010-08-02 00:00:00,2004-10-19 00:00:00,"813.07","Other and unspecified closed fractures of proximal end of radius (alone)",65,244.4,62,"F","W",5,40.6658461538462,1993-09-13 18:17:00,2021-03-31 00:00:00,75,1520,NA,NA,NA,"Alendronate 70 Mg Tablet"
"179","1283133","Dual-energy X-ray absorptiometry (DXA), bone density study, 1 or more sites; axial skeleton (eg, hips, pelvis, spine)",2008-08-25 00:00:00,2004-10-19 00:00:00,"813.07","Other and unspecified closed fractures of proximal end of radius (alone)",65,244.4,62,"F","W",5,40.6658461538462,1993-09-13 18:17:00,2021-03-31 00:00:00,75,1520,NA,NA,NA,"Alendronate 70 Mg Tablet"
"180","1289607","Dual-energy X-ray absorptiometry (DXA), bone density study, 1 or more sites; axial skeleton (eg, hips, pelvis, spine)",2011-04-25 00:00:00,2019-10-11 20:06:00,"733.14","Pathologic fracture of neck of femur",62,140.3,81,"F","W",4,25.6584027055151,1997-03-06 09:00:00,2021-01-14 00:00:00,259,202,NA,NA,NA,NA
"181","1290269","Dual-energy X-ray absorptiometry (DXA), bone density study, 1 or more sites; axial skeleton (eg, hips, pelvis, spine)",2018-09-21 13:18:00,2018-07-25 09:57:00,"M80.052A","Age-related osteoporosis with current pathological fracture, left femur, initial encounter for fracture",70,130.3,71,"M","W",5,18.6940612244898,2001-05-01 00:00:00,2021-03-25 09:57:00,365,1380,NA,NA,NA,"Teriparatide 20 Mcg/Dose (600 Mcg/2.4 Ml) Subcutaneous Pen Injector"
"182","1290269","Dual-energy X-ray absorptiometry (DXA), bone density study, 1 or more sites; axial skeleton (eg, hips, pelvis, spine)",2018-09-21 13:25:00,2018-07-25 09:57:00,"M80.052A","Age-related osteoporosis with current pathological fracture, left femur, initial encounter for fracture",70,130.3,71,"M","W",5,18.6940612244898,2001-05-01 00:00:00,2021-03-25 09:57:00,365,1380,NA,NA,NA,"Teriparatide 20 Mcg/Dose (600 Mcg/2.4 Ml) Subcutaneous Pen Injector"
"183","1296052","Dual-energy X-ray absorptiometry (DXA), bone density study, 1 or more sites; axial skeleton (eg, hips, pelvis, spine)",2007-01-18 00:00:00,2007-01-18 06:50:00,"733.19","Pathologic fracture of other specified site",63,144.4,78,"F","W",3,25.5765180146133,1991-12-31 10:12:00,2017-03-29 17:02:00,60,386,NA,NA,NA,"Conjugated Estrogens 0.625 Mg/Gram Vaginal Cream"
"184","1299655","Dual-energy X-ray absorptiometry (DXA), bone density study, 1 or more sites; axial skeleton (eg, hips, pelvis, spine)",2019-11-06 10:22:00,2019-08-21 13:24:00,"820.09","Other closed transcervical fracture of neck of femur",71.654,134.5,65,"M","W",4,18.4160603966271,2009-03-03 00:00:00,2021-02-24 13:24:00,13,198,NA,NA,NA,NA
"185","1299655","Dual-energy X-ray absorptiometry (DXA), bone density study, 1 or more sites; axial skeleton (eg, hips, pelvis, spine)",2019-11-06 10:36:00,2019-08-21 13:24:00,"820.09","Other closed transcervical fracture of neck of femur",71.654,134.5,65,"M","W",4,18.4160603966271,2009-03-03 00:00:00,2021-02-24 13:24:00,13,198,NA,NA,NA,NA
"186","1300237","Dual-energy X-ray absorptiometry (DXA), bone density study, 1 or more sites; axial skeleton (eg, hips, pelvis, spine)",2010-07-26 00:00:00,2008-07-20 00:00:00,"807.00","Closed fracture of rib(s), unspecified",60.5,147.6,76,"F","W",4,28.3485554265419,1996-12-17 13:58:00,2021-03-10 00:00:00,34,979,NA,NA,NA,NA
"187","1310803","Dual-energy X-ray absorptiometry (DXA), bone density study, 1 or more sites; axial skeleton (eg, hips, pelvis, spine)",2012-03-08 00:00:00,2011-09-23 00:00:00,"820.22","Closed fracture of subtrochanteric section of neck of femur",69.02,146.06,80,"M","W",4,21.5544383802342,2008-07-23 00:00:00,2014-12-23 15:33:00,220,927,NA,NA,NA,NA
"188","1310803","Dual-energy X-ray absorptiometry (DXA), bone density study, 1 or more sites; axial skeleton (eg, hips, pelvis, spine)",2012-03-08 00:00:00,2011-09-23 00:00:00,"820.22","Closed fracture of subtrochanteric section of neck of femur",69.02,146.06,80,"M","W",4,21.5544383802342,2008-07-23 00:00:00,2014-12-23 15:33:00,220,927,NA,NA,NA,NA
"189","1313036","Dual-energy X-ray absorptiometry (DXA), bone density study, 1 or more sites; axial skeleton (eg, hips, pelvis, spine)",2009-05-14 00:00:00,2005-08-22 00:00:00,"826.0","Closed fracture of one or more phalanges of foot",62,113.2,70,"F","W",4,20.7022892819979,2003-09-02 00:00:00,2019-10-03 15:38:00,258,16343,NA,NA,NA,NA
"190","1315044","Dual-energy X-ray absorptiometry (DXA), bone density study, 1 or more sites; axial skeleton (eg, hips, pelvis, spine)",2007-11-29 00:00:00,2016-12-06 00:00:00,"M81.0","Age-related osteoporosis without current pathological fracture",56.5,146.2,84,"F","B",3,32.1962878847208,2005-06-22 09:55:00,2021-03-23 14:01:00,284,244,NA,NA,NA,"Ibandronate 150 Mg Tablet"
"191","1315044","Dual-energy X-ray absorptiometry (DXA), bone density study, 1 or more sites; axial skeleton (eg, hips, pelvis, spine)",2009-12-03 00:00:00,2016-12-06 00:00:00,"M81.0","Age-related osteoporosis without current pathological fracture",56.5,146.2,84,"F","B",3,32.1962878847208,2005-06-22 09:55:00,2021-03-23 14:01:00,284,244,NA,NA,NA,"Ibandronate 150 Mg Tablet"
"192","1315476","Dual-energy X-ray absorptiometry (DXA), bone density study, 1 or more sites; axial skeleton (eg, hips, pelvis, spine)",2015-12-08 10:10:00,2010-12-28 10:30:00,"733.19","Pathologic fracture of other specified site",66,94.2,35,"F","B",4,15.2026170798898,1994-01-06 13:31:00,2021-03-03 17:22:00,161,441,NA,NA,NA,NA
"193","1315476","Dual-energy X-ray absorptiometry (DXA), bone density study, 1 or more sites; axial skeleton (eg, hips, pelvis, spine)",2015-12-08 10:20:00,2010-12-28 10:30:00,"733.19","Pathologic fracture of other specified site",66,94.2,35,"F","B",4,15.2026170798898,1994-01-06 13:31:00,2021-03-03 17:22:00,161,441,NA,NA,NA,NA
"194","1317986","Dual-energy X-ray absorptiometry (DXA), bone density study, 1 or more sites; axial skeleton (eg, hips, pelvis, spine)",2017-02-08 14:09:00,2016-09-27 22:28:00,"733.14","Pathologic fracture of neck of femur",74.016,132.8,82,"M","B",4,17.0412786503997,1992-08-30 08:20:00,2021-02-27 23:00:00,1727,1717,NA,NA,NA,NA
"195","1317986","Dual-energy X-ray absorptiometry (DXA), bone density study, 1 or more sites; axial skeleton (eg, hips, pelvis, spine)",2017-02-08 14:17:00,2016-09-27 22:28:00,"733.14","Pathologic fracture of neck of femur",74.016,132.8,82,"M","B",4,17.0412786503997,1992-08-30 08:20:00,2021-02-27 23:00:00,1727,1717,NA,NA,NA,NA
"196","1321302","Dual-energy X-ray absorptiometry (DXA), bone density study, 1 or more sites; axial skeleton (eg, hips, pelvis, spine)",2020-08-28 09:52:00,2020-03-21 20:40:00,"S72.011A","Unspecified intracapsular fracture of right femur, initial encounter for closed fracture",59.2,145.4,82,"F","W",4,29.1659628378378,2009-04-24 00:00:00,2021-03-29 00:00:00,363,204,NA,NA,NA,"Alendronate 70 Mg Tablet"
"197","1321302","Dual-energy X-ray absorptiometry (DXA), bone density study, 1 or more sites; axial skeleton (eg, hips, pelvis, spine)",2020-08-28 09:59:00,2020-03-21 20:40:00,"S72.011A","Unspecified intracapsular fracture of right femur, initial encounter for closed fracture",59.2,145.4,82,"F","W",4,29.1659628378378,2009-04-24 00:00:00,2021-03-29 00:00:00,363,204,NA,NA,NA,"Alendronate 70 Mg Tablet"
"198","1327697","Dual-energy X-ray absorptiometry (DXA), bone density study, 1 or more sites; axial skeleton (eg, hips, pelvis, spine)",2007-05-10 00:00:00,1997-11-20 00:00:00,"824.2","Fracture of lateral malleolus, closed",62,212.2,62,"F","W",4,38.8076482830385,1987-04-27 13:56:00,2020-02-07 09:47:00,3,3199,NA,NA,NA,"Alendronate 70 Mg Tablet"
"199","1327697","Dual-energy X-ray absorptiometry (DXA), bone density study, 1 or more sites; appendicular skeleton (peripheral) (eg, radius, wrist, heel)",2007-05-10 00:00:00,1997-11-20 00:00:00,"824.2","Fracture of lateral malleolus, closed",62,212.2,62,"F","W",4,38.8076482830385,1987-04-27 13:56:00,2020-02-07 09:47:00,3,3199,NA,NA,NA,"Alendronate 70 Mg Tablet"
"200","1327697","Dual-energy X-ray absorptiometry (DXA), bone density study, 1 or more sites; axial skeleton (eg, hips, pelvis, spine)",2011-03-01 00:00:00,1997-11-20 00:00:00,"824.2","Fracture of lateral malleolus, closed",62,212.2,62,"F","W",4,38.8076482830385,1987-04-27 13:56:00,2020-02-07 09:47:00,3,3199,NA,NA,NA,"Alendronate 70 Mg Tablet"
"201","1327697","Dual-energy X-ray absorptiometry (DXA), bone density study, 1 or more sites; axial skeleton (eg, hips, pelvis, spine)",2011-03-01 00:00:00,1997-11-20 00:00:00,"824.2","Fracture of lateral malleolus, closed",62,212.2,62,"F","W",4,38.8076482830385,1987-04-27 13:56:00,2020-02-07 09:47:00,3,3199,NA,NA,NA,"Alendronate 70 Mg Tablet"
"202","1330179","Dual-energy X-ray absorptiometry (DXA), bone density study, 1 or more sites; axial skeleton (eg, hips, pelvis, spine)",2007-06-04 00:00:00,2001-05-13 00:00:00,"820.03","Closed fracture of base of neck of femur",63,117.8,71,"F","W",3,20.8650541698161,1999-08-03 10:40:00,2020-10-16 14:53:00,4,559,NA,NA,NA,"Conjugated Estrogens 0.625 Mg/Gram Vaginal Cream"
"203","1330179","Dual-energy X-ray absorptiometry (DXA), bone density study, 1 or more sites; appendicular skeleton (peripheral) (eg, radius, wrist, heel)",2007-06-04 00:00:00,2001-05-13 00:00:00,"820.03","Closed fracture of base of neck of femur",63,117.8,71,"F","W",3,20.8650541698161,1999-08-03 10:40:00,2020-10-16 14:53:00,4,559,NA,NA,NA,"Conjugated Estrogens 0.625 Mg/Gram Vaginal Cream"
"204","1332442","Dual-energy X-ray absorptiometry (DXA), bone density study, 1 or more sites; axial skeleton (eg, hips, pelvis, spine)",2015-02-18 13:46:00,2007-07-24 00:00:00,"826.0","Closed fracture of one or more phalanges of foot",62,122.3,59,"F","W",4,22.3665192507804,2003-01-01 00:00:00,2021-03-10 00:00:00,141,1647,NA,NA,NA,"Teriparatide 20 Mcg/Dose (600 Mcg/2.4 Ml) Subcutaneous Pen Injector"
"205","1332442","Dual-energy X-ray absorptiometry (DXA), bone density study, 1 or more sites; axial skeleton (eg, hips, pelvis, spine)",2015-02-18 14:30:00,2007-07-24 00:00:00,"826.0","Closed fracture of one or more phalanges of foot",62,122.3,59,"F","W",4,22.3665192507804,2003-01-01 00:00:00,2021-03-10 00:00:00,141,1647,NA,NA,NA,"Teriparatide 20 Mcg/Dose (600 Mcg/2.4 Ml) Subcutaneous Pen Injector"
"206","1332442","Dual-energy X-ray absorptiometry (DXA), bone density study, 1 or more sites; axial skeleton (eg, hips, pelvis, spine)",2017-12-07 14:18:00,2007-07-24 00:00:00,"826.0","Closed fracture of one or more phalanges of foot",62,122.3,59,"F","W",4,22.3665192507804,2003-01-01 00:00:00,2021-03-10 00:00:00,141,1647,NA,NA,NA,"Teriparatide 20 Mcg/Dose (600 Mcg/2.4 Ml) Subcutaneous Pen Injector"
"207","1332442","Dual-energy X-ray absorptiometry (DXA), bone density study, 1 or more sites; axial skeleton (eg, hips, pelvis, spine)",2017-12-07 14:36:00,2007-07-24 00:00:00,"826.0","Closed fracture of one or more phalanges of foot",62,122.3,59,"F","W",4,22.3665192507804,2003-01-01 00:00:00,2021-03-10 00:00:00,141,1647,NA,NA,NA,"Teriparatide 20 Mcg/Dose (600 Mcg/2.4 Ml) Subcutaneous Pen Injector"
"208","1344277","Dual-energy X-ray absorptiometry (DXA), bone density study, 1 or more sites; axial skeleton (eg, hips, pelvis, spine)",2010-11-23 00:00:00,2013-10-02 00:00:00,"S72.142A","Displaced intertrochanteric fracture of left femur, initial encounter for closed fracture",61,178.8,86,"F","W",4,33.7802741198603,1996-02-12 08:00:00,2020-07-23 09:34:00,559,1169,NA,NA,NA,"Teriparatide 20 Mcg/Dose (600 Mcg/2.4 Ml) Subcutaneous Pen Injector"
"209","1344277","Dual-energy X-ray absorptiometry (DXA), bone density study, 1 or more sites; axial skeleton (eg, hips, pelvis, spine)",2010-11-23 00:00:00,2013-10-02 00:00:00,"S72.142A","Displaced intertrochanteric fracture of left femur, initial encounter for closed fracture",61,178.8,86,"F","W",4,33.7802741198603,1996-02-12 08:00:00,2020-07-23 09:34:00,559,1169,NA,NA,NA,"Teriparatide 20 Mcg/Dose (600 Mcg/2.4 Ml) Subcutaneous Pen Injector"
"210","1346702","Dual-energy X-ray absorptiometry (DXA), bone density study, 1 or more sites; axial skeleton (eg, hips, pelvis, spine)",2018-05-18 13:07:00,2015-02-27 00:00:00,"813.42","Other closed fractures of distal end of radius (alone)",67,138.9,83,"M","W",4,21.752439296057,1989-04-18 19:34:00,2020-12-14 00:00:00,366,3241,NA,NA,NA,"Denosumab 60 Mg/Ml Subcutaneous Syringe"
"211","1346702","Dual-energy X-ray absorptiometry (DXA), bone density study, 1 or more sites; axial skeleton (eg, hips, pelvis, spine)",2018-05-18 13:11:00,2015-02-27 00:00:00,"813.42","Other closed fractures of distal end of radius (alone)",67,138.9,83,"M","W",4,21.752439296057,1989-04-18 19:34:00,2020-12-14 00:00:00,366,3241,NA,NA,NA,"Denosumab 60 Mg/Ml Subcutaneous Syringe"
"212","1359962","Dual-energy X-ray absorptiometry (DXA), bone density study, 1 or more sites; axial skeleton (eg, hips, pelvis, spine)",2007-07-26 00:00:00,2001-11-05 00:00:00,"820.09","Other closed transcervical fracture of neck of femur",66,118.3,60,"F","W",4,19.0920339761249,2001-11-05 00:00:00,2017-08-31 10:51:00,0,1119,NA,NA,NA,"Alendronate 5 Mg Tablet"
"213","1359962","Dual-energy X-ray absorptiometry (DXA), bone density study, 1 or more sites; appendicular skeleton (peripheral) (eg, radius, wrist, heel)",2007-07-26 00:00:00,2001-11-05 00:00:00,"820.09","Other closed transcervical fracture of neck of femur",66,118.3,60,"F","W",4,19.0920339761249,2001-11-05 00:00:00,2017-08-31 10:51:00,0,1119,NA,NA,NA,"Alendronate 5 Mg Tablet"
"214","1359962","Dual-energy X-ray absorptiometry (DXA), bone density study, 1 or more sites; axial skeleton (eg, hips, pelvis, spine)",2010-12-28 00:00:00,2001-11-05 00:00:00,"820.09","Other closed transcervical fracture of neck of femur",66,118.3,60,"F","W",4,19.0920339761249,2001-11-05 00:00:00,2017-08-31 10:51:00,0,1119,NA,NA,NA,"Alendronate 5 Mg Tablet"
"215","1359962","Dual-energy X-ray absorptiometry (DXA), bone density study, 1 or more sites; axial skeleton (eg, hips, pelvis, spine)",2010-12-28 00:00:00,2001-11-05 00:00:00,"820.09","Other closed transcervical fracture of neck of femur",66,118.3,60,"F","W",4,19.0920339761249,2001-11-05 00:00:00,2017-08-31 10:51:00,0,1119,NA,NA,NA,"Alendronate 5 Mg Tablet"
"216","1361517","Dual-energy X-ray absorptiometry (DXA), bone density study, 1 or more sites; axial skeleton (eg, hips, pelvis, spine)",2009-06-30 00:00:00,2015-07-29 19:15:00,"820.09","Other closed transcervical fracture of neck of femur",65,103.3,64,"F","W",4,17.1881420118343,2001-10-11 00:00:00,2021-03-30 11:34:00,1254,8229,NA,NA,NA,NA
"217","1361517","Dual-energy X-ray absorptiometry (DXA), bone density study, 1 or more sites; axial skeleton (eg, hips, pelvis, spine)",2011-07-05 00:00:00,2015-07-29 19:15:00,"820.09","Other closed transcervical fracture of neck of femur",65,103.3,64,"F","W",4,17.1881420118343,2001-10-11 00:00:00,2021-03-30 11:34:00,1254,8229,NA,NA,NA,NA
"218","1361517","Dual-energy X-ray absorptiometry (DXA), bone density study, 1 or more sites; axial skeleton (eg, hips, pelvis, spine)",2011-07-05 00:00:00,2015-07-29 19:15:00,"820.09","Other closed transcervical fracture of neck of femur",65,103.3,64,"F","W",4,17.1881420118343,2001-10-11 00:00:00,2021-03-30 11:34:00,1254,8229,NA,NA,NA,NA
"219","1361517","Dual-energy X-ray absorptiometry (DXA), bone density study, 1 or more sites; axial skeleton (eg, hips, pelvis, spine)",2007-07-24 00:00:00,2015-07-29 19:15:00,"820.09","Other closed transcervical fracture of neck of femur",65,103.3,64,"F","W",4,17.1881420118343,2001-10-11 00:00:00,2021-03-30 11:34:00,1254,8229,NA,NA,NA,NA
"220","1361517","Dual-energy X-ray absorptiometry (DXA), bone density study, 1 or more sites; axial skeleton (eg, hips, pelvis, spine)",2014-06-30 15:00:00,2015-07-29 19:15:00,"820.09","Other closed transcervical fracture of neck of femur",65,103.3,64,"F","W",4,17.1881420118343,2001-10-11 00:00:00,2021-03-30 11:34:00,1254,8229,NA,NA,NA,NA
"221","1361517","Dual-energy X-ray absorptiometry (DXA), bone density study, 1 or more sites; axial skeleton (eg, hips, pelvis, spine)",2014-06-30 15:21:00,2015-07-29 19:15:00,"820.09","Other closed transcervical fracture of neck of femur",65,103.3,64,"F","W",4,17.1881420118343,2001-10-11 00:00:00,2021-03-30 11:34:00,1254,8229,NA,NA,NA,NA
"222","1362837","Dual-energy X-ray absorptiometry (DXA), bone density study, 1 or more sites; axial skeleton (eg, hips, pelvis, spine)",2007-10-08 00:00:00,2007-09-14 00:00:00,"825.22","Closed fracture of navicular [scaphoid], foot",67,137.1,77,"F","W",4,21.4705502339051,2007-09-07 00:00:00,2021-02-26 00:00:00,4,3324,NA,NA,NA,"Conjugated Estrogens 0.625 Mg/Gram Vaginal Cream"
"223","1362837","Dual-energy X-ray absorptiometry (DXA), bone density study, 1 or more sites; appendicular skeleton (peripheral) (eg, radius, wrist, heel)",2007-10-08 00:00:00,2007-09-14 00:00:00,"825.22","Closed fracture of navicular [scaphoid], foot",67,137.1,77,"F","W",4,21.4705502339051,2007-09-07 00:00:00,2021-02-26 00:00:00,4,3324,NA,NA,NA,"Conjugated Estrogens 0.625 Mg/Gram Vaginal Cream"
"224","1365927","Dual-energy X-ray absorptiometry (DXA), bone density study, 1 or more sites; axial skeleton (eg, hips, pelvis, spine)",2009-04-09 00:00:00,2001-09-04 00:00:00,"820.21","Closed fracture of intertrochanteric section of neck of femur",63.98,219,67,"F","W",3,37.6106611934548,1994-01-19 13:00:00,2009-06-27 07:14:00,6,347,NA,NA,NA,NA
"225","1371194","Dual-energy X-ray absorptiometry (DXA), bone density study, 1 or more sites; axial skeleton (eg, hips, pelvis, spine)",2009-03-05 00:00:00,1989-07-08 00:31:00,"805.4","Closed fracture of lumbar vertebra without mention of spinal cord injury",64,155.4,54,"F","B",4,26.671435546875,1989-07-08 00:31:00,2021-03-31 00:00:00,0,1219,NA,NA,NA,"Alendronate 70 Mg Tablet"
"226","1371548","Dual-energy X-ray absorptiometry (DXA), bone density study, 1 or more sites; axial skeleton (eg, hips, pelvis, spine)",2010-09-01 00:00:00,2008-02-05 00:00:00,"820.21","Closed fracture of intertrochanteric section of neck of femur",61,98.2,81,"F","W",3,18.5527008868584,2008-01-23 00:00:00,2017-09-07 11:59:00,50,1493,NA,NA,NA,"Teriparatide 20 Mcg/Dose (600 Mcg/2.4 Ml) Subcutaneous Pen Injector"
"227","1381125","Dual-energy X-ray absorptiometry (DXA), bone density study, 1 or more sites; axial skeleton (eg, hips, pelvis, spine)",2012-02-21 00:00:00,2019-08-07 12:55:00,"820.8","Closed fracture of unspecified part of neck of femur",71,194.25,87,"M","W",4,27.0894167823844,2000-06-26 00:00:00,2020-07-22 12:35:00,1354,780,NA,NA,NA,"Use of other agents affecting estrogen receptors and estrogen levels"
"228","1389856","Dual-energy X-ray absorptiometry (DXA), bone density study, 1 or more sites; axial skeleton (eg, hips, pelvis, spine)",2007-07-09 00:00:00,2009-05-16 00:00:00,"733.14","Pathologic fracture of neck of femur",66.98,193.98,66,"F","W",4,30.3963889872868,1997-11-26 00:00:00,2012-04-24 10:45:00,281,2126,NA,NA,NA,NA
"229","1389856","Dual-energy X-ray absorptiometry (DXA), bone density study, 1 or more sites; axial skeleton (eg, hips, pelvis, spine)",2009-01-05 00:00:00,2009-05-16 00:00:00,"733.14","Pathologic fracture of neck of femur",66.98,193.98,66,"F","W",4,30.3963889872868,1997-11-26 00:00:00,2012-04-24 10:45:00,281,2126,NA,NA,NA,NA
"230","1395904","Dual-energy X-ray absorptiometry (DXA), bone density study, 1 or more sites; axial skeleton (eg, hips, pelvis, spine)",2009-09-01 00:00:00,2011-01-12 00:00:00,"812.40","Closed fracture of unspecified part of lower end of humerus",55,220,54,"F","W",4,51.1272727272727,2006-06-21 00:00:00,2021-03-31 22:50:00,78,3955,NA,NA,NA,"Alendronate 70 Mg Tablet"
"231","1395904","Dual-energy X-ray absorptiometry (DXA), bone density study, 1 or more sites; axial skeleton (eg, hips, pelvis, spine)",2007-04-19 00:00:00,2011-01-12 00:00:00,"812.40","Closed fracture of unspecified part of lower end of humerus",55,220,54,"F","W",4,51.1272727272727,2006-06-21 00:00:00,2021-03-31 22:50:00,78,3955,NA,NA,NA,"Alendronate 70 Mg Tablet"
"232","1396240","Dual-energy X-ray absorptiometry (DXA), bone density study, 1 or more sites; axial skeleton (eg, hips, pelvis, spine)",2020-02-11 11:09:00,2019-11-01 18:28:00,"733.14","Pathologic fracture of neck of femur",62,136.7,71,"F","W",3,25.0000260145682,2006-09-11 00:00:00,2021-03-31 00:00:00,363,359,NA,NA,NA,NA
"233","1396240","Dual-energy X-ray absorptiometry (DXA), bone density study, 1 or more sites; axial skeleton (eg, hips, pelvis, spine)",2020-02-11 11:22:00,2019-11-01 18:28:00,"733.14","Pathologic fracture of neck of femur",62,136.7,71,"F","W",3,25.0000260145682,2006-09-11 00:00:00,2021-03-31 00:00:00,363,359,NA,NA,NA,NA
"234","1396986","Dual-energy X-ray absorptiometry (DXA), bone density study, 1 or more sites; axial skeleton (eg, hips, pelvis, spine)",2008-03-10 00:00:00,2012-03-10 00:00:00,"810.02","Closed fracture of shaft of clavicle",69,73.56,72,"F","B",5,10.8617265280403,2007-08-03 14:06:00,2021-03-05 12:45:00,2209,1140,NA,NA,NA,"Estrogen receptor positive status [ER+]"
"235","1408588","Dual-energy X-ray absorptiometry (DXA), bone density study, 1 or more sites; axial skeleton (eg, hips, pelvis, spine)",2019-02-05 10:46:00,2017-11-01 00:00:00,"M81.0","Age-related osteoporosis without current pathological fracture",64,183.6,72,"F","W",3,31.51142578125,2016-05-27 09:01:00,2021-03-31 00:00:00,23,3557,NA,NA,NA,"Denosumab 60 Mg/Ml Subcutaneous Syringe"
"236","1411498","Dual-energy X-ray absorptiometry (DXA), bone density study, 1 or more sites; axial skeleton (eg, hips, pelvis, spine)",2017-10-26 11:52:00,2015-02-16 00:00:00,"813.42","Other closed fractures of distal end of radius (alone)",67,230.6,76,"F","W",4,36.1131209623524,1996-07-12 20:45:00,2021-03-29 10:01:00,48,586,NA,NA,NA,"Denosumab 60 Mg/Ml Subcutaneous Syringe"
"237","1411498","Dual-energy X-ray absorptiometry (DXA), bone density study, 1 or more sites; axial skeleton (eg, hips, pelvis, spine)",2017-10-26 12:05:00,2015-02-16 00:00:00,"813.42","Other closed fractures of distal end of radius (alone)",67,230.6,76,"F","W",4,36.1131209623524,1996-07-12 20:45:00,2021-03-29 10:01:00,48,586,NA,NA,NA,"Denosumab 60 Mg/Ml Subcutaneous Syringe"
"238","1413509","Dual-energy X-ray absorptiometry (DXA), bone density study, 1 or more sites; axial skeleton (eg, hips, pelvis, spine)",2009-06-29 00:00:00,1994-01-29 09:12:00,"813.44","Closed fracture of lower end of radius with ulna",61,116,53,"F","W",3,21.915614082236,1994-01-29 09:12:00,2016-01-28 10:54:00,0,361,NA,NA,NA,"Teriparatide 20 Mcg/Dose (600 Mcg/2.4 Ml) Subcutaneous Pen Injector"
"239","1413509","Dual-energy X-ray absorptiometry (DXA), bone density study, 1 or more sites; axial skeleton (eg, hips, pelvis, spine)",2007-07-26 00:00:00,1994-01-29 09:12:00,"813.44","Closed fracture of lower end of radius with ulna",61,116,53,"F","W",3,21.915614082236,1994-01-29 09:12:00,2016-01-28 10:54:00,0,361,NA,NA,NA,"Teriparatide 20 Mcg/Dose (600 Mcg/2.4 Ml) Subcutaneous Pen Injector"
"240","1413509","Dual-energy X-ray absorptiometry (DXA), bone density study, 1 or more sites; axial skeleton (eg, hips, pelvis, spine)",2014-09-15 09:10:00,1994-01-29 09:12:00,"813.44","Closed fracture of lower end of radius with ulna",61,116,53,"F","W",3,21.915614082236,1994-01-29 09:12:00,2016-01-28 10:54:00,0,361,NA,NA,NA,"Teriparatide 20 Mcg/Dose (600 Mcg/2.4 Ml) Subcutaneous Pen Injector"
"241","1413509","Dual-energy X-ray absorptiometry (DXA), bone density study, 1 or more sites; axial skeleton (eg, hips, pelvis, spine)",2014-09-15 09:28:00,1994-01-29 09:12:00,"813.44","Closed fracture of lower end of radius with ulna",61,116,53,"F","W",3,21.915614082236,1994-01-29 09:12:00,2016-01-28 10:54:00,0,361,NA,NA,NA,"Teriparatide 20 Mcg/Dose (600 Mcg/2.4 Ml) Subcutaneous Pen Injector"
"242","1414724","Dual-energy X-ray absorptiometry (DXA), bone density study, 1 or more sites; axial skeleton (eg, hips, pelvis, spine)",2018-05-22 08:41:00,2017-11-13 00:00:00,"810.03","Closed fracture of acromial end of clavicle",60,116,74,"F","W",4,22.6522222222222,1990-06-01 06:30:00,2021-03-22 16:39:00,208,550,NA,NA,NA,"Teriparatide 20 Mcg/Dose (600 Mcg/2.4 Ml) Subcutaneous Pen Injector"
"243","1414724","Dual-energy X-ray absorptiometry (DXA), bone density study, 1 or more sites; axial skeleton (eg, hips, pelvis, spine)",2018-05-22 08:56:00,2017-11-13 00:00:00,"810.03","Closed fracture of acromial end of clavicle",60,116,74,"F","W",4,22.6522222222222,1990-06-01 06:30:00,2021-03-22 16:39:00,208,550,NA,NA,NA,"Teriparatide 20 Mcg/Dose (600 Mcg/2.4 Ml) Subcutaneous Pen Injector"
"244","1414724","Dual-energy X-ray absorptiometry (DXA), bone density study, 1 or more sites; axial skeleton (eg, hips, pelvis, spine)",2020-08-14 09:30:00,2017-11-13 00:00:00,"810.03","Closed fracture of acromial end of clavicle",60,116,74,"F","W",4,22.6522222222222,1990-06-01 06:30:00,2021-03-22 16:39:00,208,550,NA,NA,NA,"Teriparatide 20 Mcg/Dose (600 Mcg/2.4 Ml) Subcutaneous Pen Injector"
"245","1414724","Dual-energy X-ray absorptiometry (DXA), bone density study, 1 or more sites; axial skeleton (eg, hips, pelvis, spine)",2020-08-14 09:52:00,2017-11-13 00:00:00,"810.03","Closed fracture of acromial end of clavicle",60,116,74,"F","W",4,22.6522222222222,1990-06-01 06:30:00,2021-03-22 16:39:00,208,550,NA,NA,NA,"Teriparatide 20 Mcg/Dose (600 Mcg/2.4 Ml) Subcutaneous Pen Injector"
"246","1430426","Dual-energy X-ray absorptiometry (DXA), bone density study, 1 or more sites; axial skeleton (eg, hips, pelvis, spine)",2018-09-05 14:41:00,2016-11-05 00:00:00,"S72.002A","Fracture of unspecified part of neck of left femur, initial encounter for closed fracture",64,205.5,41,"F","W",4,35.2701416015625,2016-09-13 23:07:00,2021-03-03 00:00:00,7,696,NA,NA,NA,NA
"247","1433336","Dual-energy X-ray absorptiometry (DXA), bone density study, 1 or more sites; axial skeleton (eg, hips, pelvis, spine)",2015-09-25 10:18:00,2017-07-04 00:00:00,"S72.001A","Fracture of unspecified part of neck of right femur, initial encounter for closed fracture",61,151.4,77,"F","W",4,28.60365493147,2007-08-09 00:00:00,2018-01-02 00:00:00,667,650,NA,NA,NA,"Estrogen receptor positive status [ER+]"
"248","1433336","Dual-energy X-ray absorptiometry (DXA), bone density study, 1 or more sites; axial skeleton (eg, hips, pelvis, spine)",2015-09-25 10:56:00,2017-07-04 00:00:00,"S72.001A","Fracture of unspecified part of neck of right femur, initial encounter for closed fracture",61,151.4,77,"F","W",4,28.60365493147,2007-08-09 00:00:00,2018-01-02 00:00:00,667,650,NA,NA,NA,"Estrogen receptor positive status [ER+]"
"249","1452314","Dual-energy X-ray absorptiometry (DXA), bone density study, 1 or more sites; axial skeleton (eg, hips, pelvis, spine)",2010-04-20 00:00:00,2011-05-11 00:00:00,"807.06","Closed fracture of six ribs",66,192.02,73,"F","W",4,30.9894536271809,1995-04-26 14:52:00,2021-03-30 00:00:00,176,684,NA,NA,NA,"Conjugated Estrogens 0.625 Mg Tablet"
"250","1452314","Dual-energy X-ray absorptiometry (DXA), bone density study, 1 or more sites; axial skeleton (eg, hips, pelvis, spine)",2014-04-16 13:49:00,2011-05-11 00:00:00,"807.06","Closed fracture of six ribs",66,192.02,73,"F","W",4,30.9894536271809,1995-04-26 14:52:00,2021-03-30 00:00:00,176,684,NA,NA,NA,"Conjugated Estrogens 0.625 Mg Tablet"
"251","1452314","Dual-energy X-ray absorptiometry (DXA), bone density study, 1 or more sites; axial skeleton (eg, hips, pelvis, spine)",2014-04-16 14:07:00,2011-05-11 00:00:00,"807.06","Closed fracture of six ribs",66,192.02,73,"F","W",4,30.9894536271809,1995-04-26 14:52:00,2021-03-30 00:00:00,176,684,NA,NA,NA,"Conjugated Estrogens 0.625 Mg Tablet"
"252","1456127","Dual-energy X-ray absorptiometry (DXA), bone density study, 1 or more sites; axial skeleton (eg, hips, pelvis, spine)",2018-10-04 11:02:00,2012-03-01 00:00:00,"733.97","Stress fracture of shaft of femur",60.5,130.3,65,"F","W",3,25.0258588894201,2003-09-23 00:00:00,2021-03-20 00:00:00,145,544,NA,NA,NA,NA
"253","1456364","Dual-energy X-ray absorptiometry (DXA), bone density study, 1 or more sites; axial skeleton (eg, hips, pelvis, spine)",2009-12-01 00:00:00,2017-03-28 00:00:00,"733.14","Pathologic fracture of neck of femur",67.5,130.3,67,"F","W",4,20.1044499314129,2007-02-16 00:00:00,2021-03-18 00:00:00,458,302,NA,NA,NA,"Denosumab 60 Mg/Ml Subcutaneous Syringe"
"254","1456364","Dual-energy X-ray absorptiometry (DXA), bone density study, 1 or more sites; axial skeleton (eg, hips, pelvis, spine)",2007-03-23 00:00:00,2017-03-28 00:00:00,"733.14","Pathologic fracture of neck of femur",67.5,130.3,67,"F","W",4,20.1044499314129,2007-02-16 00:00:00,2021-03-18 00:00:00,458,302,NA,NA,NA,"Denosumab 60 Mg/Ml Subcutaneous Syringe"
"255","1456364","Dual-energy X-ray absorptiometry (DXA), bone density study, 1 or more sites; axial skeleton (eg, hips, pelvis, spine)",2009-03-20 00:00:00,2017-03-28 00:00:00,"733.14","Pathologic fracture of neck of femur",67.5,130.3,67,"F","W",4,20.1044499314129,2007-02-16 00:00:00,2021-03-18 00:00:00,458,302,NA,NA,NA,"Denosumab 60 Mg/Ml Subcutaneous Syringe"
"256","1456364","Dual-energy X-ray absorptiometry (DXA), bone density study, 1 or more sites; axial skeleton (eg, hips, pelvis, spine)",2011-03-29 00:00:00,2017-03-28 00:00:00,"733.14","Pathologic fracture of neck of femur",67.5,130.3,67,"F","W",4,20.1044499314129,2007-02-16 00:00:00,2021-03-18 00:00:00,458,302,NA,NA,NA,"Denosumab 60 Mg/Ml Subcutaneous Syringe"
"257","1456364","Dual-energy X-ray absorptiometry (DXA), bone density study, 1 or more sites; axial skeleton (eg, hips, pelvis, spine)",2011-03-29 00:00:00,2017-03-28 00:00:00,"733.14","Pathologic fracture of neck of femur",67.5,130.3,67,"F","W",4,20.1044499314129,2007-02-16 00:00:00,2021-03-18 00:00:00,458,302,NA,NA,NA,"Denosumab 60 Mg/Ml Subcutaneous Syringe"
"258","1456364","Dual-energy X-ray absorptiometry (DXA), bone density study, 1 or more sites; axial skeleton (eg, hips, pelvis, spine)",2013-05-13 09:22:00,2017-03-28 00:00:00,"733.14","Pathologic fracture of neck of femur",67.5,130.3,67,"F","W",4,20.1044499314129,2007-02-16 00:00:00,2021-03-18 00:00:00,458,302,NA,NA,NA,"Denosumab 60 Mg/Ml Subcutaneous Syringe"
"259","1456364","Dual-energy X-ray absorptiometry (DXA), bone density study, 1 or more sites; axial skeleton (eg, hips, pelvis, spine)",2015-06-09 09:11:00,2017-03-28 00:00:00,"733.14","Pathologic fracture of neck of femur",67.5,130.3,67,"F","W",4,20.1044499314129,2007-02-16 00:00:00,2021-03-18 00:00:00,458,302,NA,NA,NA,"Denosumab 60 Mg/Ml Subcutaneous Syringe"
"260","1456364","Dual-energy X-ray absorptiometry (DXA), bone density study, 1 or more sites; axial skeleton (eg, hips, pelvis, spine)",2015-06-09 09:35:00,2017-03-28 00:00:00,"733.14","Pathologic fracture of neck of femur",67.5,130.3,67,"F","W",4,20.1044499314129,2007-02-16 00:00:00,2021-03-18 00:00:00,458,302,NA,NA,NA,"Denosumab 60 Mg/Ml Subcutaneous Syringe"
"261","1456982","Dual-energy X-ray absorptiometry (DXA), bone density study, 1 or more sites; axial skeleton (eg, hips, pelvis, spine)",2018-06-12 09:53:00,2009-11-04 00:00:00,"733.97","Stress fracture of shaft of femur",64.75,95,60,"F","W",3,15.9293987865416,2009-11-04 00:00:00,2020-12-14 00:00:00,0,144,NA,NA,NA,"Conjugated Estrogens 0.625 Mg/Gram Vaginal Cream"
"262","1459799","Dual-energy X-ray absorptiometry (DXA), bone density study, 1 or more sites; axial skeleton (eg, hips, pelvis, spine)",2020-01-16 09:45:00,1998-07-27 00:00:00,"824.8","Unspecified fracture of ankle, closed",66,85.2,58,"F","W",4,13.7501377410468,1992-12-18 12:20:00,2021-03-25 00:00:00,17,880,NA,NA,NA,"Alendronate 70 Mg Tablet"
"263","1463234","Dual-energy X-ray absorptiometry (DXA), bone density study, 1 or more sites; axial skeleton (eg, hips, pelvis, spine)",2009-03-10 00:00:00,2009-06-16 13:20:00,"733.96","Stress fracture of femoral neck",63.5,225.3,70,"F","W",4,39.2797817595635,1987-05-10 16:00:00,2021-03-17 00:00:00,282,1692,NA,NA,NA,"Alendronate 70 Mg Tablet"
"264","1464348","Dual-energy X-ray absorptiometry (DXA), bone density study, 1 or more sites; axial skeleton (eg, hips, pelvis, spine)",2009-10-06 00:00:00,2015-12-22 00:00:00,"M84.459G","Pathological fracture, hip, unspecified, subsequent encounter for fracture with delayed healing",62,225.5,66,"F","W",3,41.2399843912591,1999-04-08 00:00:00,2018-03-14 18:00:00,313,827,NA,NA,NA,"Denosumab 120 Mg/1.7 Ml (70 Mg/Ml) Subcutaneous Solution"
"265","1464348","Dual-energy X-ray absorptiometry (DXA), bone density study, 1 or more sites; axial skeleton (eg, hips, pelvis, spine)",2011-10-07 00:00:00,2015-12-22 00:00:00,"M84.459G","Pathological fracture, hip, unspecified, subsequent encounter for fracture with delayed healing",62,225.5,66,"F","W",3,41.2399843912591,1999-04-08 00:00:00,2018-03-14 18:00:00,313,827,NA,NA,NA,"Denosumab 120 Mg/1.7 Ml (70 Mg/Ml) Subcutaneous Solution"
"266","1464348","Dual-energy X-ray absorptiometry (DXA), bone density study, 1 or more sites; axial skeleton (eg, hips, pelvis, spine)",2011-10-07 00:00:00,2015-12-22 00:00:00,"M84.459G","Pathological fracture, hip, unspecified, subsequent encounter for fracture with delayed healing",62,225.5,66,"F","W",3,41.2399843912591,1999-04-08 00:00:00,2018-03-14 18:00:00,313,827,NA,NA,NA,"Denosumab 120 Mg/1.7 Ml (70 Mg/Ml) Subcutaneous Solution"
"267","1471231","Dual-energy X-ray absorptiometry (DXA), bone density study, 1 or more sites; axial skeleton (eg, hips, pelvis, spine)",2008-06-16 00:00:00,2011-07-01 00:00:00,"M81.0","Age-related osteoporosis without current pathological fracture",64,134.1,69,"F","W",3,23.0156982421875,2007-11-15 00:00:00,2021-01-25 12:22:00,16,438,NA,NA,NA,"Alendronate 70 Mg Tablet"
"268","1472557","Dual-energy X-ray absorptiometry (DXA), bone density study, 1 or more sites; axial skeleton (eg, hips, pelvis, spine)",2016-06-23 14:16:00,2011-01-31 00:00:00,"733.82","Nonunion of fracture",65,159.1,63,"F","W",5,26.4727337278107,2009-05-28 00:00:00,2019-01-22 00:00:00,194,6913,NA,NA,NA,"Teriparatide 20 Mcg/Dose (600 Mcg/2.4 Ml) Subcutaneous Pen Injector"
"269","1472557","Dual-energy X-ray absorptiometry (DXA), bone density study, 1 or more sites; axial skeleton (eg, hips, pelvis, spine)",2016-06-23 15:02:00,2011-01-31 00:00:00,"733.82","Nonunion of fracture",65,159.1,63,"F","W",5,26.4727337278107,2009-05-28 00:00:00,2019-01-22 00:00:00,194,6913,NA,NA,NA,"Teriparatide 20 Mcg/Dose (600 Mcg/2.4 Ml) Subcutaneous Pen Injector"
"270","1476319","Dual-energy X-ray absorptiometry (DXA), bone density study, 1 or more sites; axial skeleton (eg, hips, pelvis, spine)",2020-12-31 15:00:00,2019-10-19 00:01:00,"733.14","Pathologic fracture of neck of femur",62,223.2,63,"F","B",4,40.8193548387097,1999-01-21 00:00:00,2021-03-24 11:19:00,37,296,NA,NA,NA,"Alendronate 70 Mg Tablet"
"271","1476319","Dual-energy X-ray absorptiometry (DXA), bone density study, 1 or more sites; axial skeleton (eg, hips, pelvis, spine)",2020-12-31 15:14:00,2019-10-19 00:01:00,"733.14","Pathologic fracture of neck of femur",62,223.2,63,"F","B",4,40.8193548387097,1999-01-21 00:00:00,2021-03-24 11:19:00,37,296,NA,NA,NA,"Alendronate 70 Mg Tablet"
"272","1480804","Dual-energy X-ray absorptiometry (DXA), bone density study, 1 or more sites; axial skeleton (eg, hips, pelvis, spine)",2009-04-28 00:00:00,2001-12-02 00:00:00,"812.00","Closed fracture of unspecified part of upper end of humerus",61,115.8,78,"F","W",4,21.8778285407149,1988-11-28 15:05:00,2018-03-15 14:56:00,63,702,NA,NA,NA,"Estrogen receptor positive status [ER+]"
"273","1480804","Dual-energy X-ray absorptiometry (DXA), bone density study, 1 or more sites; axial skeleton (eg, hips, pelvis, spine)",2012-04-11 00:00:00,2001-12-02 00:00:00,"812.00","Closed fracture of unspecified part of upper end of humerus",61,115.8,78,"F","W",4,21.8778285407149,1988-11-28 15:05:00,2018-03-15 14:56:00,63,702,NA,NA,NA,"Estrogen receptor positive status [ER+]"
"274","1480804","Dual-energy X-ray absorptiometry (DXA), bone density study, 1 or more sites; axial skeleton (eg, hips, pelvis, spine)",2012-04-11 00:00:00,2001-12-02 00:00:00,"812.00","Closed fracture of unspecified part of upper end of humerus",61,115.8,78,"F","W",4,21.8778285407149,1988-11-28 15:05:00,2018-03-15 14:56:00,63,702,NA,NA,NA,"Estrogen receptor positive status [ER+]"
"275","1482512","Dual-energy X-ray absorptiometry (DXA), bone density study, 1 or more sites; axial skeleton (eg, hips, pelvis, spine)",2018-04-12 15:43:00,2014-01-29 00:00:00,"M81.0","Age-related osteoporosis without current pathological fracture",64,126.1,61,"F","W",4,21.6426513671875,1996-11-12 00:00:00,2021-03-29 09:00:00,115,869,NA,NA,NA,"Alendronate 70 Mg Tablet"
"276","1482512","Dual-energy X-ray absorptiometry (DXA), bone density study, 1 or more sites; axial skeleton (eg, hips, pelvis, spine)",2020-08-07 10:20:00,2014-01-29 00:00:00,"M81.0","Age-related osteoporosis without current pathological fracture",64,126.1,61,"F","W",4,21.6426513671875,1996-11-12 00:00:00,2021-03-29 09:00:00,115,869,NA,NA,NA,"Alendronate 70 Mg Tablet"
"277","1482780","Dual-energy X-ray absorptiometry (DXA), bone density study, 1 or more sites; axial skeleton (eg, hips, pelvis, spine)",2007-12-27 00:00:00,2013-11-21 00:00:00,"820.8","Closed fracture of unspecified part of neck of femur",62,129.3,74,"F","W",3,23.6466961498439,1989-01-01 00:00:00,2021-03-31 19:00:00,489,5315,NA,NA,NA,"Risedronate 150 Mg Tablet"
"278","1482780","Dual-energy X-ray absorptiometry (DXA), bone density study, 1 or more sites; axial skeleton (eg, hips, pelvis, spine)",2012-03-27 00:00:00,2013-11-21 00:00:00,"820.8","Closed fracture of unspecified part of neck of femur",62,129.3,74,"F","W",3,23.6466961498439,1989-01-01 00:00:00,2021-03-31 19:00:00,489,5315,NA,NA,NA,"Risedronate 150 Mg Tablet"
"279","1482780","Dual-energy X-ray absorptiometry (DXA), bone density study, 1 or more sites; axial skeleton (eg, hips, pelvis, spine)",2012-03-27 00:00:00,2013-11-21 00:00:00,"820.8","Closed fracture of unspecified part of neck of femur",62,129.3,74,"F","W",3,23.6466961498439,1989-01-01 00:00:00,2021-03-31 19:00:00,489,5315,NA,NA,NA,"Risedronate 150 Mg Tablet"
"280","1491377","Dual-energy X-ray absorptiometry (DXA), bone density study, 1 or more sites; axial skeleton (eg, hips, pelvis, spine)",2008-05-23 00:00:00,2011-01-21 00:00:00,"807.00","Closed fracture of rib(s), unspecified",65,199.3,68,"F","W",3,33.1616331360947,1988-04-01 00:00:00,2021-03-30 10:22:00,180,728,NA,NA,NA,"Estrogen receptor positive status [ER+]"
"281","1491377","Dual-energy X-ray absorptiometry (DXA), bone density study, 1 or more sites; axial skeleton (eg, hips, pelvis, spine)",2011-01-05 00:00:00,2011-01-21 00:00:00,"807.00","Closed fracture of rib(s), unspecified",65,199.3,68,"F","W",3,33.1616331360947,1988-04-01 00:00:00,2021-03-30 10:22:00,180,728,NA,NA,NA,"Estrogen receptor positive status [ER+]"
"282","1491377","Dual-energy X-ray absorptiometry (DXA), bone density study, 1 or more sites; axial skeleton (eg, hips, pelvis, spine)",2011-01-05 00:00:00,2011-01-21 00:00:00,"807.00","Closed fracture of rib(s), unspecified",65,199.3,68,"F","W",3,33.1616331360947,1988-04-01 00:00:00,2021-03-30 10:22:00,180,728,NA,NA,NA,"Estrogen receptor positive status [ER+]"
"283","1493171","Dual-energy X-ray absorptiometry (DXA), bone density study, 1 or more sites; axial skeleton (eg, hips, pelvis, spine)",2010-01-12 00:00:00,1997-04-25 00:00:00,"813.83","Closed fracture of unspecified part of radius with ulna",61.98,130,30,"F","W",3,23.7900597898686,1997-04-25 00:00:00,2011-12-29 10:20:00,0,218,NA,NA,NA,NA
"284","1493171","Dual-energy X-ray absorptiometry (DXA), bone density study, 1 or more sites; axial skeleton (eg, hips, pelvis, spine)",2008-09-11 00:00:00,1997-04-25 00:00:00,"813.83","Closed fracture of unspecified part of radius with ulna",61.98,130,30,"F","W",3,23.7900597898686,1997-04-25 00:00:00,2011-12-29 10:20:00,0,218,NA,NA,NA,NA
"285","1493171","Dual-energy X-ray absorptiometry (DXA), bone density study, 1 or more sites; axial skeleton (eg, hips, pelvis, spine)",2010-12-30 00:00:00,1997-04-25 00:00:00,"813.83","Closed fracture of unspecified part of radius with ulna",61.98,130,30,"F","W",3,23.7900597898686,1997-04-25 00:00:00,2011-12-29 10:20:00,0,218,NA,NA,NA,NA
"286","1493171","Dual-energy X-ray absorptiometry (DXA), bone density study, 1 or more sites; axial skeleton (eg, hips, pelvis, spine)",2010-12-30 00:00:00,1997-04-25 00:00:00,"813.83","Closed fracture of unspecified part of radius with ulna",61.98,130,30,"F","W",3,23.7900597898686,1997-04-25 00:00:00,2011-12-29 10:20:00,0,218,NA,NA,NA,NA
"287","1493171","Dual-energy X-ray absorptiometry (DXA), bone density study, 1 or more sites; axial skeleton (eg, hips, pelvis, spine)",2011-12-29 00:00:00,1997-04-25 00:00:00,"813.83","Closed fracture of unspecified part of radius with ulna",61.98,130,30,"F","W",3,23.7900597898686,1997-04-25 00:00:00,2011-12-29 10:20:00,0,218,NA,NA,NA,NA
"288","1493171","Dual-energy X-ray absorptiometry (DXA), bone density study, 1 or more sites; axial skeleton (eg, hips, pelvis, spine)",2011-12-29 00:00:00,1997-04-25 00:00:00,"813.83","Closed fracture of unspecified part of radius with ulna",61.98,130,30,"F","W",3,23.7900597898686,1997-04-25 00:00:00,2011-12-29 10:20:00,0,218,NA,NA,NA,NA
"289","1493171","Dual-energy X-ray absorptiometry (DXA), bone density study, 1 or more sites; appendicular skeleton (peripheral) (eg, radius, wrist, heel)",2011-12-29 00:00:00,1997-04-25 00:00:00,"813.83","Closed fracture of unspecified part of radius with ulna",61.98,130,30,"F","W",3,23.7900597898686,1997-04-25 00:00:00,2011-12-29 10:20:00,0,218,NA,NA,NA,NA
"290","1493171","Dual-energy X-ray absorptiometry (DXA), bone density study, 1 or more sites; appendicular skeleton (peripheral) (eg, radius, wrist, heel)",2011-12-29 00:00:00,1997-04-25 00:00:00,"813.83","Closed fracture of unspecified part of radius with ulna",61.98,130,30,"F","W",3,23.7900597898686,1997-04-25 00:00:00,2011-12-29 10:20:00,0,218,NA,NA,NA,NA
"291","1501142","Dual-energy X-ray absorptiometry (DXA), bone density study, 1 or more sites; axial skeleton (eg, hips, pelvis, spine)",2018-04-13 14:47:00,2002-10-09 00:00:00,"822.0","Closed fracture of patella",63.78,105.4,76,"F","W",4,18.2149048140062,2002-01-28 17:21:00,2021-03-08 00:00:00,7,1407,NA,NA,NA,"Conjugated Estrogens 0.625 Mg/Gram Vaginal Cream"
"292","1501142","Dual-energy X-ray absorptiometry (DXA), bone density study, 1 or more sites; axial skeleton (eg, hips, pelvis, spine)",2018-04-13 14:58:00,2002-10-09 00:00:00,"822.0","Closed fracture of patella",63.78,105.4,76,"F","W",4,18.2149048140062,2002-01-28 17:21:00,2021-03-08 00:00:00,7,1407,NA,NA,NA,"Conjugated Estrogens 0.625 Mg/Gram Vaginal Cream"
"293","1508884","Dual-energy X-ray absorptiometry (DXA), bone density study, 1 or more sites; axial skeleton (eg, hips, pelvis, spine)",2007-05-30 00:00:00,2013-03-12 00:00:00,"M81.0","Age-related osteoporosis without current pathological fracture",65,280.7,84,"F","W",3,46.7058224852071,2000-11-07 00:00:00,2019-05-20 16:00:00,145,1065,NA,NA,NA,"Zoledronic Acid 5 Mg/100 Ml In Mannitol 5 % And Water Intravenous"
"294","1508884","Dual-energy X-ray absorptiometry (DXA), bone density study, 1 or more sites; axial skeleton (eg, hips, pelvis, spine)",2010-05-03 00:00:00,2013-03-12 00:00:00,"M81.0","Age-related osteoporosis without current pathological fracture",65,280.7,84,"F","W",3,46.7058224852071,2000-11-07 00:00:00,2019-05-20 16:00:00,145,1065,NA,NA,NA,"Zoledronic Acid 5 Mg/100 Ml In Mannitol 5 % And Water Intravenous"
"295","1510602","Dual-energy X-ray absorptiometry (DXA), bone density study, 1 or more sites; axial skeleton (eg, hips, pelvis, spine)",2020-09-04 10:20:00,2020-07-07 00:00:00,"820.8","Closed fracture of unspecified part of neck of femur",69,122.9,62,"M","W",4,18.147174963243,2009-05-17 00:00:00,2020-11-30 00:00:00,21,354,NA,NA,NA,NA
"296","1510644","Dual-energy X-ray absorptiometry (DXA), bone density study, 1 or more sites; axial skeleton (eg, hips, pelvis, spine)",2018-04-20 13:46:00,2018-03-20 00:00:00,"733.14","Pathologic fracture of neck of femur",69,190,79,"M","W",4,28.0550304557866,1997-06-10 00:00:00,2021-03-29 13:35:00,764,224,NA,NA,NA,"Denosumab 60 Mg/Ml Subcutaneous Syringe"
"297","1510644","Dual-energy X-ray absorptiometry (DXA), bone density study, 1 or more sites; axial skeleton (eg, hips, pelvis, spine)",2018-04-20 13:53:00,2018-03-20 00:00:00,"733.14","Pathologic fracture of neck of femur",69,190,79,"M","W",4,28.0550304557866,1997-06-10 00:00:00,2021-03-29 13:35:00,764,224,NA,NA,NA,"Denosumab 60 Mg/Ml Subcutaneous Syringe"
"298","1510644","Dual-energy X-ray absorptiometry (DXA), bone density study, 1 or more sites; axial skeleton (eg, hips, pelvis, spine)",2019-04-23 08:47:00,2018-03-20 00:00:00,"733.14","Pathologic fracture of neck of femur",69,190,79,"M","W",4,28.0550304557866,1997-06-10 00:00:00,2021-03-29 13:35:00,764,224,NA,NA,NA,"Denosumab 60 Mg/Ml Subcutaneous Syringe"
"299","1510644","Dual-energy X-ray absorptiometry (DXA), bone density study, 1 or more sites; axial skeleton (eg, hips, pelvis, spine)",2019-04-23 08:59:00,2018-03-20 00:00:00,"733.14","Pathologic fracture of neck of femur",69,190,79,"M","W",4,28.0550304557866,1997-06-10 00:00:00,2021-03-29 13:35:00,764,224,NA,NA,NA,"Denosumab 60 Mg/Ml Subcutaneous Syringe"
"300","1510644","Dual-energy X-ray absorptiometry (DXA), bone density study, 1 or more sites; axial skeleton (eg, hips, pelvis, spine)",2020-06-09 08:46:00,2018-03-20 00:00:00,"733.14","Pathologic fracture of neck of femur",69,190,79,"M","W",4,28.0550304557866,1997-06-10 00:00:00,2021-03-29 13:35:00,764,224,NA,NA,NA,"Denosumab 60 Mg/Ml Subcutaneous Syringe"
"301","1510644","Dual-energy X-ray absorptiometry (DXA), bone density study, 1 or more sites; axial skeleton (eg, hips, pelvis, spine)",2020-06-09 08:58:00,2018-03-20 00:00:00,"733.14","Pathologic fracture of neck of femur",69,190,79,"M","W",4,28.0550304557866,1997-06-10 00:00:00,2021-03-29 13:35:00,764,224,NA,NA,NA,"Denosumab 60 Mg/Ml Subcutaneous Syringe"
"302","1510987","Dual-energy X-ray absorptiometry (DXA), bone density study, 1 or more sites; axial skeleton (eg, hips, pelvis, spine)",2015-01-27 10:18:00,2014-04-20 00:00:00,"820.8","Closed fracture of unspecified part of neck of femur",66,131.1,87,"F","W",4,21.157782369146,2005-11-07 00:00:00,2018-10-03 00:00:00,111,651,NA,NA,NA,"Alendronate 70 Mg Tablet"
"303","1510987","Dual-energy X-ray absorptiometry (DXA), bone density study, 1 or more sites; axial skeleton (eg, hips, pelvis, spine)",2015-01-27 10:35:00,2014-04-20 00:00:00,"820.8","Closed fracture of unspecified part of neck of femur",66,131.1,87,"F","W",4,21.157782369146,2005-11-07 00:00:00,2018-10-03 00:00:00,111,651,NA,NA,NA,"Alendronate 70 Mg Tablet"
"304","1520191","Dual-energy X-ray absorptiometry (DXA), bone density study, 1 or more sites; axial skeleton (eg, hips, pelvis, spine)",2014-08-11 13:24:00,2013-08-20 00:00:00,"807.00","Closed fracture of rib(s), unspecified",64.961,200.4,79,"M","W",4,33.3847123582269,2005-05-31 00:00:00,2020-11-18 00:00:00,864,2926,NA,NA,NA,"Denosumab 60 Mg/Ml Subcutaneous Syringe"
"305","1520191","Dual-energy X-ray absorptiometry (DXA), bone density study, 1 or more sites; axial skeleton (eg, hips, pelvis, spine)",2014-08-11 13:44:00,2013-08-20 00:00:00,"807.00","Closed fracture of rib(s), unspecified",64.961,200.4,79,"M","W",4,33.3847123582269,2005-05-31 00:00:00,2020-11-18 00:00:00,864,2926,NA,NA,NA,"Denosumab 60 Mg/Ml Subcutaneous Syringe"
"306","1520191","Dual-energy X-ray absorptiometry (DXA), bone density study, 1 or more sites; axial skeleton (eg, hips, pelvis, spine)",2017-07-11 09:48:00,2013-08-20 00:00:00,"807.00","Closed fracture of rib(s), unspecified",64.961,200.4,79,"M","W",4,33.3847123582269,2005-05-31 00:00:00,2020-11-18 00:00:00,864,2926,NA,NA,NA,"Denosumab 60 Mg/Ml Subcutaneous Syringe"
"307","1520191","Dual-energy X-ray absorptiometry (DXA), bone density study, 1 or more sites; axial skeleton (eg, hips, pelvis, spine)",2017-07-11 10:21:00,2013-08-20 00:00:00,"807.00","Closed fracture of rib(s), unspecified",64.961,200.4,79,"M","W",4,33.3847123582269,2005-05-31 00:00:00,2020-11-18 00:00:00,864,2926,NA,NA,NA,"Denosumab 60 Mg/Ml Subcutaneous Syringe"
"308","1520191","Dual-energy X-ray absorptiometry (DXA), bone density study, 1 or more sites; axial skeleton (eg, hips, pelvis, spine)",2018-07-18 12:44:00,2013-08-20 00:00:00,"807.00","Closed fracture of rib(s), unspecified",64.961,200.4,79,"M","W",4,33.3847123582269,2005-05-31 00:00:00,2020-11-18 00:00:00,864,2926,NA,NA,NA,"Denosumab 60 Mg/Ml Subcutaneous Syringe"
"309","1520191","Dual-energy X-ray absorptiometry (DXA), bone density study, 1 or more sites; axial skeleton (eg, hips, pelvis, spine)",2018-07-18 13:14:00,2013-08-20 00:00:00,"807.00","Closed fracture of rib(s), unspecified",64.961,200.4,79,"M","W",4,33.3847123582269,2005-05-31 00:00:00,2020-11-18 00:00:00,864,2926,NA,NA,NA,"Denosumab 60 Mg/Ml Subcutaneous Syringe"
"310","1520219","Dual-energy X-ray absorptiometry (DXA), bone density study, 1 or more sites; axial skeleton (eg, hips, pelvis, spine)",2015-11-04 12:51:00,2018-01-18 00:00:00,"733.14","Pathologic fracture of neck of femur",68,169.3,60,"F","W",5,25.7391652249135,1996-03-21 08:00:00,2021-03-23 00:00:00,500,259,NA,NA,NA,"Conjugated Estrogens 0.3 Mg Tablet"
"311","1520219","Dual-energy X-ray absorptiometry (DXA), bone density study, 1 or more sites; axial skeleton (eg, hips, pelvis, spine)",2015-11-04 13:02:00,2018-01-18 00:00:00,"733.14","Pathologic fracture of neck of femur",68,169.3,60,"F","W",5,25.7391652249135,1996-03-21 08:00:00,2021-03-23 00:00:00,500,259,NA,NA,NA,"Conjugated Estrogens 0.3 Mg Tablet"
"312","1520219","Dual-energy X-ray absorptiometry (DXA), bone density study, 1 or more sites; axial skeleton (eg, hips, pelvis, spine)",2018-03-27 09:00:00,2018-01-18 00:00:00,"733.14","Pathologic fracture of neck of femur",68,169.3,60,"F","W",5,25.7391652249135,1996-03-21 08:00:00,2021-03-23 00:00:00,500,259,NA,NA,NA,"Conjugated Estrogens 0.3 Mg Tablet"
"313","1520219","Dual-energy X-ray absorptiometry (DXA), bone density study, 1 or more sites; axial skeleton (eg, hips, pelvis, spine)",2018-03-27 09:13:00,2018-01-18 00:00:00,"733.14","Pathologic fracture of neck of femur",68,169.3,60,"F","W",5,25.7391652249135,1996-03-21 08:00:00,2021-03-23 00:00:00,500,259,NA,NA,NA,"Conjugated Estrogens 0.3 Mg Tablet"
"314","1522772","Dual-energy X-ray absorptiometry (DXA), bone density study, 1 or more sites; axial skeleton (eg, hips, pelvis, spine)",2019-12-30 10:52:00,2017-03-31 00:00:00,"M81.0","Age-related osteoporosis without current pathological fracture",65,164.3,71,"F","W",3,27.3379644970414,2007-06-18 00:00:00,2021-03-30 00:00:00,150,592,NA,NA,NA,NA
"315","1526036","Dual-energy X-ray absorptiometry (DXA), bone density study, 1 or more sites; axial skeleton (eg, hips, pelvis, spine)",2017-04-26 14:01:00,2004-05-04 00:00:00,"829.0","Fracture of unspecified bone, closed",58,115.3,76,"F","W",4,24.0950951248514,1997-08-15 00:00:00,2021-03-31 13:06:00,66,2131,NA,NA,NA,"Teriparatide 20 Mcg/Dose (600 Mcg/2.4 Ml) Subcutaneous Pen Injector"
"316","1526036","Dual-energy X-ray absorptiometry (DXA), bone density study, 1 or more sites; axial skeleton (eg, hips, pelvis, spine)",2017-04-26 14:11:00,2004-05-04 00:00:00,"829.0","Fracture of unspecified bone, closed",58,115.3,76,"F","W",4,24.0950951248514,1997-08-15 00:00:00,2021-03-31 13:06:00,66,2131,NA,NA,NA,"Teriparatide 20 Mcg/Dose (600 Mcg/2.4 Ml) Subcutaneous Pen Injector"
"317","1526036","Dual-energy X-ray absorptiometry (DXA), bone density study, 1 or more sites; axial skeleton (eg, hips, pelvis, spine)",2019-09-27 14:30:00,2004-05-04 00:00:00,"829.0","Fracture of unspecified bone, closed",58,115.3,76,"F","W",4,24.0950951248514,1997-08-15 00:00:00,2021-03-31 13:06:00,66,2131,NA,NA,NA,"Teriparatide 20 Mcg/Dose (600 Mcg/2.4 Ml) Subcutaneous Pen Injector"
"318","1526036","Dual-energy X-ray absorptiometry (DXA), bone density study, 1 or more sites; axial skeleton (eg, hips, pelvis, spine)",2019-09-27 14:59:00,2004-05-04 00:00:00,"829.0","Fracture of unspecified bone, closed",58,115.3,76,"F","W",4,24.0950951248514,1997-08-15 00:00:00,2021-03-31 13:06:00,66,2131,NA,NA,NA,"Teriparatide 20 Mcg/Dose (600 Mcg/2.4 Ml) Subcutaneous Pen Injector"
"319","1526890","Dual-energy X-ray absorptiometry (DXA), bone density study, 1 or more sites; axial skeleton (eg, hips, pelvis, spine)",2021-03-22 11:39:00,2019-11-16 16:24:00,"820.8","Closed fracture of unspecified part of neck of femur",68,172.9,45,"F","W",4,26.2864835640138,2006-07-21 00:00:00,2021-03-25 15:28:00,777,1248,NA,NA,NA,NA
"320","1535154","Dual-energy X-ray absorptiometry (DXA), bone density study, 1 or more sites; axial skeleton (eg, hips, pelvis, spine)",2014-07-03 10:02:00,2014-05-29 00:00:00,"M81.0","Age-related osteoporosis without current pathological fracture",65,266.2,87,"F","W",3,44.2931597633136,1996-11-04 00:00:00,2021-03-02 15:04:00,215,107,NA,NA,NA,NA
"321","1535154","Dual-energy X-ray absorptiometry (DXA), bone density study, 1 or more sites; axial skeleton (eg, hips, pelvis, spine)",2014-07-03 10:26:00,2014-05-29 00:00:00,"M81.0","Age-related osteoporosis without current pathological fracture",65,266.2,87,"F","W",3,44.2931597633136,1996-11-04 00:00:00,2021-03-02 15:04:00,215,107,NA,NA,NA,NA
"322","1536106","Dual-energy X-ray absorptiometry (DXA), bone density study, 1 or more sites; axial skeleton (eg, hips, pelvis, spine)",2017-03-30 08:55:00,2017-03-23 00:00:00,"M80.052D","Age-related osteoporosis with current pathological fracture, left femur, subsequent encounter for fracture with routine healing",60,115.7,85,"F","W",2,22.5936388888889,2009-07-14 00:00:00,2021-03-08 09:54:00,24,171,NA,NA,NA,NA
"323","1536850","Dual-energy X-ray absorptiometry (DXA), bone density study, 1 or more sites; axial skeleton (eg, hips, pelvis, spine)",2008-09-25 00:00:00,2005-10-04 00:00:00,"733.11","Pathologic fracture of humerus",59.99,126.99,63,"F","B",3,24.8065931753197,1987-09-19 00:59:00,2013-03-08 11:57:00,119,3682,NA,NA,NA,NA
"324","1537169","Dual-energy X-ray absorptiometry (DXA), bone density study, 1 or more sites; axial skeleton (eg, hips, pelvis, spine)",2009-02-05 00:00:00,1999-05-04 00:00:00,"815.00","Closed fracture of metacarpal bone(s), site unspecified",66,162.4,62,"F","W",3,26.2091827364555,1997-08-07 00:00:00,2017-07-05 17:00:00,19,1511,NA,NA,NA,"Denosumab 120 Mg/1.7 Ml (70 Mg/Ml) Subcutaneous Solution"
"325","1537169","Dual-energy X-ray absorptiometry (DXA), bone density study, 1 or more sites; axial skeleton (eg, hips, pelvis, spine)",2011-02-08 00:00:00,1999-05-04 00:00:00,"815.00","Closed fracture of metacarpal bone(s), site unspecified",66,162.4,62,"F","W",3,26.2091827364555,1997-08-07 00:00:00,2017-07-05 17:00:00,19,1511,NA,NA,NA,"Denosumab 120 Mg/1.7 Ml (70 Mg/Ml) Subcutaneous Solution"
"326","1537169","Dual-energy X-ray absorptiometry (DXA), bone density study, 1 or more sites; axial skeleton (eg, hips, pelvis, spine)",2011-02-08 00:00:00,1999-05-04 00:00:00,"815.00","Closed fracture of metacarpal bone(s), site unspecified",66,162.4,62,"F","W",3,26.2091827364555,1997-08-07 00:00:00,2017-07-05 17:00:00,19,1511,NA,NA,NA,"Denosumab 120 Mg/1.7 Ml (70 Mg/Ml) Subcutaneous Solution"
"327","1537169","Dual-energy X-ray absorptiometry (DXA), bone density study, 1 or more sites; appendicular skeleton (peripheral) (eg, radius, wrist, heel)",2011-02-08 00:00:00,1999-05-04 00:00:00,"815.00","Closed fracture of metacarpal bone(s), site unspecified",66,162.4,62,"F","W",3,26.2091827364555,1997-08-07 00:00:00,2017-07-05 17:00:00,19,1511,NA,NA,NA,"Denosumab 120 Mg/1.7 Ml (70 Mg/Ml) Subcutaneous Solution"
"328","1538066","Dual-energy X-ray absorptiometry (DXA), bone density study, 1 or more sites; axial skeleton (eg, hips, pelvis, spine)",2007-10-26 00:00:00,2008-05-09 00:27:00,"733.13","Pathologic fracture of vertebrae",62.992,165,58,"F","B",5,29.2326693524355,1994-08-17 00:00:00,2020-02-19 15:33:00,176,7600,NA,NA,NA,"Zoledronic Acid Ivpb (Beacon)"
"329","1544693","Dual-energy X-ray absorptiometry (DXA), bone density study, 1 or more sites; axial skeleton (eg, hips, pelvis, spine)",2020-02-28 13:48:00,2015-11-19 00:00:00,"805.4","Closed fracture of lumbar vertebra without mention of spinal cord injury",62,290.7,67,"F","W",4,53.1639177939646,1997-08-29 00:00:00,2021-03-01 11:45:00,13,455,NA,NA,NA,"Teriparatide 20 Mcg/Dose (600 Mcg/2.4 Ml) Subcutaneous Pen Injector"
"330","1544693","Dual-energy X-ray absorptiometry (DXA), bone density study, 1 or more sites; axial skeleton (eg, hips, pelvis, spine)",2020-02-28 14:00:00,2015-11-19 00:00:00,"805.4","Closed fracture of lumbar vertebra without mention of spinal cord injury",62,290.7,67,"F","W",4,53.1639177939646,1997-08-29 00:00:00,2021-03-01 11:45:00,13,455,NA,NA,NA,"Teriparatide 20 Mcg/Dose (600 Mcg/2.4 Ml) Subcutaneous Pen Injector"
"331","1546866","Dual-energy X-ray absorptiometry (DXA), bone density study, 1 or more sites; axial skeleton (eg, hips, pelvis, spine)",2013-10-04 10:05:00,2004-10-11 13:00:00,"826.0","Closed fracture of one or more phalanges of foot",64,266.5,74,"F","W",4,45.7396240234375,2001-01-31 10:54:00,2020-01-07 10:24:00,3,1360,NA,NA,NA,"Calcitonin (Salmon) 200 Unit/Actuation Nasal Spray"
"332","1546866","Dual-energy X-ray absorptiometry (DXA), bone density study, 1 or more sites; axial skeleton (eg, hips, pelvis, spine)",2013-10-04 10:08:00,2004-10-11 13:00:00,"826.0","Closed fracture of one or more phalanges of foot",64,266.5,74,"F","W",4,45.7396240234375,2001-01-31 10:54:00,2020-01-07 10:24:00,3,1360,NA,NA,NA,"Calcitonin (Salmon) 200 Unit/Actuation Nasal Spray"
"333","1551013","Dual-energy X-ray absorptiometry (DXA), bone density study, 1 or more sites; axial skeleton (eg, hips, pelvis, spine)",2010-01-25 00:00:00,2004-04-09 00:00:00,"808.2","Closed fracture of pubis",62.008,176,75,"F","W",4,32.1790000968907,1993-10-26 11:02:00,2021-03-29 15:32:00,302,2683,NA,NA,NA,"Alendronate 70 Mg Tablet"
"334","1552454","Dual-energy X-ray absorptiometry (DXA), bone density study, 1 or more sites; axial skeleton (eg, hips, pelvis, spine)",2008-05-22 00:00:00,2007-05-10 00:00:00,"813.42","Other closed fractures of distal end of radius (alone)",66,241.19,71,"F","W",5,38.9248324150597,1991-09-05 09:00:00,2016-12-06 14:51:00,256,1682,NA,NA,NA,"Conjugated Estrogens 0.625 Mg/Gram Vaginal Cream"
"335","1557598","Dual-energy X-ray absorptiometry (DXA), bone density study, 1 or more sites; axial skeleton (eg, hips, pelvis, spine)",2015-02-04 15:00:00,2008-10-30 00:00:00,"805.2","Closed fracture of dorsal [thoracic] vertebra without mention of spinal cord injury",78,195.9,83,"M","W",4,22.6360453648915,1999-09-03 00:00:00,2020-02-10 00:00:00,48,1391,NA,NA,NA,NA
"336","1557598","Dual-energy X-ray absorptiometry (DXA), bone density study, 1 or more sites; axial skeleton (eg, hips, pelvis, spine)",2015-02-04 15:45:00,2008-10-30 00:00:00,"805.2","Closed fracture of dorsal [thoracic] vertebra without mention of spinal cord injury",78,195.9,83,"M","W",4,22.6360453648915,1999-09-03 00:00:00,2020-02-10 00:00:00,48,1391,NA,NA,NA,NA
"337","1560570","Dual-energy X-ray absorptiometry (DXA), bone density study, 1 or more sites; axial skeleton (eg, hips, pelvis, spine)",2009-05-12 00:00:00,2017-12-31 13:18:00,"M80.052A","Age-related osteoporosis with current pathological fracture, left femur, initial encounter for fracture",64,186.5,75,"F","W",3,32.0091552734375,1996-11-06 00:00:00,2021-03-30 08:28:00,502,287,NA,NA,NA,"Alendronate 70 Mg Tablet"
"338","1562982","Dual-energy X-ray absorptiometry (DXA), bone density study, 1 or more sites; axial skeleton (eg, hips, pelvis, spine)",2008-11-18 00:00:00,2013-02-27 00:00:00,"S72.009A","Fracture of unspecified part of neck of unspecified femur, initial encounter for closed fracture",57,84.31,82,"F","W",4,18.242514619883,1995-11-03 18:40:00,2015-01-03 16:25:00,759,505,NA,NA,NA,NA
"339","1562982","Dual-energy X-ray absorptiometry (DXA), bone density study, 1 or more sites; axial skeleton (eg, hips, pelvis, spine)",2007-10-30 00:00:00,2013-02-27 00:00:00,"S72.009A","Fracture of unspecified part of neck of unspecified femur, initial encounter for closed fracture",57,84.31,82,"F","W",4,18.242514619883,1995-11-03 18:40:00,2015-01-03 16:25:00,759,505,NA,NA,NA,NA
"340","1563970","Dual-energy X-ray absorptiometry (DXA), bone density study, 1 or more sites; axial skeleton (eg, hips, pelvis, spine)",2008-06-12 00:00:00,2013-05-18 00:00:00,"821.00","Closed fracture of unspecified part of femur",64,154.5,55,"F","W",3,26.5169677734375,1997-08-28 10:47:00,2013-06-23 21:00:00,275,1085,NA,NA,NA,NA
"341","1565565","Dual-energy X-ray absorptiometry (DXA), bone density study, 1 or more sites; axial skeleton (eg, hips, pelvis, spine)",2009-11-09 00:00:00,2007-12-17 00:00:00,"733.14","Pathologic fracture of neck of femur",65,142.99,75,"F","W",3,23.7921822485207,1996-08-09 13:00:00,2021-03-26 00:00:00,70,1486,NA,NA,NA,"Zoledronic Acid 5 Mg/100 Ml In Mannitol 5 % And Water Intravenous"
"342","1565565","Dual-energy X-ray absorptiometry (DXA), bone density study, 1 or more sites; axial skeleton (eg, hips, pelvis, spine)",2007-10-22 00:00:00,2007-12-17 00:00:00,"733.14","Pathologic fracture of neck of femur",65,142.99,75,"F","W",3,23.7921822485207,1996-08-09 13:00:00,2021-03-26 00:00:00,70,1486,NA,NA,NA,"Zoledronic Acid 5 Mg/100 Ml In Mannitol 5 % And Water Intravenous"
"343","1565565","Dual-energy X-ray absorptiometry (DXA), bone density study, 1 or more sites; axial skeleton (eg, hips, pelvis, spine)",2011-11-10 00:00:00,2007-12-17 00:00:00,"733.14","Pathologic fracture of neck of femur",65,142.99,75,"F","W",3,23.7921822485207,1996-08-09 13:00:00,2021-03-26 00:00:00,70,1486,NA,NA,NA,"Zoledronic Acid 5 Mg/100 Ml In Mannitol 5 % And Water Intravenous"
"344","1565565","Dual-energy X-ray absorptiometry (DXA), bone density study, 1 or more sites; axial skeleton (eg, hips, pelvis, spine)",2011-11-10 00:00:00,2007-12-17 00:00:00,"733.14","Pathologic fracture of neck of femur",65,142.99,75,"F","W",3,23.7921822485207,1996-08-09 13:00:00,2021-03-26 00:00:00,70,1486,NA,NA,NA,"Zoledronic Acid 5 Mg/100 Ml In Mannitol 5 % And Water Intravenous"
"345","1569820","Dual-energy X-ray absorptiometry (DXA), bone density study, 1 or more sites; axial skeleton (eg, hips, pelvis, spine)",2010-02-09 00:00:00,2004-10-20 00:00:00,"802.0","Closed fracture of nasal bones",64,155.4,65,"F","W",4,26.671435546875,1986-03-13 14:02:00,2021-03-29 11:10:00,50,1776,NA,NA,NA,"Zoledronic Acid 5 Mg/100 Ml In Mannitol 5 % And Water Intravenous"
"346","1569820","Dual-energy X-ray absorptiometry (DXA), bone density study, 1 or more sites; axial skeleton (eg, hips, pelvis, spine)",2012-03-19 00:00:00,2004-10-20 00:00:00,"802.0","Closed fracture of nasal bones",64,155.4,65,"F","W",4,26.671435546875,1986-03-13 14:02:00,2021-03-29 11:10:00,50,1776,NA,NA,NA,"Zoledronic Acid 5 Mg/100 Ml In Mannitol 5 % And Water Intravenous"
"347","1569820","Dual-energy X-ray absorptiometry (DXA), bone density study, 1 or more sites; axial skeleton (eg, hips, pelvis, spine)",2012-03-19 00:00:00,2004-10-20 00:00:00,"802.0","Closed fracture of nasal bones",64,155.4,65,"F","W",4,26.671435546875,1986-03-13 14:02:00,2021-03-29 11:10:00,50,1776,NA,NA,NA,"Zoledronic Acid 5 Mg/100 Ml In Mannitol 5 % And Water Intravenous"
"348","1569820","Dual-energy X-ray absorptiometry (DXA), bone density study, 1 or more sites; appendicular skeleton (peripheral) (eg, radius, wrist, heel)",2012-03-19 00:00:00,2004-10-20 00:00:00,"802.0","Closed fracture of nasal bones",64,155.4,65,"F","W",4,26.671435546875,1986-03-13 14:02:00,2021-03-29 11:10:00,50,1776,NA,NA,NA,"Zoledronic Acid 5 Mg/100 Ml In Mannitol 5 % And Water Intravenous"
"349","1569820","Dual-energy X-ray absorptiometry (DXA), bone density study, 1 or more sites; appendicular skeleton (peripheral) (eg, radius, wrist, heel)",2012-03-19 00:00:00,2004-10-20 00:00:00,"802.0","Closed fracture of nasal bones",64,155.4,65,"F","W",4,26.671435546875,1986-03-13 14:02:00,2021-03-29 11:10:00,50,1776,NA,NA,NA,"Zoledronic Acid 5 Mg/100 Ml In Mannitol 5 % And Water Intravenous"
"350","1569820","Dual-energy X-ray absorptiometry (DXA), bone density study, 1 or more sites; axial skeleton (eg, hips, pelvis, spine)",2008-02-07 00:00:00,2004-10-20 00:00:00,"802.0","Closed fracture of nasal bones",64,155.4,65,"F","W",4,26.671435546875,1986-03-13 14:02:00,2021-03-29 11:10:00,50,1776,NA,NA,NA,"Zoledronic Acid 5 Mg/100 Ml In Mannitol 5 % And Water Intravenous"
"351","1573279","Dual-energy X-ray absorptiometry (DXA), bone density study, 1 or more sites; axial skeleton (eg, hips, pelvis, spine)",2010-09-23 00:00:00,2006-11-09 00:00:00,"812.00","Closed fracture of unspecified part of upper end of humerus",59.252,146.5,56,"F","B",5,29.3350559844445,2005-04-12 00:00:00,2021-03-31 17:01:00,97,4606,NA,NA,NA,"Teriparatide 20 Mcg/Dose (600 Mcg/2.4 Ml) Subcutaneous Pen Injector"
"352","1573279","Dual-energy X-ray absorptiometry (DXA), bone density study, 1 or more sites; axial skeleton (eg, hips, pelvis, spine)",2008-04-22 00:00:00,2006-11-09 00:00:00,"812.00","Closed fracture of unspecified part of upper end of humerus",59.252,146.5,56,"F","B",5,29.3350559844445,2005-04-12 00:00:00,2021-03-31 17:01:00,97,4606,NA,NA,NA,"Teriparatide 20 Mcg/Dose (600 Mcg/2.4 Ml) Subcutaneous Pen Injector"
"353","1574490","Dual-energy X-ray absorptiometry (DXA), bone density study, 1 or more sites; axial skeleton (eg, hips, pelvis, spine)",2008-06-23 00:00:00,2010-03-22 00:00:00,"733.13","Pathologic fracture of vertebrae",60.99,122.14,62,"F","B",3,23.0831978481739,1991-08-09 11:18:00,2011-07-14 16:59:00,1064,2478,NA,NA,NA,NA
"354","1574735","Dual-energy X-ray absorptiometry (DXA), bone density study, 1 or more sites; axial skeleton (eg, hips, pelvis, spine)",2008-11-24 00:00:00,2013-12-06 00:00:00,"825.25","Closed fracture of metatarsal bone(s)",68,122.14,64,"F","W",4,18.569294982699,1997-07-15 07:54:00,2021-03-24 17:54:00,511,509,NA,NA,NA,"Conjugated Estrogens 0.625 Mg/Gram Vaginal Cream"
"355","1574735","Dual-energy X-ray absorptiometry (DXA), bone density study, 1 or more sites; axial skeleton (eg, hips, pelvis, spine)",2018-08-17 12:54:00,2013-12-06 00:00:00,"825.25","Closed fracture of metatarsal bone(s)",68,122.14,64,"F","W",4,18.569294982699,1997-07-15 07:54:00,2021-03-24 17:54:00,511,509,NA,NA,NA,"Conjugated Estrogens 0.625 Mg/Gram Vaginal Cream"
"356","1574735","Dual-energy X-ray absorptiometry (DXA), bone density study, 1 or more sites; axial skeleton (eg, hips, pelvis, spine)",2018-08-17 13:00:00,2013-12-06 00:00:00,"825.25","Closed fracture of metatarsal bone(s)",68,122.14,64,"F","W",4,18.569294982699,1997-07-15 07:54:00,2021-03-24 17:54:00,511,509,NA,NA,NA,"Conjugated Estrogens 0.625 Mg/Gram Vaginal Cream"
"357","1574735","Dual-energy X-ray absorptiometry (DXA), bone density study, 1 or more sites; axial skeleton (eg, hips, pelvis, spine)",2020-09-01 09:52:00,2013-12-06 00:00:00,"825.25","Closed fracture of metatarsal bone(s)",68,122.14,64,"F","W",4,18.569294982699,1997-07-15 07:54:00,2021-03-24 17:54:00,511,509,NA,NA,NA,"Conjugated Estrogens 0.625 Mg/Gram Vaginal Cream"
"358","1574735","Dual-energy X-ray absorptiometry (DXA), bone density study, 1 or more sites; axial skeleton (eg, hips, pelvis, spine)",2020-09-01 10:06:00,2013-12-06 00:00:00,"825.25","Closed fracture of metatarsal bone(s)",68,122.14,64,"F","W",4,18.569294982699,1997-07-15 07:54:00,2021-03-24 17:54:00,511,509,NA,NA,NA,"Conjugated Estrogens 0.625 Mg/Gram Vaginal Cream"
"359","1576784","Dual-energy X-ray absorptiometry (DXA), bone density study, 1 or more sites; axial skeleton (eg, hips, pelvis, spine)",2019-10-02 09:42:00,2014-08-29 22:39:00,"807.01","Closed fracture of one rib",65.984,165.7,59,"M","W",5,26.7547289114441,1995-06-26 14:07:00,2021-03-11 14:42:00,187,1824,NA,NA,NA,"Denosumab 60 Mg/Ml Subcutaneous Syringe"
"360","1576784","Dual-energy X-ray absorptiometry (DXA), bone density study, 1 or more sites; axial skeleton (eg, hips, pelvis, spine)",2019-10-02 09:43:00,2014-08-29 22:39:00,"807.01","Closed fracture of one rib",65.984,165.7,59,"M","W",5,26.7547289114441,1995-06-26 14:07:00,2021-03-11 14:42:00,187,1824,NA,NA,NA,"Denosumab 60 Mg/Ml Subcutaneous Syringe"
"361","1576784","Dual-energy X-ray absorptiometry (DXA), bone density study, 1 or more sites; axial skeleton (eg, hips, pelvis, spine)",2020-12-15 10:17:00,2014-08-29 22:39:00,"807.01","Closed fracture of one rib",65.984,165.7,59,"M","W",5,26.7547289114441,1995-06-26 14:07:00,2021-03-11 14:42:00,187,1824,NA,NA,NA,"Denosumab 60 Mg/Ml Subcutaneous Syringe"
"362","1576784","Dual-energy X-ray absorptiometry (DXA), bone density study, 1 or more sites; axial skeleton (eg, hips, pelvis, spine)",2020-12-15 10:20:00,2014-08-29 22:39:00,"807.01","Closed fracture of one rib",65.984,165.7,59,"M","W",5,26.7547289114441,1995-06-26 14:07:00,2021-03-11 14:42:00,187,1824,NA,NA,NA,"Denosumab 60 Mg/Ml Subcutaneous Syringe"
"363","1577106","Dual-energy X-ray absorptiometry (DXA), bone density study, 1 or more sites; axial skeleton (eg, hips, pelvis, spine)",2009-05-20 00:00:00,2013-02-26 00:00:00,"M81.0","Age-related osteoporosis without current pathological fracture",66.5,285.7,67,"F","W",5,45.4174006444683,2003-08-18 00:00:00,2021-03-17 11:16:00,340,2218,NA,NA,NA,"Denosumab 60 Mg/Ml Subcutaneous Syringe"
"364","1582860","Dual-energy X-ray absorptiometry (DXA), bone density study, 1 or more sites; axial skeleton (eg, hips, pelvis, spine)",2011-12-15 00:00:00,2013-01-08 21:23:00,"820.8","Closed fracture of unspecified part of neck of femur",59,143.56,93,"F","W",3,28.9924389543235,1994-06-15 08:00:00,2014-07-18 08:38:00,251,729,NA,NA,NA,NA
"365","1584662","Dual-energy X-ray absorptiometry (DXA), bone density study, 1 or more sites; axial skeleton (eg, hips, pelvis, spine)",2011-04-11 00:00:00,2013-01-07 00:00:00,"M81.0","Age-related osteoporosis without current pathological fracture",64,184.06,74,"F","W",3,31.5903759765625,2002-05-28 00:00:00,2021-03-31 00:00:00,154,946,NA,NA,NA,"Alendronate 35 Mg Tablet"
"366","1587512","Dual-energy X-ray absorptiometry (DXA), bone density study, 1 or more sites; axial skeleton (eg, hips, pelvis, spine)",2007-12-31 00:00:00,2007-04-04 00:00:00,"814.00","Closed fracture of carpal bone, unspecified",64,124.3,65,"F","W",5,21.3337158203125,1991-08-16 02:00:00,2021-03-22 14:27:00,180,4892,NA,NA,NA,"Alendronate 70 Mg Tablet"
"367","1588558","Dual-energy X-ray absorptiometry (DXA), bone density study, 1 or more sites; axial skeleton (eg, hips, pelvis, spine)",2007-03-23 00:00:00,2011-11-15 09:00:00,"808.0","Closed fracture of acetabulum",65,200,80,"F","W",3,33.2781065088757,1995-06-07 14:23:00,2021-03-15 00:00:00,273,1022,NA,NA,NA,"Alendronate 70 Mg Tablet"
"368","1588558","Dual-energy X-ray absorptiometry (DXA), bone density study, 1 or more sites; axial skeleton (eg, hips, pelvis, spine)",2012-01-24 00:00:00,2011-11-15 09:00:00,"808.0","Closed fracture of acetabulum",65,200,80,"F","W",3,33.2781065088757,1995-06-07 14:23:00,2021-03-15 00:00:00,273,1022,NA,NA,NA,"Alendronate 70 Mg Tablet"
"369","1588558","Dual-energy X-ray absorptiometry (DXA), bone density study, 1 or more sites; axial skeleton (eg, hips, pelvis, spine)",2012-01-24 00:00:00,2011-11-15 09:00:00,"808.0","Closed fracture of acetabulum",65,200,80,"F","W",3,33.2781065088757,1995-06-07 14:23:00,2021-03-15 00:00:00,273,1022,NA,NA,NA,"Alendronate 70 Mg Tablet"
"370","1588558","Dual-energy X-ray absorptiometry (DXA), bone density study, 1 or more sites; axial skeleton (eg, hips, pelvis, spine)",2009-06-02 00:00:00,2011-11-15 09:00:00,"808.0","Closed fracture of acetabulum",65,200,80,"F","W",3,33.2781065088757,1995-06-07 14:23:00,2021-03-15 00:00:00,273,1022,NA,NA,NA,"Alendronate 70 Mg Tablet"
"371","1595215","Dual-energy X-ray absorptiometry (DXA), bone density study, 1 or more sites; axial skeleton (eg, hips, pelvis, spine)",2009-10-01 00:00:00,2009-06-22 00:00:00,"820.02","Closed fracture of midcervical section of neck of femur",59,109.4,69,"F","W",4,22.0937087043953,1992-10-09 08:59:00,2017-01-21 18:00:00,84,2070,NA,NA,NA,"Alendronate 70 Mg Tablet"
"372","1595215","Dual-energy X-ray absorptiometry (DXA), bone density study, 1 or more sites; axial skeleton (eg, hips, pelvis, spine)",2011-10-11 00:00:00,2009-06-22 00:00:00,"820.02","Closed fracture of midcervical section of neck of femur",59,109.4,69,"F","W",4,22.0937087043953,1992-10-09 08:59:00,2017-01-21 18:00:00,84,2070,NA,NA,NA,"Alendronate 70 Mg Tablet"
"373","1595215","Dual-energy X-ray absorptiometry (DXA), bone density study, 1 or more sites; axial skeleton (eg, hips, pelvis, spine)",2011-10-11 00:00:00,2009-06-22 00:00:00,"820.02","Closed fracture of midcervical section of neck of femur",59,109.4,69,"F","W",4,22.0937087043953,1992-10-09 08:59:00,2017-01-21 18:00:00,84,2070,NA,NA,NA,"Alendronate 70 Mg Tablet"
"374","1595297","Dual-energy X-ray absorptiometry (DXA), bone density study, 1 or more sites; axial skeleton (eg, hips, pelvis, spine)",2008-08-11 00:00:00,2007-02-26 00:00:00,"813.44","Closed fracture of lower end of radius with ulna",63.5,112.1,58,"F","B",3,19.544001488003,1992-03-20 19:50:00,2021-02-10 14:45:00,64,832,NA,NA,NA,NA
"375","1595297","Dual-energy X-ray absorptiometry (DXA), bone density study, 1 or more sites; axial skeleton (eg, hips, pelvis, spine)",2014-03-21 09:50:00,2007-02-26 00:00:00,"813.44","Closed fracture of lower end of radius with ulna",63.5,112.1,58,"F","B",3,19.544001488003,1992-03-20 19:50:00,2021-02-10 14:45:00,64,832,NA,NA,NA,NA
"376","1595297","Dual-energy X-ray absorptiometry (DXA), bone density study, 1 or more sites; axial skeleton (eg, hips, pelvis, spine)",2014-03-21 09:58:00,2007-02-26 00:00:00,"813.44","Closed fracture of lower end of radius with ulna",63.5,112.1,58,"F","B",3,19.544001488003,1992-03-20 19:50:00,2021-02-10 14:45:00,64,832,NA,NA,NA,NA
"377","1595297","Dual-energy X-ray absorptiometry (DXA), bone density study, 1 or more sites; axial skeleton (eg, hips, pelvis, spine)",2017-05-25 15:30:00,2007-02-26 00:00:00,"813.44","Closed fracture of lower end of radius with ulna",63.5,112.1,58,"F","B",3,19.544001488003,1992-03-20 19:50:00,2021-02-10 14:45:00,64,832,NA,NA,NA,NA
"378","1595297","Dual-energy X-ray absorptiometry (DXA), bone density study, 1 or more sites; axial skeleton (eg, hips, pelvis, spine)",2017-05-25 15:40:00,2007-02-26 00:00:00,"813.44","Closed fracture of lower end of radius with ulna",63.5,112.1,58,"F","B",3,19.544001488003,1992-03-20 19:50:00,2021-02-10 14:45:00,64,832,NA,NA,NA,NA
"379","1595593","Dual-energy X-ray absorptiometry (DXA), bone density study, 1 or more sites; axial skeleton (eg, hips, pelvis, spine)",2008-09-19 00:00:00,2001-11-15 00:00:00,"820.09","Other closed transcervical fracture of neck of femur",65,120.4,69,"F","W",3,20.0334201183432,1994-01-10 13:00:00,2020-06-15 00:00:00,10,1359,NA,NA,NA,"Denosumab 60 Mg/Ml Subcutaneous Syringe"
"380","1595593","Dual-energy X-ray absorptiometry (DXA), bone density study, 1 or more sites; axial skeleton (eg, hips, pelvis, spine)",2011-03-28 00:00:00,2001-11-15 00:00:00,"820.09","Other closed transcervical fracture of neck of femur",65,120.4,69,"F","W",3,20.0334201183432,1994-01-10 13:00:00,2020-06-15 00:00:00,10,1359,NA,NA,NA,"Denosumab 60 Mg/Ml Subcutaneous Syringe"
"381","1595593","Dual-energy X-ray absorptiometry (DXA), bone density study, 1 or more sites; axial skeleton (eg, hips, pelvis, spine)",2011-03-28 00:00:00,2001-11-15 00:00:00,"820.09","Other closed transcervical fracture of neck of femur",65,120.4,69,"F","W",3,20.0334201183432,1994-01-10 13:00:00,2020-06-15 00:00:00,10,1359,NA,NA,NA,"Denosumab 60 Mg/Ml Subcutaneous Syringe"
"382","1596806","Dual-energy X-ray absorptiometry (DXA), bone density study, 1 or more sites; axial skeleton (eg, hips, pelvis, spine)",2009-02-20 00:00:00,2006-05-24 00:00:00,"802.0","Closed fracture of nasal bones",62,149,75,"F","W",4,27.2494797086368,1991-11-12 09:06:00,2020-11-16 00:00:00,61,824,NA,NA,NA,NA
"383","1596806","Dual-energy X-ray absorptiometry (DXA), bone density study, 1 or more sites; axial skeleton (eg, hips, pelvis, spine)",2007-02-26 00:00:00,2006-05-24 00:00:00,"802.0","Closed fracture of nasal bones",62,149,75,"F","W",4,27.2494797086368,1991-11-12 09:06:00,2020-11-16 00:00:00,61,824,NA,NA,NA,NA
"384","1596806","Dual-energy X-ray absorptiometry (DXA), bone density study, 1 or more sites; axial skeleton (eg, hips, pelvis, spine)",2012-03-02 00:00:00,2006-05-24 00:00:00,"802.0","Closed fracture of nasal bones",62,149,75,"F","W",4,27.2494797086368,1991-11-12 09:06:00,2020-11-16 00:00:00,61,824,NA,NA,NA,NA
"385","1596806","Dual-energy X-ray absorptiometry (DXA), bone density study, 1 or more sites; axial skeleton (eg, hips, pelvis, spine)",2012-03-02 00:00:00,2006-05-24 00:00:00,"802.0","Closed fracture of nasal bones",62,149,75,"F","W",4,27.2494797086368,1991-11-12 09:06:00,2020-11-16 00:00:00,61,824,NA,NA,NA,NA
"386","1598891","Dual-energy X-ray absorptiometry (DXA), bone density study, 1 or more sites; axial skeleton (eg, hips, pelvis, spine)",2011-07-26 00:00:00,2011-10-11 00:00:00,"M81.0","Age-related osteoporosis without current pathological fracture",61,134,78,"F","W",4,25.3163128191346,2010-04-06 00:00:00,2021-03-30 00:00:00,18,618,NA,NA,NA,"Teriparatide 20 Mcg/Dose (600 Mcg/2.4 Ml) Subcutaneous Pen Injector"
"387","1598891","Dual-energy X-ray absorptiometry (DXA), bone density study, 1 or more sites; axial skeleton (eg, hips, pelvis, spine)",2015-11-24 11:22:00,2011-10-11 00:00:00,"M81.0","Age-related osteoporosis without current pathological fracture",61,134,78,"F","W",4,25.3163128191346,2010-04-06 00:00:00,2021-03-30 00:00:00,18,618,NA,NA,NA,"Teriparatide 20 Mcg/Dose (600 Mcg/2.4 Ml) Subcutaneous Pen Injector"
"388","1598891","Dual-energy X-ray absorptiometry (DXA), bone density study, 1 or more sites; axial skeleton (eg, hips, pelvis, spine)",2015-11-24 11:34:00,2011-10-11 00:00:00,"M81.0","Age-related osteoporosis without current pathological fracture",61,134,78,"F","W",4,25.3163128191346,2010-04-06 00:00:00,2021-03-30 00:00:00,18,618,NA,NA,NA,"Teriparatide 20 Mcg/Dose (600 Mcg/2.4 Ml) Subcutaneous Pen Injector"
"389","1598891","Dual-energy X-ray absorptiometry (DXA), bone density study, 1 or more sites; axial skeleton (eg, hips, pelvis, spine)",2017-11-28 10:59:00,2011-10-11 00:00:00,"M81.0","Age-related osteoporosis without current pathological fracture",61,134,78,"F","W",4,25.3163128191346,2010-04-06 00:00:00,2021-03-30 00:00:00,18,618,NA,NA,NA,"Teriparatide 20 Mcg/Dose (600 Mcg/2.4 Ml) Subcutaneous Pen Injector"
"390","1598891","Dual-energy X-ray absorptiometry (DXA), bone density study, 1 or more sites; axial skeleton (eg, hips, pelvis, spine)",2017-11-28 11:05:00,2011-10-11 00:00:00,"M81.0","Age-related osteoporosis without current pathological fracture",61,134,78,"F","W",4,25.3163128191346,2010-04-06 00:00:00,2021-03-30 00:00:00,18,618,NA,NA,NA,"Teriparatide 20 Mcg/Dose (600 Mcg/2.4 Ml) Subcutaneous Pen Injector"
"391","1598891","Dual-energy X-ray absorptiometry (DXA), bone density study, 1 or more sites; axial skeleton (eg, hips, pelvis, spine)",2020-07-17 11:00:00,2011-10-11 00:00:00,"M81.0","Age-related osteoporosis without current pathological fracture",61,134,78,"F","W",4,25.3163128191346,2010-04-06 00:00:00,2021-03-30 00:00:00,18,618,NA,NA,NA,"Teriparatide 20 Mcg/Dose (600 Mcg/2.4 Ml) Subcutaneous Pen Injector"
"392","1598891","Dual-energy X-ray absorptiometry (DXA), bone density study, 1 or more sites; axial skeleton (eg, hips, pelvis, spine)",2020-07-17 11:05:00,2011-10-11 00:00:00,"M81.0","Age-related osteoporosis without current pathological fracture",61,134,78,"F","W",4,25.3163128191346,2010-04-06 00:00:00,2021-03-30 00:00:00,18,618,NA,NA,NA,"Teriparatide 20 Mcg/Dose (600 Mcg/2.4 Ml) Subcutaneous Pen Injector"
"393","1599149","Dual-energy X-ray absorptiometry (DXA), bone density study, 1 or more sites; axial skeleton (eg, hips, pelvis, spine)",2011-03-01 00:00:00,2009-11-14 00:00:00,"805.2","Closed fracture of dorsal [thoracic] vertebra without mention of spinal cord injury",64.016,120.3,81,"F","W",3,20.6368726566796,2009-04-29 00:00:00,2013-07-10 09:11:00,538,1562,NA,NA,NA,NA
"394","1599149","Dual-energy X-ray absorptiometry (DXA), bone density study, 1 or more sites; axial skeleton (eg, hips, pelvis, spine)",2011-03-01 00:00:00,2009-11-14 00:00:00,"805.2","Closed fracture of dorsal [thoracic] vertebra without mention of spinal cord injury",64.016,120.3,81,"F","W",3,20.6368726566796,2009-04-29 00:00:00,2013-07-10 09:11:00,538,1562,NA,NA,NA,NA
"395","1599726","Dual-energy X-ray absorptiometry (DXA), bone density study, 1 or more sites; axial skeleton (eg, hips, pelvis, spine)",2009-09-08 00:00:00,2009-08-11 15:50:00,"805.2","Closed fracture of dorsal [thoracic] vertebra without mention of spinal cord injury",59,91.6,73,"F","I",3,18.498937087044,2009-08-11 00:00:00,2021-03-18 11:14:00,1,310,NA,NA,NA,"Denosumab 60 Mg/Ml Subcutaneous Syringe"
"396","1600278","Dual-energy X-ray absorptiometry (DXA), bone density study, 1 or more sites; axial skeleton (eg, hips, pelvis, spine)",2008-07-29 00:00:00,2005-05-26 11:24:00,"824.8","Unspecified fracture of ankle, closed",59.016,147.1,70,"F","W",3,29.6912482971145,1992-01-16 15:02:00,2021-03-31 16:18:00,41,707,NA,NA,NA,"Estrogen receptor positive status [ER+]"
"397","1600278","Dual-energy X-ray absorptiometry (DXA), bone density study, 1 or more sites; appendicular skeleton (peripheral) (eg, radius, wrist, heel)",2008-07-29 00:00:00,2005-05-26 11:24:00,"824.8","Unspecified fracture of ankle, closed",59.016,147.1,70,"F","W",3,29.6912482971145,1992-01-16 15:02:00,2021-03-31 16:18:00,41,707,NA,NA,NA,"Estrogen receptor positive status [ER+]"
"398","1600278","Dual-energy X-ray absorptiometry (DXA), bone density study, 1 or more sites; axial skeleton (eg, hips, pelvis, spine)",2019-02-05 09:37:00,2005-05-26 11:24:00,"824.8","Unspecified fracture of ankle, closed",59.016,147.1,70,"F","W",3,29.6912482971145,1992-01-16 15:02:00,2021-03-31 16:18:00,41,707,NA,NA,NA,"Estrogen receptor positive status [ER+]"
"399","1600278","Dual-energy X-ray absorptiometry (DXA), bone density study, 1 or more sites; axial skeleton (eg, hips, pelvis, spine)",2019-02-05 09:46:00,2005-05-26 11:24:00,"824.8","Unspecified fracture of ankle, closed",59.016,147.1,70,"F","W",3,29.6912482971145,1992-01-16 15:02:00,2021-03-31 16:18:00,41,707,NA,NA,NA,"Estrogen receptor positive status [ER+]"
"400","1600278","Dual-energy X-ray absorptiometry (DXA), bone density study, 1 or more sites; axial skeleton (eg, hips, pelvis, spine)",2020-07-29 13:30:00,2005-05-26 11:24:00,"824.8","Unspecified fracture of ankle, closed",59.016,147.1,70,"F","W",3,29.6912482971145,1992-01-16 15:02:00,2021-03-31 16:18:00,41,707,NA,NA,NA,"Estrogen receptor positive status [ER+]"
"401","1600278","Dual-energy X-ray absorptiometry (DXA), bone density study, 1 or more sites; axial skeleton (eg, hips, pelvis, spine)",2020-07-29 13:35:00,2005-05-26 11:24:00,"824.8","Unspecified fracture of ankle, closed",59.016,147.1,70,"F","W",3,29.6912482971145,1992-01-16 15:02:00,2021-03-31 16:18:00,41,707,NA,NA,NA,"Estrogen receptor positive status [ER+]"
"402","1605249","Dual-energy X-ray absorptiometry (DXA), bone density study, 1 or more sites; axial skeleton (eg, hips, pelvis, spine)",2008-04-21 00:00:00,1993-08-18 21:11:00,"805.00","Closed fracture of cervical vertebra, unspecified level",65,171.3,56,"F","W",3,28.5026982248521,1993-08-18 21:11:00,2021-03-19 00:00:00,0,966,NA,NA,NA,NA
"403","1605249","Dual-energy X-ray absorptiometry (DXA), bone density study, 1 or more sites; appendicular skeleton (peripheral) (eg, radius, wrist, heel)",2008-04-21 00:00:00,1993-08-18 21:11:00,"805.00","Closed fracture of cervical vertebra, unspecified level",65,171.3,56,"F","W",3,28.5026982248521,1993-08-18 21:11:00,2021-03-19 00:00:00,0,966,NA,NA,NA,NA
"404","1605249","Dual-energy X-ray absorptiometry (DXA), bone density study, 1 or more sites; axial skeleton (eg, hips, pelvis, spine)",2010-05-24 00:00:00,1993-08-18 21:11:00,"805.00","Closed fracture of cervical vertebra, unspecified level",65,171.3,56,"F","W",3,28.5026982248521,1993-08-18 21:11:00,2021-03-19 00:00:00,0,966,NA,NA,NA,NA
"405","1605271","Dual-energy X-ray absorptiometry (DXA), bone density study, 1 or more sites; axial skeleton (eg, hips, pelvis, spine)",2007-10-09 00:00:00,2009-03-27 00:00:00,"813.81","Closed fracture of unspecified part of radius (alone)",65,157.13,88,"F","W",3,26.1449443786982,1995-05-10 10:00:00,2016-07-30 22:18:00,64,482,NA,NA,NA,"Alendronate 70 Mg Tablet"
"406","1605900","Dual-energy X-ray absorptiometry (DXA), bone density study, 1 or more sites; axial skeleton (eg, hips, pelvis, spine)",2007-04-25 00:00:00,2012-01-10 00:00:00,"820.21","Closed fracture of intertrochanteric section of neck of femur",64,164.02,82,"F","W",3,28.1508935546875,1994-11-23 11:15:00,2021-03-24 10:34:00,412,975,NA,NA,NA,NA
"407","1606027","Dual-energy X-ray absorptiometry (DXA), bone density study, 1 or more sites; axial skeleton (eg, hips, pelvis, spine)",2017-11-20 11:07:00,2017-10-13 21:22:00,"807.09","Closed fracture of multiple ribs, unspecified",66,214.5,90,"F","W",3,34.6174242424242,2016-05-10 10:29:00,2021-02-11 16:05:00,51,854,NA,NA,NA,"Alendronate 10 Mg Tablet"
"408","1607410","Dual-energy X-ray absorptiometry (DXA), bone density study, 1 or more sites; axial skeleton (eg, hips, pelvis, spine)",2011-07-28 00:00:00,2002-08-17 00:00:00,"816.11","Open fracture of middle or proximal phalanx or phalanges of hand",71,150.5,61,"M","B",4,20.9881967863519,1992-05-15 00:15:00,2019-11-14 14:05:00,22,3232,NA,NA,NA,"Denosumab 120 Mg/1.7 Ml (70 Mg/Ml) Subcutaneous Solution"
"409","1607462","Dual-energy X-ray absorptiometry (DXA), bone density study, 1 or more sites; axial skeleton (eg, hips, pelvis, spine)",2016-10-07 14:07:00,2016-08-07 13:32:00,"733.82","Nonunion of fracture",69,162.4,71,"M","W",4,23.979668136946,2001-08-29 13:00:00,2019-04-10 00:00:00,651,858,NA,NA,NA,"Teriparatide 20 Mcg/Dose (600 Mcg/2.4 Ml) Subcutaneous Pen Injector"
"410","1607462","Dual-energy X-ray absorptiometry (DXA), bone density study, 1 or more sites; axial skeleton (eg, hips, pelvis, spine)",2016-10-07 14:40:00,2016-08-07 13:32:00,"733.82","Nonunion of fracture",69,162.4,71,"M","W",4,23.979668136946,2001-08-29 13:00:00,2019-04-10 00:00:00,651,858,NA,NA,NA,"Teriparatide 20 Mcg/Dose (600 Mcg/2.4 Ml) Subcutaneous Pen Injector"
"411","1607792","Dual-energy X-ray absorptiometry (DXA), bone density study, 1 or more sites; axial skeleton (eg, hips, pelvis, spine)",2009-07-06 00:00:00,2018-08-27 00:00:00,"733.96","Stress fracture of femoral neck",66,195,64,"F","B",4,31.4703856749311,1994-02-15 08:00:00,2021-03-26 00:00:00,11025,3504,NA,NA,NA,"Alendronate 10 Mg Tablet"
"412","1610791","Dual-energy X-ray absorptiometry (DXA), bone density study, 1 or more sites; axial skeleton (eg, hips, pelvis, spine)",2008-11-11 00:00:00,2005-09-28 00:00:00,"733.15","Pathologic fracture of other specified part of femur",73,288.7,51,"M","W",4,38.0852129855508,2004-08-03 00:00:00,2021-03-24 16:14:00,1051,2071,NA,NA,NA,NA
"413","1610791","Dual-energy X-ray absorptiometry (DXA), bone density study, 1 or more sites; axial skeleton (eg, hips, pelvis, spine)",2019-03-25 14:02:00,2005-09-28 00:00:00,"733.15","Pathologic fracture of other specified part of femur",73,288.7,51,"M","W",4,38.0852129855508,2004-08-03 00:00:00,2021-03-24 16:14:00,1051,2071,NA,NA,NA,NA
"414","1610791","Dual-energy X-ray absorptiometry (DXA), bone density study, 1 or more sites; axial skeleton (eg, hips, pelvis, spine)",2019-03-25 14:08:00,2005-09-28 00:00:00,"733.15","Pathologic fracture of other specified part of femur",73,288.7,51,"M","W",4,38.0852129855508,2004-08-03 00:00:00,2021-03-24 16:14:00,1051,2071,NA,NA,NA,NA
"415","1610902","Dual-energy X-ray absorptiometry (DXA), bone density study, 1 or more sites; axial skeleton (eg, hips, pelvis, spine)",2020-09-02 11:33:00,2020-03-06 15:05:00,"M84.352A","Stress fracture, left femur, initial encounter for fracture",61,265.6,53,"F","W",2,50.1791991400161,2016-03-23 08:55:00,2021-03-01 00:00:00,84,44,NA,NA,NA,"Alendronate 70 Mg Tablet"
"416","1613472","Dual-energy X-ray absorptiometry (DXA), bone density study, 1 or more sites; axial skeleton (eg, hips, pelvis, spine)",2011-02-23 00:00:00,2010-08-03 00:00:00,"733.13","Pathologic fracture of vertebrae",64.02,99.2,57,"F","W",3,17.0151451226631,2006-11-29 00:00:00,2015-04-27 00:00:00,6,625,NA,NA,NA,"Zoledronic Acid 4 Mg/5 Ml Intravenous Solution"
"417","1613472","Dual-energy X-ray absorptiometry (DXA), bone density study, 1 or more sites; axial skeleton (eg, hips, pelvis, spine)",2011-02-23 00:00:00,2010-08-03 00:00:00,"733.13","Pathologic fracture of vertebrae",64.02,99.2,57,"F","W",3,17.0151451226631,2006-11-29 00:00:00,2015-04-27 00:00:00,6,625,NA,NA,NA,"Zoledronic Acid 4 Mg/5 Ml Intravenous Solution"
"418","1613736","Dual-energy X-ray absorptiometry (DXA), bone density study, 1 or more sites; axial skeleton (eg, hips, pelvis, spine)",2007-03-14 00:00:00,1992-09-06 18:53:00,"805.2","Closed fracture of dorsal [thoracic] vertebra without mention of spinal cord injury",71,198.7,28,"M","W",4,27.7099980162666,1992-09-05 11:28:00,2019-09-05 09:55:00,2,2666,NA,NA,NA,"Calcitonin (Salmon) 200 Unit/Actuation Nasal Spray"
"419","1613736","Dual-energy X-ray absorptiometry (DXA), bone density study, 1 or more sites; axial skeleton (eg, hips, pelvis, spine)",2015-12-22 08:35:00,1992-09-06 18:53:00,"805.2","Closed fracture of dorsal [thoracic] vertebra without mention of spinal cord injury",71,198.7,28,"M","W",4,27.7099980162666,1992-09-05 11:28:00,2019-09-05 09:55:00,2,2666,NA,NA,NA,"Calcitonin (Salmon) 200 Unit/Actuation Nasal Spray"
"420","1613736","Dual-energy X-ray absorptiometry (DXA), bone density study, 1 or more sites; axial skeleton (eg, hips, pelvis, spine)",2015-12-22 09:02:00,1992-09-06 18:53:00,"805.2","Closed fracture of dorsal [thoracic] vertebra without mention of spinal cord injury",71,198.7,28,"M","W",4,27.7099980162666,1992-09-05 11:28:00,2019-09-05 09:55:00,2,2666,NA,NA,NA,"Calcitonin (Salmon) 200 Unit/Actuation Nasal Spray"
"421","1618178","Dual-energy X-ray absorptiometry (DXA), bone density study, 1 or more sites; axial skeleton (eg, hips, pelvis, spine)",2010-04-28 00:00:00,2012-03-05 00:00:00,"829.0","Fracture of unspecified bone, closed",62,139.2,74,"F","W",4,25.457232049948,2008-09-16 09:58:00,2017-02-01 12:04:00,124,1314,NA,NA,NA,NA
"422","1620996","Dual-energy X-ray absorptiometry (DXA), bone density study, 1 or more sites; axial skeleton (eg, hips, pelvis, spine)",2016-11-30 13:42:00,2012-09-14 00:00:00,"M81.0","Age-related osteoporosis without current pathological fracture",62,261,71,"F","W",4,47.7323100936524,2010-06-14 00:00:00,2021-03-16 11:04:00,1444,1351,NA,NA,NA,"Ibandronate 150 Mg Tablet"
"423","1620996","Dual-energy X-ray absorptiometry (DXA), bone density study, 1 or more sites; axial skeleton (eg, hips, pelvis, spine)",2016-11-30 14:15:00,2012-09-14 00:00:00,"M81.0","Age-related osteoporosis without current pathological fracture",62,261,71,"F","W",4,47.7323100936524,2010-06-14 00:00:00,2021-03-16 11:04:00,1444,1351,NA,NA,NA,"Ibandronate 150 Mg Tablet"
"424","1620996","Dual-energy X-ray absorptiometry (DXA), bone density study, 1 or more sites; axial skeleton (eg, hips, pelvis, spine)",2019-04-08 12:13:00,2012-09-14 00:00:00,"M81.0","Age-related osteoporosis without current pathological fracture",62,261,71,"F","W",4,47.7323100936524,2010-06-14 00:00:00,2021-03-16 11:04:00,1444,1351,NA,NA,NA,"Ibandronate 150 Mg Tablet"
"425","1620996","Dual-energy X-ray absorptiometry (DXA), bone density study, 1 or more sites; axial skeleton (eg, hips, pelvis, spine)",2019-04-08 12:23:00,2012-09-14 00:00:00,"M81.0","Age-related osteoporosis without current pathological fracture",62,261,71,"F","W",4,47.7323100936524,2010-06-14 00:00:00,2021-03-16 11:04:00,1444,1351,NA,NA,NA,"Ibandronate 150 Mg Tablet"
"426","1620996","Dual-energy X-ray absorptiometry (DXA), bone density study, 1 or more sites; axial skeleton (eg, hips, pelvis, spine)",2020-05-26 12:56:00,2012-09-14 00:00:00,"M81.0","Age-related osteoporosis without current pathological fracture",62,261,71,"F","W",4,47.7323100936524,2010-06-14 00:00:00,2021-03-16 11:04:00,1444,1351,NA,NA,NA,"Ibandronate 150 Mg Tablet"
"427","1620996","Dual-energy X-ray absorptiometry (DXA), bone density study, 1 or more sites; axial skeleton (eg, hips, pelvis, spine)",2020-05-26 13:03:00,2012-09-14 00:00:00,"M81.0","Age-related osteoporosis without current pathological fracture",62,261,71,"F","W",4,47.7323100936524,2010-06-14 00:00:00,2021-03-16 11:04:00,1444,1351,NA,NA,NA,"Ibandronate 150 Mg Tablet"
"428","1637469","Dual-energy X-ray absorptiometry (DXA), bone density study, 1 or more sites; axial skeleton (eg, hips, pelvis, spine)",2014-08-22 09:37:00,2013-02-08 00:00:00,"M81.0","Age-related osteoporosis without current pathological fracture",56,184.4,59,"F","W",5,41.3371173469388,2010-08-10 00:00:00,2020-03-22 12:06:00,391,3832,NA,NA,NA,"Teriparatide 20 Mcg/Dose (600 Mcg/2.4 Ml) Subcutaneous Pen Injector"
"429","1637469","Dual-energy X-ray absorptiometry (DXA), bone density study, 1 or more sites; axial skeleton (eg, hips, pelvis, spine)",2014-08-22 10:24:00,2013-02-08 00:00:00,"M81.0","Age-related osteoporosis without current pathological fracture",56,184.4,59,"F","W",5,41.3371173469388,2010-08-10 00:00:00,2020-03-22 12:06:00,391,3832,NA,NA,NA,"Teriparatide 20 Mcg/Dose (600 Mcg/2.4 Ml) Subcutaneous Pen Injector"
"430","1637469","Dual-energy X-ray absorptiometry (DXA), bone density study, 1 or more sites; axial skeleton (eg, hips, pelvis, spine)",2018-02-23 13:10:00,2013-02-08 00:00:00,"M81.0","Age-related osteoporosis without current pathological fracture",56,184.4,59,"F","W",5,41.3371173469388,2010-08-10 00:00:00,2020-03-22 12:06:00,391,3832,NA,NA,NA,"Teriparatide 20 Mcg/Dose (600 Mcg/2.4 Ml) Subcutaneous Pen Injector"
"431","1637469","Dual-energy X-ray absorptiometry (DXA), bone density study, 1 or more sites; axial skeleton (eg, hips, pelvis, spine)",2018-02-23 13:30:00,2013-02-08 00:00:00,"M81.0","Age-related osteoporosis without current pathological fracture",56,184.4,59,"F","W",5,41.3371173469388,2010-08-10 00:00:00,2020-03-22 12:06:00,391,3832,NA,NA,NA,"Teriparatide 20 Mcg/Dose (600 Mcg/2.4 Ml) Subcutaneous Pen Injector"
"432","1703113","Dual-energy X-ray absorptiometry (DXA), bone density study, 1 or more sites; axial skeleton (eg, hips, pelvis, spine)",2021-01-27 09:28:00,2020-11-16 00:00:00,"905.3","Late effect of fracture of neck of femur",63,190.9,49,"F","W",3,33.8127236079617,2011-02-28 00:00:00,2021-03-31 14:47:00,173,181,NA,NA,NA,NA
"433","1706132","Dual-energy X-ray absorptiometry (DXA), bone density study, 1 or more sites; axial skeleton (eg, hips, pelvis, spine)",2015-02-27 11:00:00,2014-12-26 00:00:00,"820.8","Closed fracture of unspecified part of neck of femur",63,156.4,85,"F","W",4,27.7019904257999,2011-02-14 00:00:00,2016-06-01 15:37:00,216,237,NA,NA,NA,NA
"434","1706132","Dual-energy X-ray absorptiometry (DXA), bone density study, 1 or more sites; axial skeleton (eg, hips, pelvis, spine)",2015-02-27 11:14:00,2014-12-26 00:00:00,"820.8","Closed fracture of unspecified part of neck of femur",63,156.4,85,"F","W",4,27.7019904257999,2011-02-14 00:00:00,2016-06-01 15:37:00,216,237,NA,NA,NA,NA
"435","1714680","Dual-energy X-ray absorptiometry (DXA), bone density study, 1 or more sites; axial skeleton (eg, hips, pelvis, spine)",2014-04-14 13:54:00,2011-08-29 00:00:00,"804.36","Closed fractures involving skull or face with other bones, with other and unspecified intracranial hemorrhage, with loss of consciousness of unspecified duration",66,111.3,77,"M","W",4,17.9623278236915,2011-03-09 00:00:00,2016-02-09 00:00:00,14,2711,NA,NA,NA,"Denosumab 60 Mg/Ml Subcutaneous Syringe"
"436","1714680","Dual-energy X-ray absorptiometry (DXA), bone density study, 1 or more sites; axial skeleton (eg, hips, pelvis, spine)",2014-04-14 14:09:00,2011-08-29 00:00:00,"804.36","Closed fractures involving skull or face with other bones, with other and unspecified intracranial hemorrhage, with loss of consciousness of unspecified duration",66,111.3,77,"M","W",4,17.9623278236915,2011-03-09 00:00:00,2016-02-09 00:00:00,14,2711,NA,NA,NA,"Denosumab 60 Mg/Ml Subcutaneous Syringe"
"437","1749072","Dual-energy X-ray absorptiometry (DXA), bone density study, 1 or more sites; axial skeleton (eg, hips, pelvis, spine)",2020-12-23 16:00:00,2011-05-12 00:00:00,"800.06","Closed fracture of vault of skull without mention of intracranial injury, with loss of consciousness of unspecified duration",69,119.6,56,"M","W",4,17.6599033816425,2011-05-12 00:00:00,2021-03-22 00:00:00,0,272,NA,NA,NA,NA
"438","1763358","Dual-energy X-ray absorptiometry (DXA), bone density study, 1 or more sites; axial skeleton (eg, hips, pelvis, spine)",2017-06-02 13:02:00,2014-01-09 00:00:00,"820.8","Closed fracture of unspecified part of neck of femur",62,125.3,70,"F","W",4,22.9151664932362,2011-10-18 00:00:00,2020-03-06 14:06:00,2,344,NA,NA,NA,"Zoledronic Acid 5 Mg/100 Ml In Mannitol 5 % And Water Intravenous"
"439","1763358","Dual-energy X-ray absorptiometry (DXA), bone density study, 1 or more sites; axial skeleton (eg, hips, pelvis, spine)",2017-06-02 13:36:00,2014-01-09 00:00:00,"820.8","Closed fracture of unspecified part of neck of femur",62,125.3,70,"F","W",4,22.9151664932362,2011-10-18 00:00:00,2020-03-06 14:06:00,2,344,NA,NA,NA,"Zoledronic Acid 5 Mg/100 Ml In Mannitol 5 % And Water Intravenous"
"440","1768627","Dual-energy X-ray absorptiometry (DXA), bone density study, 1 or more sites; axial skeleton (eg, hips, pelvis, spine)",2019-10-23 14:08:00,2020-10-21 00:00:00,"S72.141A","Displaced intertrochanteric fracture of right femur, initial encounter for closed fracture",66,210.5,70,"F","W",4,33.9718778696051,2011-08-15 00:00:00,2021-03-29 00:00:00,200,649,NA,NA,NA,"Denosumab 60 Mg/Ml Subcutaneous Syringe"
"441","1768627","Dual-energy X-ray absorptiometry (DXA), bone density study, 1 or more sites; axial skeleton (eg, hips, pelvis, spine)",2021-03-02 11:41:00,2020-10-21 00:00:00,"S72.141A","Displaced intertrochanteric fracture of right femur, initial encounter for closed fracture",66,210.5,70,"F","W",4,33.9718778696051,2011-08-15 00:00:00,2021-03-29 00:00:00,200,649,NA,NA,NA,"Denosumab 60 Mg/Ml Subcutaneous Syringe"
"442","1769317","Dual-energy X-ray absorptiometry (DXA), bone density study, 1 or more sites; axial skeleton (eg, hips, pelvis, spine)",2021-01-13 13:34:00,2020-09-28 16:38:00,"820.20","Closed fracture of trochanteric section of neck of femur",67,82,78,"M","W",5,12.8416128313656,2011-08-10 11:00:00,2021-03-25 13:41:00,449,440,NA,NA,NA,"Denosumab 60 Mg/Ml Subcutaneous Syringe"
"443","1771758","Dual-energy X-ray absorptiometry (DXA), bone density study, 1 or more sites; axial skeleton (eg, hips, pelvis, spine)",2012-06-13 00:00:00,2014-09-08 18:26:00,"822.0","Closed fracture of patella",62,164.4,70,"F","B",4,30.0658688865765,1974-11-26 00:00:00,2021-03-22 12:55:00,536,3419,NA,NA,NA,NA
"444","1810111","Dual-energy X-ray absorptiometry (DXA), bone density study, 1 or more sites; axial skeleton (eg, hips, pelvis, spine)",2012-01-10 00:00:00,2012-02-17 00:00:00,"733.14","Pathologic fracture of neck of femur",64.98,231,54,"F","W",3,38.4598769931909,2012-01-10 00:00:00,2012-03-01 13:40:00,80,22,NA,NA,NA,NA
"445","1810111","Dual-energy X-ray absorptiometry (DXA), bone density study, 1 or more sites; axial skeleton (eg, hips, pelvis, spine)",2012-01-10 00:00:00,2012-02-17 00:00:00,"733.14","Pathologic fracture of neck of femur",64.98,231,54,"F","W",3,38.4598769931909,2012-01-10 00:00:00,2012-03-01 13:40:00,80,22,NA,NA,NA,NA
"446","1819072","Dual-energy X-ray absorptiometry (DXA), bone density study, 1 or more sites; axial skeleton (eg, hips, pelvis, spine)",2014-06-19 14:00:00,2014-01-20 04:01:00,"812.01","Closed fracture of surgical neck of humerus",63,103.3,80,"F","W",3,18.2967750062988,2012-04-01 00:00:00,2018-08-30 00:00:00,234,521,NA,NA,NA,"Alendronate 35 Mg Tablet"
"447","1819072","Dual-energy X-ray absorptiometry (DXA), bone density study, 1 or more sites; axial skeleton (eg, hips, pelvis, spine)",2014-06-19 14:37:00,2014-01-20 04:01:00,"812.01","Closed fracture of surgical neck of humerus",63,103.3,80,"F","W",3,18.2967750062988,2012-04-01 00:00:00,2018-08-30 00:00:00,234,521,NA,NA,NA,"Alendronate 35 Mg Tablet"
"448","1832155","Dual-energy X-ray absorptiometry (DXA), bone density study, 1 or more sites; axial skeleton (eg, hips, pelvis, spine)",2020-01-15 10:13:00,2019-10-12 16:24:00,"820.8","Closed fracture of unspecified part of neck of femur",69.5,160.8,62,"F","W",3,23.4030122664458,2012-06-19 00:00:00,2020-05-19 09:19:00,61,477,NA,NA,NA,NA
"449","1832155","Dual-energy X-ray absorptiometry (DXA), bone density study, 1 or more sites; axial skeleton (eg, hips, pelvis, spine)",2020-01-15 10:22:00,2019-10-12 16:24:00,"820.8","Closed fracture of unspecified part of neck of femur",69.5,160.8,62,"F","W",3,23.4030122664458,2012-06-19 00:00:00,2020-05-19 09:19:00,61,477,NA,NA,NA,NA
"450","1932453","Dual-energy X-ray absorptiometry (DXA), bone density study, 1 or more sites; axial skeleton (eg, hips, pelvis, spine)",2017-09-29 13:00:00,2017-07-28 00:00:00,"M84.451A","Pathological fracture, right femur, initial encounter for fracture",70.5,185.5,73,"M","W",3,26.2374126049997,2013-03-07 00:00:00,2019-10-22 00:00:00,11,115,NA,NA,NA,NA
"451","1932453","Dual-energy X-ray absorptiometry (DXA), bone density study, 1 or more sites; axial skeleton (eg, hips, pelvis, spine)",2017-09-29 13:29:00,2017-07-28 00:00:00,"M84.451A","Pathological fracture, right femur, initial encounter for fracture",70.5,185.5,73,"M","W",3,26.2374126049997,2013-03-07 00:00:00,2019-10-22 00:00:00,11,115,NA,NA,NA,NA
"452","1953301","Dual-energy X-ray absorptiometry (DXA), bone density study, 1 or more sites; axial skeleton (eg, hips, pelvis, spine)",2020-03-04 13:52:00,2020-03-04 13:52:00,"Z87.81","Personal history of (healed) traumatic fracture",62,150.4,65,"F","W",4,27.5055150884495,2013-10-31 00:00:00,2021-03-31 17:00:00,142,916,NA,NA,NA,NA
"453","1953301","Dual-energy X-ray absorptiometry (DXA), bone density study, 1 or more sites; axial skeleton (eg, hips, pelvis, spine)",2020-03-04 13:59:00,2020-03-04 13:52:00,"Z87.81","Personal history of (healed) traumatic fracture",62,150.4,65,"F","W",4,27.5055150884495,2013-10-31 00:00:00,2021-03-31 17:00:00,142,916,NA,NA,NA,NA
"454","1953534","Dual-energy X-ray absorptiometry (DXA), bone density study, 1 or more sites; axial skeleton (eg, hips, pelvis, spine)",2015-05-11 09:18:00,2015-11-16 00:00:00,"733.96","Stress fracture of femoral neck",59.75,162.4,66,"F","W",3,31.9790479858546,2013-03-25 00:00:00,2021-03-17 08:22:00,113,355,NA,NA,NA,"Conjugated Estrogens 0.625 Mg/Gram Vaginal Cream"
"455","1953534","Dual-energy X-ray absorptiometry (DXA), bone density study, 1 or more sites; axial skeleton (eg, hips, pelvis, spine)",2015-05-11 10:15:00,2015-11-16 00:00:00,"733.96","Stress fracture of femoral neck",59.75,162.4,66,"F","W",3,31.9790479858546,2013-03-25 00:00:00,2021-03-17 08:22:00,113,355,NA,NA,NA,"Conjugated Estrogens 0.625 Mg/Gram Vaginal Cream"
"456","1955865","Dual-energy X-ray absorptiometry (DXA), bone density study, 1 or more sites; axial skeleton (eg, hips, pelvis, spine)",2013-12-13 09:59:00,2013-03-20 23:04:00,"823.00","Closed fracture of upper end of tibia alone",61,132.3,53,"F","W",4,24.9951357162053,2013-03-20 00:00:00,2021-03-22 10:25:00,1,768,NA,NA,NA,"Teriparatide 20 Mcg/Dose (600 Mcg/2.4 Ml) Subcutaneous Pen Injector"
"457","1955865","Dual-energy X-ray absorptiometry (DXA), bone density study, 1 or more sites; axial skeleton (eg, hips, pelvis, spine)",2013-12-13 10:06:00,2013-03-20 23:04:00,"823.00","Closed fracture of upper end of tibia alone",61,132.3,53,"F","W",4,24.9951357162053,2013-03-20 00:00:00,2021-03-22 10:25:00,1,768,NA,NA,NA,"Teriparatide 20 Mcg/Dose (600 Mcg/2.4 Ml) Subcutaneous Pen Injector"
"458","1955865","Dual-energy X-ray absorptiometry (DXA), bone density study, 1 or more sites; axial skeleton (eg, hips, pelvis, spine)",2016-03-22 08:55:00,2013-03-20 23:04:00,"823.00","Closed fracture of upper end of tibia alone",61,132.3,53,"F","W",4,24.9951357162053,2013-03-20 00:00:00,2021-03-22 10:25:00,1,768,NA,NA,NA,"Teriparatide 20 Mcg/Dose (600 Mcg/2.4 Ml) Subcutaneous Pen Injector"
"459","1955865","Dual-energy X-ray absorptiometry (DXA), bone density study, 1 or more sites; axial skeleton (eg, hips, pelvis, spine)",2016-03-22 09:00:00,2013-03-20 23:04:00,"823.00","Closed fracture of upper end of tibia alone",61,132.3,53,"F","W",4,24.9951357162053,2013-03-20 00:00:00,2021-03-22 10:25:00,1,768,NA,NA,NA,"Teriparatide 20 Mcg/Dose (600 Mcg/2.4 Ml) Subcutaneous Pen Injector"
"460","1955865","Dual-energy X-ray absorptiometry (DXA), bone density study, 1 or more sites; axial skeleton (eg, hips, pelvis, spine)",2017-05-12 09:41:00,2013-03-20 23:04:00,"823.00","Closed fracture of upper end of tibia alone",61,132.3,53,"F","W",4,24.9951357162053,2013-03-20 00:00:00,2021-03-22 10:25:00,1,768,NA,NA,NA,"Teriparatide 20 Mcg/Dose (600 Mcg/2.4 Ml) Subcutaneous Pen Injector"
"461","1955865","Dual-energy X-ray absorptiometry (DXA), bone density study, 1 or more sites; axial skeleton (eg, hips, pelvis, spine)",2017-05-12 09:46:00,2013-03-20 23:04:00,"823.00","Closed fracture of upper end of tibia alone",61,132.3,53,"F","W",4,24.9951357162053,2013-03-20 00:00:00,2021-03-22 10:25:00,1,768,NA,NA,NA,"Teriparatide 20 Mcg/Dose (600 Mcg/2.4 Ml) Subcutaneous Pen Injector"
"462","1955865","Dual-energy X-ray absorptiometry (DXA), bone density study, 1 or more sites; axial skeleton (eg, hips, pelvis, spine)",2018-09-11 10:06:00,2013-03-20 23:04:00,"823.00","Closed fracture of upper end of tibia alone",61,132.3,53,"F","W",4,24.9951357162053,2013-03-20 00:00:00,2021-03-22 10:25:00,1,768,NA,NA,NA,"Teriparatide 20 Mcg/Dose (600 Mcg/2.4 Ml) Subcutaneous Pen Injector"
"463","1955865","Dual-energy X-ray absorptiometry (DXA), bone density study, 1 or more sites; axial skeleton (eg, hips, pelvis, spine)",2018-09-11 10:22:00,2013-03-20 23:04:00,"823.00","Closed fracture of upper end of tibia alone",61,132.3,53,"F","W",4,24.9951357162053,2013-03-20 00:00:00,2021-03-22 10:25:00,1,768,NA,NA,NA,"Teriparatide 20 Mcg/Dose (600 Mcg/2.4 Ml) Subcutaneous Pen Injector"
"464","2005919","Dual-energy X-ray absorptiometry (DXA), bone density study, 1 or more sites; axial skeleton (eg, hips, pelvis, spine)",2017-01-23 11:07:00,2016-10-28 13:02:00,"733.14","Pathologic fracture of neck of femur",65,156.4,62,"F","W",3,26.0234792899408,2014-10-03 00:00:00,2021-03-03 10:47:00,11,644,NA,NA,NA,"Teriparatide 20 Mcg/Dose (600 Mcg/2.4 Ml) Subcutaneous Pen Injector"
"465","2005919","Dual-energy X-ray absorptiometry (DXA), bone density study, 1 or more sites; axial skeleton (eg, hips, pelvis, spine)",2017-01-23 11:23:00,2016-10-28 13:02:00,"733.14","Pathologic fracture of neck of femur",65,156.4,62,"F","W",3,26.0234792899408,2014-10-03 00:00:00,2021-03-03 10:47:00,11,644,NA,NA,NA,"Teriparatide 20 Mcg/Dose (600 Mcg/2.4 Ml) Subcutaneous Pen Injector"
"466","2005919","Dual-energy X-ray absorptiometry (DXA), bone density study, 1 or more sites; axial skeleton (eg, hips, pelvis, spine)",2020-11-16 12:28:00,2016-10-28 13:02:00,"733.14","Pathologic fracture of neck of femur",65,156.4,62,"F","W",3,26.0234792899408,2014-10-03 00:00:00,2021-03-03 10:47:00,11,644,NA,NA,NA,"Teriparatide 20 Mcg/Dose (600 Mcg/2.4 Ml) Subcutaneous Pen Injector"
"467","2005919","Dual-energy X-ray absorptiometry (DXA), bone density study, 1 or more sites; axial skeleton (eg, hips, pelvis, spine)",2020-11-16 12:37:00,2016-10-28 13:02:00,"733.14","Pathologic fracture of neck of femur",65,156.4,62,"F","W",3,26.0234792899408,2014-10-03 00:00:00,2021-03-03 10:47:00,11,644,NA,NA,NA,"Teriparatide 20 Mcg/Dose (600 Mcg/2.4 Ml) Subcutaneous Pen Injector"
"468","2006575","Dual-energy X-ray absorptiometry (DXA), bone density study, 1 or more sites; axial skeleton (eg, hips, pelvis, spine)",2018-01-16 12:50:00,2017-11-10 00:00:00,"S72.141A","Displaced intertrochanteric fracture of right femur, initial encounter for closed fracture",61,143.3,56,"F","W",5,27.0733404998656,2015-09-02 00:00:00,2021-03-22 00:00:00,33,246,NA,NA,NA,"Alendronate 70 Mg Tablet"
"469","2006575","Dual-energy X-ray absorptiometry (DXA), bone density study, 1 or more sites; axial skeleton (eg, hips, pelvis, spine)",2018-01-16 13:12:00,2017-11-10 00:00:00,"S72.141A","Displaced intertrochanteric fracture of right femur, initial encounter for closed fracture",61,143.3,56,"F","W",5,27.0733404998656,2015-09-02 00:00:00,2021-03-22 00:00:00,33,246,NA,NA,NA,"Alendronate 70 Mg Tablet"
"470","2014151","Dual-energy X-ray absorptiometry (DXA), bone density study, 1 or more sites; axial skeleton (eg, hips, pelvis, spine)",2017-02-16 13:43:00,2011-01-27 00:00:00,"M81.0","Age-related osteoporosis without current pathological fracture",62,100.7,81,"F","I",3,18.4162591050989,2008-12-18 00:00:00,2017-02-16 13:43:00,2,611,NA,NA,NA,"Alendronate 70 Mg Tablet"
"471","2014151","Dual-energy X-ray absorptiometry (DXA), bone density study, 1 or more sites; axial skeleton (eg, hips, pelvis, spine)",2017-02-16 13:51:00,2011-01-27 00:00:00,"M81.0","Age-related osteoporosis without current pathological fracture",62,100.7,81,"F","I",3,18.4162591050989,2008-12-18 00:00:00,2017-02-16 13:43:00,2,611,NA,NA,NA,"Alendronate 70 Mg Tablet"
"472","2018960","Dual-energy X-ray absorptiometry (DXA), bone density study, 1 or more sites; axial skeleton (eg, hips, pelvis, spine)",2019-09-25 10:26:00,2019-09-11 00:00:00,"Z87.81","Personal history of (healed) traumatic fracture",70,82.9,76,"M","W",3,11.893612244898,2014-12-24 00:00:00,2021-03-24 00:00:00,188,141,NA,NA,NA,NA
"473","2022771","Dual-energy X-ray absorptiometry (DXA), bone density study, 1 or more sites; axial skeleton (eg, hips, pelvis, spine)",2016-10-05 10:44:00,2018-10-17 00:00:00,"733.96","Stress fracture of femoral neck",62,75.2,82,"F","W",3,13.7527575442248,2014-10-16 00:00:00,2021-03-12 19:35:00,119,174,NA,NA,NA,"Conjugated Estrogens 0.625 Mg/Gram Vaginal Cream"
"474","2022771","Dual-energy X-ray absorptiometry (DXA), bone density study, 1 or more sites; axial skeleton (eg, hips, pelvis, spine)",2016-10-05 11:01:00,2018-10-17 00:00:00,"733.96","Stress fracture of femoral neck",62,75.2,82,"F","W",3,13.7527575442248,2014-10-16 00:00:00,2021-03-12 19:35:00,119,174,NA,NA,NA,"Conjugated Estrogens 0.625 Mg/Gram Vaginal Cream"
"475","2064514","Dual-energy X-ray absorptiometry (DXA), bone density study, 1 or more sites; axial skeleton (eg, hips, pelvis, spine)",2014-04-18 09:40:00,2016-08-08 11:11:00,"M84.511D","Pathological fracture in neoplastic disease, right shoulder, subsequent encounter for fracture with routine healing",65,166.4,60,"F","W",3,27.6873846153846,2013-06-03 00:00:00,2018-03-14 00:00:00,838,1143,NA,NA,NA,"Denosumab 120 Mg/1.7 Ml (70 Mg/Ml) Subcutaneous Solution"
"476","2064514","Dual-energy X-ray absorptiometry (DXA), bone density study, 1 or more sites; axial skeleton (eg, hips, pelvis, spine)",2014-04-18 09:47:00,2016-08-08 11:11:00,"M84.511D","Pathological fracture in neoplastic disease, right shoulder, subsequent encounter for fracture with routine healing",65,166.4,60,"F","W",3,27.6873846153846,2013-06-03 00:00:00,2018-03-14 00:00:00,838,1143,NA,NA,NA,"Denosumab 120 Mg/1.7 Ml (70 Mg/Ml) Subcutaneous Solution"
"477","2084369","Dual-energy X-ray absorptiometry (DXA), bone density study, 1 or more sites; axial skeleton (eg, hips, pelvis, spine)",2016-09-08 13:26:00,2018-08-07 06:31:00,"M80.051A","Age-related osteoporosis with current pathological fracture, right femur, initial encounter for fracture",65.984,169.1,68,"F","I",4,27.3037094684683,2014-12-10 00:00:00,2018-08-19 12:00:00,1082,500,NA,NA,NA,NA
"478","2084369","Dual-energy X-ray absorptiometry (DXA), bone density study, 1 or more sites; axial skeleton (eg, hips, pelvis, spine)",2016-09-08 13:36:00,2018-08-07 06:31:00,"M80.051A","Age-related osteoporosis with current pathological fracture, right femur, initial encounter for fracture",65.984,169.1,68,"F","I",4,27.3037094684683,2014-12-10 00:00:00,2018-08-19 12:00:00,1082,500,NA,NA,NA,NA
"479","2096350","Dual-energy X-ray absorptiometry (DXA), bone density study, 1 or more sites; axial skeleton (eg, hips, pelvis, spine)",2019-04-09 14:43:00,2019-01-05 03:53:00,"733.14","Pathologic fracture of neck of femur",68,220.9,69,"M","B",4,33.5840614186851,2013-10-17 00:00:00,2020-10-01 19:00:00,30,445,NA,NA,NA,NA
"480","2311783","Dual-energy X-ray absorptiometry (DXA), bone density study, 1 or more sites; axial skeleton (eg, hips, pelvis, spine)",2014-04-22 13:45:00,2013-12-24 12:53:00,"812.01","Closed fracture of surgical neck of humerus",70,158.4,64,"F","W",5,22.7255510204082,2013-12-24 00:00:00,2021-03-30 00:00:00,1,382,NA,NA,NA,NA
"481","2311783","Dual-energy X-ray absorptiometry (DXA), bone density study, 1 or more sites; axial skeleton (eg, hips, pelvis, spine)",2014-04-22 13:50:00,2013-12-24 12:53:00,"812.01","Closed fracture of surgical neck of humerus",70,158.4,64,"F","W",5,22.7255510204082,2013-12-24 00:00:00,2021-03-30 00:00:00,1,382,NA,NA,NA,NA
"482","2377555","Dual-energy X-ray absorptiometry (DXA), bone density study, 1 or more sites; axial skeleton (eg, hips, pelvis, spine)",2015-01-23 09:49:00,2014-05-05 00:00:00,"M81.0","Age-related osteoporosis without current pathological fracture",65,278.7,76,"F","W",4,46.3730414201183,2014-04-25 00:00:00,2021-03-08 00:00:00,3,683,NA,NA,NA,"Teriparatide 20 Mcg/Dose (600 Mcg/2.4 Ml) Subcutaneous Pen Injector"
"483","2377555","Dual-energy X-ray absorptiometry (DXA), bone density study, 1 or more sites; axial skeleton (eg, hips, pelvis, spine)",2015-01-23 09:55:00,2014-05-05 00:00:00,"M81.0","Age-related osteoporosis without current pathological fracture",65,278.7,76,"F","W",4,46.3730414201183,2014-04-25 00:00:00,2021-03-08 00:00:00,3,683,NA,NA,NA,"Teriparatide 20 Mcg/Dose (600 Mcg/2.4 Ml) Subcutaneous Pen Injector"
"484","2377555","Dual-energy X-ray absorptiometry (DXA), bone density study, 1 or more sites; axial skeleton (eg, hips, pelvis, spine)",2017-01-19 14:55:00,2014-05-05 00:00:00,"M81.0","Age-related osteoporosis without current pathological fracture",65,278.7,76,"F","W",4,46.3730414201183,2014-04-25 00:00:00,2021-03-08 00:00:00,3,683,NA,NA,NA,"Teriparatide 20 Mcg/Dose (600 Mcg/2.4 Ml) Subcutaneous Pen Injector"
"485","2377555","Dual-energy X-ray absorptiometry (DXA), bone density study, 1 or more sites; axial skeleton (eg, hips, pelvis, spine)",2017-01-19 15:45:00,2014-05-05 00:00:00,"M81.0","Age-related osteoporosis without current pathological fracture",65,278.7,76,"F","W",4,46.3730414201183,2014-04-25 00:00:00,2021-03-08 00:00:00,3,683,NA,NA,NA,"Teriparatide 20 Mcg/Dose (600 Mcg/2.4 Ml) Subcutaneous Pen Injector"
"486","2377555","Dual-energy X-ray absorptiometry (DXA), bone density study, 1 or more sites; axial skeleton (eg, hips, pelvis, spine)",2019-04-16 08:59:00,2014-05-05 00:00:00,"M81.0","Age-related osteoporosis without current pathological fracture",65,278.7,76,"F","W",4,46.3730414201183,2014-04-25 00:00:00,2021-03-08 00:00:00,3,683,NA,NA,NA,"Teriparatide 20 Mcg/Dose (600 Mcg/2.4 Ml) Subcutaneous Pen Injector"
"487","2377555","Dual-energy X-ray absorptiometry (DXA), bone density study, 1 or more sites; axial skeleton (eg, hips, pelvis, spine)",2019-04-16 09:00:00,2014-05-05 00:00:00,"M81.0","Age-related osteoporosis without current pathological fracture",65,278.7,76,"F","W",4,46.3730414201183,2014-04-25 00:00:00,2021-03-08 00:00:00,3,683,NA,NA,NA,"Teriparatide 20 Mcg/Dose (600 Mcg/2.4 Ml) Subcutaneous Pen Injector"
"488","2377555","Dual-energy X-ray absorptiometry (DXA), bone density study, 1 or more sites; axial skeleton (eg, hips, pelvis, spine)",2020-06-12 09:00:00,2014-05-05 00:00:00,"M81.0","Age-related osteoporosis without current pathological fracture",65,278.7,76,"F","W",4,46.3730414201183,2014-04-25 00:00:00,2021-03-08 00:00:00,3,683,NA,NA,NA,"Teriparatide 20 Mcg/Dose (600 Mcg/2.4 Ml) Subcutaneous Pen Injector"
"489","2377555","Dual-energy X-ray absorptiometry (DXA), bone density study, 1 or more sites; axial skeleton (eg, hips, pelvis, spine)",2020-06-12 09:23:00,2014-05-05 00:00:00,"M81.0","Age-related osteoporosis without current pathological fracture",65,278.7,76,"F","W",4,46.3730414201183,2014-04-25 00:00:00,2021-03-08 00:00:00,3,683,NA,NA,NA,"Teriparatide 20 Mcg/Dose (600 Mcg/2.4 Ml) Subcutaneous Pen Injector"
"490","2382275","Dual-energy X-ray absorptiometry (DXA), bone density study, 1 or more sites; axial skeleton (eg, hips, pelvis, spine)",2015-07-24 10:14:00,2016-11-29 00:00:00,"820.8","Closed fracture of unspecified part of neck of femur",66,128.3,89,"F","W",4,20.7058999081726,2014-07-28 00:00:00,2021-03-12 11:46:00,93,331,NA,NA,NA,"Denosumab 60 Mg/Ml Subcutaneous Syringe"
"491","2382275","Dual-energy X-ray absorptiometry (DXA), bone density study, 1 or more sites; axial skeleton (eg, hips, pelvis, spine)",2015-07-24 10:23:00,2016-11-29 00:00:00,"820.8","Closed fracture of unspecified part of neck of femur",66,128.3,89,"F","W",4,20.7058999081726,2014-07-28 00:00:00,2021-03-12 11:46:00,93,331,NA,NA,NA,"Denosumab 60 Mg/Ml Subcutaneous Syringe"
"492","2382275","Dual-energy X-ray absorptiometry (DXA), bone density study, 1 or more sites; axial skeleton (eg, hips, pelvis, spine)",2018-04-24 08:29:00,2016-11-29 00:00:00,"820.8","Closed fracture of unspecified part of neck of femur",66,128.3,89,"F","W",4,20.7058999081726,2014-07-28 00:00:00,2021-03-12 11:46:00,93,331,NA,NA,NA,"Denosumab 60 Mg/Ml Subcutaneous Syringe"
"493","2382275","Dual-energy X-ray absorptiometry (DXA), bone density study, 1 or more sites; axial skeleton (eg, hips, pelvis, spine)",2018-04-24 08:58:00,2016-11-29 00:00:00,"820.8","Closed fracture of unspecified part of neck of femur",66,128.3,89,"F","W",4,20.7058999081726,2014-07-28 00:00:00,2021-03-12 11:46:00,93,331,NA,NA,NA,"Denosumab 60 Mg/Ml Subcutaneous Syringe"
"494","2382275","Dual-energy X-ray absorptiometry (DXA), bone density study, 1 or more sites; axial skeleton (eg, hips, pelvis, spine)",2019-05-30 12:43:00,2016-11-29 00:00:00,"820.8","Closed fracture of unspecified part of neck of femur",66,128.3,89,"F","W",4,20.7058999081726,2014-07-28 00:00:00,2021-03-12 11:46:00,93,331,NA,NA,NA,"Denosumab 60 Mg/Ml Subcutaneous Syringe"
"495","2382275","Dual-energy X-ray absorptiometry (DXA), bone density study, 1 or more sites; axial skeleton (eg, hips, pelvis, spine)",2019-05-30 12:58:00,2016-11-29 00:00:00,"820.8","Closed fracture of unspecified part of neck of femur",66,128.3,89,"F","W",4,20.7058999081726,2014-07-28 00:00:00,2021-03-12 11:46:00,93,331,NA,NA,NA,"Denosumab 60 Mg/Ml Subcutaneous Syringe"
"496","2472204","Dual-energy X-ray absorptiometry (DXA), bone density study, 1 or more sites; axial skeleton (eg, hips, pelvis, spine)",2019-04-02 10:03:00,2019-02-04 09:42:00,"733.14","Pathologic fracture of neck of femur",60,341.8,85,"F","W",3,66.7459444444444,2015-06-13 00:00:00,2021-03-30 00:00:00,66,1094,NA,NA,NA,"Risedronate 150 Mg Tablet"
"497","2570279","Dual-energy X-ray absorptiometry (DXA), bone density study, 1 or more sites; axial skeleton (eg, hips, pelvis, spine)",2015-07-14 11:30:00,2015-03-07 00:00:00,"820.21","Closed fracture of intertrochanteric section of neck of femur",62,158.3,86,"F","W",3,28.9502861602497,2015-03-07 00:00:00,2021-03-30 00:00:00,0,1478,NA,NA,NA,NA
"498","2570279","Dual-energy X-ray absorptiometry (DXA), bone density study, 1 or more sites; axial skeleton (eg, hips, pelvis, spine)",2015-07-14 11:42:00,2015-03-07 00:00:00,"820.21","Closed fracture of intertrochanteric section of neck of femur",62,158.3,86,"F","W",3,28.9502861602497,2015-03-07 00:00:00,2021-03-30 00:00:00,0,1478,NA,NA,NA,NA
"499","2592897","Dual-energy X-ray absorptiometry (DXA), bone density study, 1 or more sites; axial skeleton (eg, hips, pelvis, spine)",2019-09-13 14:49:00,2015-09-05 23:12:00,"813.42","Other closed fractures of distal end of radius (alone)",67.008,200.1,64,"F","W",3,31.3291853660547,2015-09-05 00:00:00,2021-03-29 00:00:00,2,2134,NA,NA,NA,"Alendronate 70 Mg Tablet"
"500","2592897","Dual-energy X-ray absorptiometry (DXA), bone density study, 1 or more sites; axial skeleton (eg, hips, pelvis, spine)",2019-09-13 14:59:00,2015-09-05 23:12:00,"813.42","Other closed fractures of distal end of radius (alone)",67.008,200.1,64,"F","W",3,31.3291853660547,2015-09-05 00:00:00,2021-03-29 00:00:00,2,2134,NA,NA,NA,"Alendronate 70 Mg Tablet"
"501","2601270","Dual-energy X-ray absorptiometry (DXA), bone density study, 1 or more sites; axial skeleton (eg, hips, pelvis, spine)",2018-12-20 13:22:00,2015-10-18 00:00:00,"S52.502A","Unspecified fracture of the lower end of left radius, initial encounter for closed fracture",63,198,63,"F","W",5,35.0702947845805,2015-10-18 00:00:00,2021-03-11 00:00:00,0,5065,NA,NA,NA,"Zoledronic Acid 5 Mg/100 Ml In Mannitol 5 % And Water Intravenous"
"502","2614685","Dual-energy X-ray absorptiometry (DXA), bone density study, 1 or more sites; axial skeleton (eg, hips, pelvis, spine)",2016-07-20 13:11:00,2015-10-19 00:00:00,"M81.0","Age-related osteoporosis without current pathological fracture",62.21,125.3,65,"F","W",4,22.7607198510234,2015-10-19 00:00:00,2021-02-17 00:00:00,0,449,NA,NA,NA,"Alendronate 70 Mg Tablet"
"503","2614685","Dual-energy X-ray absorptiometry (DXA), bone density study, 1 or more sites; axial skeleton (eg, hips, pelvis, spine)",2016-07-20 13:20:00,2015-10-19 00:00:00,"M81.0","Age-related osteoporosis without current pathological fracture",62.21,125.3,65,"F","W",4,22.7607198510234,2015-10-19 00:00:00,2021-02-17 00:00:00,0,449,NA,NA,NA,"Alendronate 70 Mg Tablet"
"504","2614685","Dual-energy X-ray absorptiometry (DXA), bone density study, 1 or more sites; axial skeleton (eg, hips, pelvis, spine)",2019-02-21 14:51:00,2015-10-19 00:00:00,"M81.0","Age-related osteoporosis without current pathological fracture",62.21,125.3,65,"F","W",4,22.7607198510234,2015-10-19 00:00:00,2021-02-17 00:00:00,0,449,NA,NA,NA,"Alendronate 70 Mg Tablet"
"505","2614685","Dual-energy X-ray absorptiometry (DXA), bone density study, 1 or more sites; axial skeleton (eg, hips, pelvis, spine)",2019-02-21 14:56:00,2015-10-19 00:00:00,"M81.0","Age-related osteoporosis without current pathological fracture",62.21,125.3,65,"F","W",4,22.7607198510234,2015-10-19 00:00:00,2021-02-17 00:00:00,0,449,NA,NA,NA,"Alendronate 70 Mg Tablet"
"506","2704410","Dual-energy X-ray absorptiometry (DXA), bone density study, 1 or more sites; axial skeleton (eg, hips, pelvis, spine)",2019-02-11 14:16:00,2018-10-17 14:38:00,"821.01","Closed fracture of shaft of femur",62,138.3,69,"F","W",3,25.2926378772112,2016-06-15 00:00:00,2021-03-31 00:00:00,42,322,NA,NA,NA,"Denosumab 60 Mg/Ml Subcutaneous Syringe"
"507","2712685","Dual-energy X-ray absorptiometry (DXA), bone density study, 1 or more sites; axial skeleton (eg, hips, pelvis, spine)",2018-08-27 13:30:00,2018-08-29 00:00:00,"733.14","Pathologic fracture of neck of femur",67,162.7,66,"F","W",2,25.4796391178436,2016-05-13 00:00:00,2021-03-24 00:00:00,49,62,NA,NA,NA,"Ibandronate 150 Mg Tablet"
"508","2712685","Dual-energy X-ray absorptiometry (DXA), bone density study, 1 or more sites; axial skeleton (eg, hips, pelvis, spine)",2020-11-24 11:30:00,2018-08-29 00:00:00,"733.14","Pathologic fracture of neck of femur",67,162.7,66,"F","W",2,25.4796391178436,2016-05-13 00:00:00,2021-03-24 00:00:00,49,62,NA,NA,NA,"Ibandronate 150 Mg Tablet"
"509","2714249","Dual-energy X-ray absorptiometry (DXA), bone density study, 1 or more sites; axial skeleton (eg, hips, pelvis, spine)",2018-08-17 09:16:00,2016-06-17 00:00:00,"M81.0","Age-related osteoporosis without current pathological fracture",63,141.3,77,"F","W",4,25.0274376417234,2016-06-16 00:00:00,2021-03-09 09:25:00,2,128,NA,NA,NA,"Denosumab 60 Mg/Ml Subcutaneous Syringe"
"510","2714249","Dual-energy X-ray absorptiometry (DXA), bone density study, 1 or more sites; axial skeleton (eg, hips, pelvis, spine)",2021-03-09 09:25:00,2016-06-17 00:00:00,"M81.0","Age-related osteoporosis without current pathological fracture",63,141.3,77,"F","W",4,25.0274376417234,2016-06-16 00:00:00,2021-03-09 09:25:00,2,128,NA,NA,NA,"Denosumab 60 Mg/Ml Subcutaneous Syringe"
"511","2729225","Dual-energy X-ray absorptiometry (DXA), bone density study, 1 or more sites; axial skeleton (eg, hips, pelvis, spine)",2018-07-10 09:52:00,2018-12-17 00:00:00,"M81.0","Age-related osteoporosis without current pathological fracture",67,158.4,75,"F","W",2,24.8062374693696,2015-03-04 00:00:00,2021-03-31 11:01:00,90,129,NA,NA,NA,"Alendronate 70 Mg Tablet"
"512","2729225","Dual-energy X-ray absorptiometry (DXA), bone density study, 1 or more sites; axial skeleton (eg, hips, pelvis, spine)",2018-07-10 10:00:00,2018-12-17 00:00:00,"M81.0","Age-related osteoporosis without current pathological fracture",67,158.4,75,"F","W",2,24.8062374693696,2015-03-04 00:00:00,2021-03-31 11:01:00,90,129,NA,NA,NA,"Alendronate 70 Mg Tablet"
"513","2729225","Dual-energy X-ray absorptiometry (DXA), bone density study, 1 or more sites; axial skeleton (eg, hips, pelvis, spine)",2020-07-16 15:30:00,2018-12-17 00:00:00,"M81.0","Age-related osteoporosis without current pathological fracture",67,158.4,75,"F","W",2,24.8062374693696,2015-03-04 00:00:00,2021-03-31 11:01:00,90,129,NA,NA,NA,"Alendronate 70 Mg Tablet"
"514","2729225","Dual-energy X-ray absorptiometry (DXA), bone density study, 1 or more sites; axial skeleton (eg, hips, pelvis, spine)",2020-07-16 15:40:00,2018-12-17 00:00:00,"M81.0","Age-related osteoporosis without current pathological fracture",67,158.4,75,"F","W",2,24.8062374693696,2015-03-04 00:00:00,2021-03-31 11:01:00,90,129,NA,NA,NA,"Alendronate 70 Mg Tablet"
"515","4950495","Dual-energy X-ray absorptiometry (DXA), bone density study, 1 or more sites; axial skeleton (eg, hips, pelvis, spine)",2021-02-17 08:50:00,2016-09-12 15:28:00,"805.2","Closed fracture of dorsal [thoracic] vertebra without mention of spinal cord injury",59,113.3,71,"F","W",3,22.8813272048262,2008-07-05 00:00:00,2021-03-23 09:12:00,6,1462,NA,NA,NA,NA
"516","4950495","Dual-energy X-ray absorptiometry (DXA), bone density study, 1 or more sites; axial skeleton (eg, hips, pelvis, spine)",2021-02-17 09:00:00,2016-09-12 15:28:00,"805.2","Closed fracture of dorsal [thoracic] vertebra without mention of spinal cord injury",59,113.3,71,"F","W",3,22.8813272048262,2008-07-05 00:00:00,2021-03-23 09:12:00,6,1462,NA,NA,NA,NA
"517","4950612","Dual-energy X-ray absorptiometry (DXA), bone density study, 1 or more sites; axial skeleton (eg, hips, pelvis, spine)",2016-11-15 09:00:00,2016-09-09 23:33:00,"733.14","Pathologic fracture of neck of femur",72,129.3,60,"M","W",4,17.5343171296296,2016-09-09 00:00:00,2017-02-01 13:56:00,1,272,NA,NA,NA,"Zoledronic Acid 5 Mg/100 Ml In Mannitol 5 % And Water Intravenous"
"518","4950612","Dual-energy X-ray absorptiometry (DXA), bone density study, 1 or more sites; axial skeleton (eg, hips, pelvis, spine)",2016-11-15 09:15:00,2016-09-09 23:33:00,"733.14","Pathologic fracture of neck of femur",72,129.3,60,"M","W",4,17.5343171296296,2016-09-09 00:00:00,2017-02-01 13:56:00,1,272,NA,NA,NA,"Zoledronic Acid 5 Mg/100 Ml In Mannitol 5 % And Water Intravenous"
"519","4962119","Dual-energy X-ray absorptiometry (DXA), bone density study, 1 or more sites; axial skeleton (eg, hips, pelvis, spine)",2019-04-29 11:09:00,2017-02-02 00:00:00,"M81.0","Age-related osteoporosis without current pathological fracture",60,185.4,82,"F","B",3,36.2045,2014-06-07 00:00:00,2021-03-30 15:10:00,25,456,NA,NA,NA,"Zoledronic Acid 5 Mg/100 Ml In Mannitol 5 % And Water Intravenous"
"520","5199143","Dual-energy X-ray absorptiometry (DXA), bone density study, 1 or more sites; axial skeleton (eg, hips, pelvis, spine)",2017-03-21 09:00:00,2017-08-04 20:21:00,"814.00","Closed fracture of carpal bone, unspecified",68,186.5,71,"F","W",4,28.3541306228374,2016-02-29 10:30:00,2021-03-23 13:44:00,34,289,NA,NA,NA,"Denosumab 60 Mg/Ml Subcutaneous Syringe"
"521","5199143","Dual-energy X-ray absorptiometry (DXA), bone density study, 1 or more sites; axial skeleton (eg, hips, pelvis, spine)",2019-04-29 10:50:00,2017-08-04 20:21:00,"814.00","Closed fracture of carpal bone, unspecified",68,186.5,71,"F","W",4,28.3541306228374,2016-02-29 10:30:00,2021-03-23 13:44:00,34,289,NA,NA,NA,"Denosumab 60 Mg/Ml Subcutaneous Syringe"
"522","5281762","Dual-energy X-ray absorptiometry (DXA), bone density study, 1 or more sites; axial skeleton (eg, hips, pelvis, spine)",2020-09-02 15:00:00,2020-01-14 00:00:00,"M84.374A","Stress fracture, right foot, initial encounter for fracture",61,172.4,60,"F","W",4,32.5711367911852,2010-09-06 00:00:00,2021-03-26 00:00:00,365,323,NA,NA,NA,NA
"523","5288312","Dual-energy X-ray absorptiometry (DXA), bone density study, 1 or more sites; axial skeleton (eg, hips, pelvis, spine)",2019-02-26 15:37:00,2016-10-20 10:24:00,"S72.111D","Displaced fracture of greater trochanter of right femur, subsequent encounter for closed fracture with routine healing",59,107.8,69,"F","W",3,21.770583165757,2016-03-15 10:30:00,2021-03-12 00:00:00,29,1335,NA,NA,NA,"Ibandronate 150 Mg Tablet"
"524","5289275","Dual-energy X-ray absorptiometry (DXA), bone density study, 1 or more sites; axial skeleton (eg, hips, pelvis, spine)",2019-11-14 10:50:00,2019-05-07 16:19:00,"733.14","Pathologic fracture of neck of femur",66,110,75,"F","W",4,17.7525252525253,2015-08-16 00:00:00,2021-03-18 00:00:00,42,460,NA,NA,NA,"Alendronate 70 Mg Tablet"
"525","5298714","Dual-energy X-ray absorptiometry (DXA), bone density study, 1 or more sites; axial skeleton (eg, hips, pelvis, spine)",2019-04-29 14:25:00,2018-06-29 03:46:00,"820.8","Closed fracture of unspecified part of neck of femur",62,95.2,72,"F","W",4,17.4104058272633,2016-05-27 14:15:00,2021-03-04 09:13:00,92,1649,NA,NA,NA,"Calcitonin (Salmon) 200 Unit/Actuation Nasal Spray"
"526","5317929","Dual-energy X-ray absorptiometry (DXA), bone density study, 1 or more sites; axial skeleton (eg, hips, pelvis, spine)",2020-08-07 10:00:00,2020-06-17 00:00:00,"733.96","Stress fracture of femoral neck",67,172.4,55,"F","W",3,26.9987079527734,2015-10-03 00:00:00,2021-03-31 09:22:00,77,132,NA,NA,NA,NA
"527","5359326","Dual-energy X-ray absorptiometry (DXA), bone density study, 1 or more sites; axial skeleton (eg, hips, pelvis, spine)",2018-10-24 14:26:00,2017-06-15 00:00:00,"826.0","Closed fracture of one or more phalanges of foot",65,261.8,77,"F","W",5,43.5610414201183,2016-01-13 13:20:00,2021-03-24 00:00:00,54,543,NA,NA,NA,"Alendronate 70 Mg Tablet"
"528","5377412","Dual-energy X-ray absorptiometry (DXA), bone density study, 1 or more sites; axial skeleton (eg, hips, pelvis, spine)",2019-01-24 09:45:00,2018-12-19 17:34:00,"733.14","Pathologic fracture of neck of femur",63.5,143.3,71,"F","W",3,24.9835451670903,2015-12-20 00:00:00,2021-03-15 00:00:00,181,525,NA,NA,NA,"Conjugated Estrogens 0.625 Mg/Gram Vaginal Cream"
"529","5382775","Dual-energy X-ray absorptiometry (DXA), bone density study, 1 or more sites; axial skeleton (eg, hips, pelvis, spine)",2019-10-21 14:54:00,2019-09-06 14:31:00,"733.14","Pathologic fracture of neck of femur",70,203.7,88,"M","W",4,29.2247142857143,2015-05-14 00:00:00,2021-03-16 12:01:00,1154,1922,NA,NA,NA,"Alendronate 70 Mg Tablet"
"530","5393251","Dual-energy X-ray absorptiometry (DXA), bone density study, 1 or more sites; axial skeleton (eg, hips, pelvis, spine)",2020-10-06 09:27:00,2019-11-19 00:00:00,"M84.351A","Stress fracture, right femur, initial encounter for fracture",65.25,160.4,46,"F","W",3,26.4849194815108,2014-04-03 00:00:00,2021-03-22 00:00:00,196,143,NA,NA,NA,NA
"531","5398585","Dual-energy X-ray absorptiometry (DXA), bone density study, 1 or more sites; axial skeleton (eg, hips, pelvis, spine)",2020-08-11 08:07:00,2016-06-16 14:28:00,"S52.502D","Unspecified fracture of the lower end of left radius, subsequent encounter for closed fracture with routine healing",65,123.3,72,"F","W",3,20.5159526627219,2016-06-01 13:51:00,2021-02-19 13:36:00,1,1062,NA,NA,NA,NA
"532","5425212","Dual-energy X-ray absorptiometry (DXA), bone density study, 1 or more sites; axial skeleton (eg, hips, pelvis, spine)",2018-10-16 09:58:00,2017-12-13 00:00:00,"M81.0","Age-related osteoporosis without current pathological fracture",64,210.5,85,"F","W",2,36.1282958984375,2016-01-20 08:30:00,2021-03-18 16:24:00,42,98,NA,NA,NA,"Alendronate 70 Mg Tablet"
"533","5536826","Dual-energy X-ray absorptiometry (DXA), bone density study, 1 or more sites; axial skeleton (eg, hips, pelvis, spine)",2019-11-11 08:31:00,2017-05-10 00:00:00,"805.2","Closed fracture of dorsal [thoracic] vertebra without mention of spinal cord injury",64,115.2,83,"F","W",3,19.771875,2016-03-23 09:00:00,2020-12-13 05:34:00,46,1032,NA,NA,NA,NA
"534","5537895","Dual-energy X-ray absorptiometry (DXA), bone density study, 1 or more sites; axial skeleton (eg, hips, pelvis, spine)",2019-10-07 09:56:00,2019-08-21 04:08:00,"820.8","Closed fracture of unspecified part of neck of femur",66,215.5,80,"F","W",3,34.778810835629,2016-06-24 08:30:00,2021-03-19 11:49:00,35,150,NA,NA,NA,NA
"535","5575470","Dual-energy X-ray absorptiometry (DXA), bone density study, 1 or more sites; axial skeleton (eg, hips, pelvis, spine)",2020-12-07 10:40:00,2017-12-11 00:00:00,"M81.0","Age-related osteoporosis without current pathological fracture",62,135,74,"F","W",3,24.6891259105099,2016-05-19 14:47:00,2021-03-02 14:12:00,27,347,NA,NA,NA,NA
"536","5653383","Dual-energy X-ray absorptiometry (DXA), bone density study, 1 or more sites; axial skeleton (eg, hips, pelvis, spine)",2018-08-24 08:29:00,2018-05-19 11:56:00,"821.01","Closed fracture of shaft of femur",56.5,190.5,61,"F","W",3,41.9520714229775,2016-05-21 14:40:00,2021-03-09 09:00:00,76,238,NA,NA,NA,"Ibandronate 150 Mg Tablet"
"537","5666002","Dual-energy X-ray absorptiometry (DXA), bone density study, 1 or more sites; axial skeleton (eg, hips, pelvis, spine)",2020-02-11 14:30:00,2019-08-16 00:00:00,"905.2","Late effect of fracture of upper extremities",68,134.3,82,"M","W",3,20.4180147058824,2016-05-04 12:30:00,2021-03-03 00:00:00,100,607,NA,NA,NA,"Denosumab 60 Mg/Ml Subcutaneous Syringe"
"538","5692849","Dual-energy X-ray absorptiometry (DXA), bone density study, 1 or more sites; axial skeleton (eg, hips, pelvis, spine)",2019-02-08 14:39:00,2018-06-05 10:00:00,"821.01","Closed fracture of shaft of femur",66,175.6,73,"F","W",3,28.3394857667585,2016-04-04 00:00:00,2021-02-03 00:00:00,76,111,NA,NA,NA,NA
"539","5721622","Dual-energy X-ray absorptiometry (DXA), bone density study, 1 or more sites; axial skeleton (eg, hips, pelvis, spine)",2017-09-18 10:58:00,2017-06-22 00:00:00,"820.8","Closed fracture of unspecified part of neck of femur",67,220.5,64,"F","W",2,34.5314101136111,2015-06-01 00:00:00,2021-01-19 00:00:00,26,201,NA,NA,NA,"Alendronate 70 Mg Tablet"
"540","5781608","Dual-energy X-ray absorptiometry (DXA), bone density study, 1 or more sites; axial skeleton (eg, hips, pelvis, spine)",2020-03-05 10:33:00,2020-07-07 23:07:00,"S72.142A","Displaced intertrochanteric fracture of left femur, initial encounter for closed fracture",63,240.6,78,"F","B",4,42.6157218442933,2017-02-22 00:00:00,2020-11-06 10:33:00,20,287,NA,NA,NA,NA
"541","5911216","Dual-energy X-ray absorptiometry (DXA), bone density study, 1 or more sites; axial skeleton (eg, hips, pelvis, spine)",2020-02-20 13:57:00,2020-01-12 01:22:00,"M80.052A","Age-related osteoporosis with current pathological fracture, left femur, initial encounter for fracture",69,85,73,"M","W",3,12.5509346775887,2008-06-10 00:00:00,2021-03-31 23:48:00,676,3087,NA,NA,NA,NA
"542","5911216","Dual-energy X-ray absorptiometry (DXA), bone density study, 1 or more sites; axial skeleton (eg, hips, pelvis, spine)",2020-02-20 14:02:00,2020-01-12 01:22:00,"M80.052A","Age-related osteoporosis with current pathological fracture, left femur, initial encounter for fracture",69,85,73,"M","W",3,12.5509346775887,2008-06-10 00:00:00,2021-03-31 23:48:00,676,3087,NA,NA,NA,NA
"543","6123083","Dual-energy X-ray absorptiometry (DXA), bone density study, 1 or more sites; axial skeleton (eg, hips, pelvis, spine)",2020-01-21 11:30:00,2019-08-19 00:00:00,"812.01","Closed fracture of surgical neck of humerus",63,163.2,71,"F","W",4,28.9064247921391,2017-11-03 00:00:00,2021-03-29 13:17:00,130,635,NA,NA,NA,NA
"544","6135661","Dual-energy X-ray absorptiometry (DXA), bone density study, 1 or more sites; axial skeleton (eg, hips, pelvis, spine)",2019-09-12 14:24:00,2019-09-30 00:00:00,"M81.0","Age-related osteoporosis without current pathological fracture",68,146.4,69,"F","W",3,22.2576124567474,2017-07-27 00:00:00,2021-03-29 00:00:00,176,100,NA,NA,NA,"Alendronate 70 Mg Tablet"
"545","6274649","Dual-energy X-ray absorptiometry (DXA), bone density study, 1 or more sites; axial skeleton (eg, hips, pelvis, spine)",2016-03-30 11:56:00,2016-03-23 00:00:00,"M81.0","Age-related osteoporosis without current pathological fracture",60,159.3,80,"F","W",3,31.10775,1995-09-09 16:11:00,2019-11-08 00:00:00,132,658,NA,NA,NA,"Ibandronate 150 Mg Tablet"
"546","6274649","Dual-energy X-ray absorptiometry (DXA), bone density study, 1 or more sites; axial skeleton (eg, hips, pelvis, spine)",2016-03-30 12:41:00,2016-03-23 00:00:00,"M81.0","Age-related osteoporosis without current pathological fracture",60,159.3,80,"F","W",3,31.10775,1995-09-09 16:11:00,2019-11-08 00:00:00,132,658,NA,NA,NA,"Ibandronate 150 Mg Tablet"
"547","6471349","Dual-energy X-ray absorptiometry (DXA), bone density study, 1 or more sites; axial skeleton (eg, hips, pelvis, spine)",2019-10-08 09:06:00,2019-08-09 08:57:00,"820.09","Other closed transcervical fracture of neck of femur",66.5,250,77,"F","W",3,39.7422126745435,2019-07-30 00:00:00,2021-01-08 16:55:00,13,383,NA,NA,NA,"Denosumab 60 Mg/Ml Subcutaneous Syringe"
"548","6471349","Dual-energy X-ray absorptiometry (DXA), bone density study, 1 or more sites; axial skeleton (eg, hips, pelvis, spine)",2019-10-08 09:15:00,2019-08-09 08:57:00,"820.09","Other closed transcervical fracture of neck of femur",66.5,250,77,"F","W",3,39.7422126745435,2019-07-30 00:00:00,2021-01-08 16:55:00,13,383,NA,NA,NA,"Denosumab 60 Mg/Ml Subcutaneous Syringe"
"549","6471349","Dual-energy X-ray absorptiometry (DXA), bone density study, 1 or more sites; axial skeleton (eg, hips, pelvis, spine)",2020-11-13 14:18:00,2019-08-09 08:57:00,"820.09","Other closed transcervical fracture of neck of femur",66.5,250,77,"F","W",3,39.7422126745435,2019-07-30 00:00:00,2021-01-08 16:55:00,13,383,NA,NA,NA,"Denosumab 60 Mg/Ml Subcutaneous Syringe"
"550","6471349","Dual-energy X-ray absorptiometry (DXA), bone density study, 1 or more sites; axial skeleton (eg, hips, pelvis, spine)",2020-11-13 14:39:00,2019-08-09 08:57:00,"820.09","Other closed transcervical fracture of neck of femur",66.5,250,77,"F","W",3,39.7422126745435,2019-07-30 00:00:00,2021-01-08 16:55:00,13,383,NA,NA,NA,"Denosumab 60 Mg/Ml Subcutaneous Syringe"
